








A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
Permanent WRAP URL: 




Copyright and reuse:                     
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to cite it. 
Our policy information is available from the repository home page.  
 
































Trisha L. Bailey 
 
A thesis submitted in fulfilment of the 
requirements for the degree of 
Doctor of Philosophy 
 







TABLE OF CONTENTS 
ACKNOWLEDGMENTS .................................................................................................................... vi 
DECLARATIONS ............................................................................................................................. vii 
ABSTRACT ..................................................................................................................................... viii 
ABBREVIATIONS ............................................................................................................................. ix 
LIST OF FIGURES, TABLES, AND EQUATIONS ........................................................................... xii 
1. INTRODUCTION ............................................................................................................................ 1 
 1.1 THE GOAL OF CRYOPRESERVATION ........................................................................ 1 
 1.2 CRYOPRESERVATION STATE-OF-THE-ART ............................................................. 3 
 1.3 BIOLOGICAL LIMITATIONS .......................................................................................... 8 
 1.4 NATURE’S PROTECTION ........................................................................................... 13 
 1.5 AIMS AND OBJECTIVES ............................................................................................. 17 
 1.6 REFERENCES ............................................................................................................. 20 
2. BIOPHYSICAL EFFECTS OF MACROMOLECULAR AND SMALL MOLECULAR 
CRYOPROTECTANTS ..................................................................................................................... 35 
 2.1 DECLARATIONS .......................................................................................................... 35 
 2.2 CHAPTER SUMMARY ................................................................................................. 35 
 2.3 INTRODUCTION .......................................................................................................... 36 
  2.3.1 Synthetic polymers ...................................................................................... 36 
   2.3.1.1 Poly(vinly alcohol) ...................................................................... 36 
   2.3.1.2 Polyproline ................................................................................. 38 
    2.3.1.2.1 Characterisation of polyproline ................................. 38 
   2.3.1.3 Polyampholyte ........................................................................... 40 
    2.3.1.3.1 Characterisation of polyampholyte ........................... 41 
  2.3.2 Osmotic preconditioning .............................................................................. 42 
   2.3.2.1 Alanine ....................................................................................... 43 
   2.3.2.2 Betaine ....................................................................................... 43 
   2.3.2.3 Proline ........................................................................................ 45 
 2.4 RESULTS AND DISCUSSION ..................................................................................... 46 
  2.4.1 Ice recrystallisation inhibition (IRI)  ............................................................. 46 
   2.4.1.1 PVA IRI ...................................................................................... 47 
   2.4.1.2 Polyproline IRI ........................................................................... 48 
   2.4.1.3 Polyampholyte IRI ...................................................................... 49 
 ii 
   2.4.1.4 Compatible osmolyte IRI ............................................................ 50 
  2.4.2 Differential scanning calorimetry ................................................................. 53 
   2.4.2.1 PVA DSC ................................................................................... 54 
   2.4.2.2 Polyproline proline DSC ............................................................. 59 
   2.4.2.3 Polyampholyte DSC ................................................................... 61 
   2.4.2.4 Combined osmolyte PVA DSC .................................................. 66 
 2.5 CONCLUSION .............................................................................................................. 72 
 2.6 MATERIALS AND METHODS ...................................................................................... 73 
2.6.1 Chemical structures .................................................................................... 73 
2.6.2 Reagents and solutions ............................................................................... 73 
   2.6.2.1 Synthesis of polyproline ............................................................. 74 
2.6.2.1.1 Polyproline physical and analytical methods ............ 74 
   2.6.2.2 Synthesis of polyampholyte ....................................................... 75 
2.6.2.2.1 Polyampholyte physical and analytical methods ...... 75 
  2.6.3 Splat assays ................................................................................................ 76 
  2.6.4 Differential scanning calorimetry ................................................................. 76 
  2.6.5 Statistical analysis ....................................................................................... 77 
 2.7 APPENDIX ................................................................................................................... 78 
 2.8 REFERENCES ............................................................................................................. 98 
3. BIOCOMPATIBILITY OF MOLECULAR AND MACROMOLECULAR COMPOUNDS ON A549 
CELLS ............................................................................................................................................ 108 
 3.1 DECLARATIONS ........................................................................................................ 108 
 3.2 CHAPTER SUMMARY ............................................................................................... 108 
 3.3 INTRODUCTION ........................................................................................................ 109 
 3.4 RESULTS AND DISCUSSION ................................................................................... 110 
  3.4.1 Cytotoxicity ................................................................................................ 110 
   3.4.1.1 PVA cytotoxicity ....................................................................... 111 
   3.4.1.2 Polyproline cytotoxicity ............................................................ 112 
   3.4.1.3 Polyampholyte cytotoxicity ....................................................... 113 
   3.4.1.4 Combined osmolyte cytotoxicity .............................................. 114 
  3.4.2 Growth in the presence of osmolytes ........................................................ 116 
 3.5 CONCLUSION ............................................................................................................ 120 
 3.6 MATERIALS AND METHODS .................................................................................... 122 
  3.6.1 Reagents ................................................................................................... 122 
 iii 
  3.6.2 A549 cell culture ........................................................................................ 122 
  3.6.3 Solution preparation .................................................................................. 122 
  3.6.4 Cytotoxicity of compounds ........................................................................ 123 
  3.6.5 Incubation growth assay ........................................................................... 123 
  3.6.6 Incubation recovery growth assay ............................................................. 124 
  3.6.7 Trypan blue assay ..................................................................................... 124 
  3.6.8 Statistical analysis ..................................................................................... 125 
 3.7 APPENDIX ................................................................................................................. 126 
 3.8 REFERENCES ........................................................................................................... 130 
4. MACROMOLECULAR CRYOPROTECTANTS AND OSMOTIC PRECONDITIONING FOR 
ENHANCED MAMMALIAN CELL CRYOPRESERVATION .......................................................... 133 
 4.1 DECLARATIONS ........................................................................................................ 133 
 4.2 CHAPTER SUMMARY ............................................................................................... 133 
 4.3 INTRODUCTION ........................................................................................................ 134 
 4.4 RESULTS AND DISCUSSION ................................................................................... 139 
  4.4.1 Cell cryopreservation ................................................................................ 139 
   4.4.1.1 PVA monolayer freezing .......................................................... 139 
   4.4.1.2 Combined osmolyte PVA A549 monolayer freezing ................ 140 
   4.4.1.3 Primary endometrial proline/PVA suspension freezing ............ 142 
4.4.1.4 Additional immortalized cell monolayer proline PVA variable 
concentration freezing ......................................................................... 147 
4.4.1.4.1 MC-3T3 proline PVA variable concentration 
monolayer freezing ................................................................ 147 
4.4.1.4.2 Neuro-2a proline PVA variable concentration 
monolayer freezing ................................................................ 149 
   4.4.1.5 A549 polyproline monolayer freezing ...................................... 151 
   4.4.1.6 Polyampholyte monolayer cryopreservation ............................ 152 
4.4.1.6.1 A549 polyampholyte molecular weight variable 
concentration monolayer freezing ......................................... 152 
4.4.1.6.2 A549 polyampholyte P2 variable concentration proline 
monolayer freezing  ............................................................... 153 
4.4.1.6.3 A549 polyampholyte P2 reduced DMSO monolayer 
freezing .................................................................................. 154 
 iv 
4.4.1.6.4 MC-3T3 and Neuro-2a polyampholyte P2 variable 
concentration monolayer freezing ......................................... 156 
4.4.2 Post-freeze viability ................................................................................... 157 
4.4.2.1 Osmolyte PVA post-freeze growth rates .................................. 157 
4.4.2.2 Polyproline proline post-freeze growth rates ........................... 160 
4.4.2.3 Polyampholyte post-freeze growth rates ................................. 161 
 4.5 CONCLUSION ............................................................................................................ 162 
 4.6 MATERIALS AND METHODS .................................................................................... 164 
  4.6.1 Reagents ................................................................................................... 164 
  4.6.2 A549 cell culture ........................................................................................ 164 
  4.6.3 Neuro-2a cell culture ................................................................................. 165 
  4.6.4 MC-3T3 cell culture ................................................................................... 165 
  4.6.5 Primary endothelial cell culture ................................................................. 165 
  4.6.6 Solution preparation  ................................................................................. 166 
  4.6.7 Monolayer plate collagen coating .............................................................. 166 
  4.6.8 Cryopreservation of cell monolayers ......................................................... 167 
  4.6.9 Primary endothelial suspension freezing .................................................. 168 
  4.6.10 Post-freeze cell viability assay ................................................................ 168 
  4.6.11 Statistical analysis ................................................................................... 169 
 4.7 APPENDIX ................................................................................................................. 170 
 4.8 REFERENCES ........................................................................................................... 175 
5. IMPACT OF MOLECULAR AND MACROMOLECULAR CRYOPROTECTANTS ON 
MEMBRANE INTEGRITY BEFORE AND AFTER CRYOPRESERVATION ................................. 180 
 5.1 DECLARATIONS ........................................................................................................ 180 
 5.2 CHAPTER SUMMARY ............................................................................................... 180 
 5.3 INTRODUCTION ........................................................................................................ 181 
 5.4 RESULTS AND DISCUSSION ................................................................................... 183 
  5.4.1 Permeability kinetics ................................................................................. 183 
   5.4.1.1 Standard membrane permeability kinetics ............................... 185 
   5.4.1.2 PVA and polyproline membrane permeability kinetics ............. 186 
   5.4.1.3 Polyampholyte membrane permeability kinetics  ..................... 188 
  5.4.2 Osmolyte incubation pre-freezing membrane permeability ....................... 190 
  5.4.3 Post-freeze membrane permeability ......................................................... 193 
   5.4.3.1 Osmolyte PVA post-freeze membrane permeability  ............... 194 
 v 
5.4.3.2 Polyproline post-freeze membrane permeability ..................... 199 
   5.4.3.3 Polyampholyte post-freeze membrane permeability ................ 200 
5.4.4 Polyampholyte phenotype investigation .................................................... 202 
 5.5 CONCLUSIONS ......................................................................................................... 211 
 5.6 MATERIALS AND METHODS .................................................................................... 212 
  5.6.1 Reagents ................................................................................................... 212 
5.6.1.1 Synthesis of fluorescently labelled polyampholytes ................. 212 
  5.6.2 Cell culture ................................................................................................ 213 
  5.6.3 Membrane kinetics assay .......................................................................... 213 
5.6.4 Osmolyte incubation calcein/ethidium homodimer-1 uptake ..................... 213 
5.6.5 Post-freeze membrane calcein/ethidium homodimer-1 uptake ................. 214 
5.6.6 Nile red staining ........................................................................................ 214 
 5.6.6.1 Bright-field nile red staining ..................................................... 214 
5.6.6.2 Confocal nile red staining ........................................................ 214 
5.6.7 Polyampholyte incubation calcein/ethidium homodimer-1 uptake ............ 215 
  5.6.8 Neutral red staining ................................................................................... 216 
5.6.9 Fluorescently labelled polyampholytes ..................................................... 216 
5.6.9.1 Bright-field fluorescent labelled polyampholyte uptake ............ 216 
5.6.9.2 Confocal fluorescent labelled polyampholyte uptake ............... 216 
  5.6.10 Statistical Analysis .................................................................................. 217 
 5.7 APPENDIX ................................................................................................................. 218 
 5.8 REFERENCES ........................................................................................................... 223 
CONCLUSIONS ............................................................................................................................. 227 






I would like to first recognize and thank the contribution of my Ph.D. supervisor, 
Prof Matthew Gibson, your relentless enthusiasm and insights made all this 
achievable and as painless as possible. Furthermore I would like to thank the 
Department of Chemistry and the Molecular Analytical Science (MAS) for taking 
me on and the European Research Council and the Warwick Collaborative 
Postgraduate Research Scholarship for funding my studies throughout, alongside 
the Chemistry tech team, stores staff, Rob Jenkins, Sukhjit Takhar, and Rod 
Wesson, who all solved many problems for me. I would also like to thank Prof 
Jan Brosens and his group at the University Hospitals Coventry and 
Warwickshire for allowing me the opportunity to work with their primary cells. I 
wish to thank Dr Michael Menze for the use of the Biocision CoolCell throughout 
my reserach. I would like to specifically acknowledge Dr Kathryn Murray, our 
paths barely crossed but your constant encouragement, help, and presence were 
a major contributor to this thesis existing, thank you. I also wish to acknowledge 
my appreciation for the support that the members of the Gibson Group as a 
whole have provided, from the Postdocs to the rest of my cohort, this is an 
amazingly kind and knowledgeable group and I am grateful I was a part of it. And 
finally, to Mike, your unwavering support has made the impossible possible, I just 










The work presented in this thesis is entirely my own work, except where 
acknowledged accordingly in the text:  
 
§ All polyampholyte polymers were synthesised and characterised by Dr 
Christopher Stubbs  
§ All polyproline polymers were synthesised and characterised by Dr Ben 
Graham 
§ Confocal imaging assistance was provided by Ruben Tomás 
§ Confocal images were processed solely by Ruben Tomás  
 
I confirm that this thesis has not been submitted for a degree at another 
University. 
 
Parts of the work derived from this thesis have been published by the author. 
 
T. L. Bailey, C. Stubbs, K. Murray, R. M. F. Tomás, L. Otten, and M. I. Gibson, 
“Synthetically Scalable Poly(ampholyte) Which Dramatically Enhances Cellular 
Cryopreservation.,” Biomacromolecules, vol. 20, no. 8, pp. 3104–3114, Aug. 
2019.  
 
B. Graham, T. L. Bailey, J. R. J. Healey, M. Marcellini, S. Deville, and M. I. 
Gibson, “Polyproline as a Minimal Antifreeze Protein Mimic That Enhances the 
Cryopreservation of Cell Monolayers,” Angew. Chemie - Int. Ed., vol. 56, no. 50, 




Complex cell preservation methods, such as attached monolayers, have failed to 
achieve a level of success that would provide insights and pathways for potential 
whole organ preservation. Ice crystal growth during freezing can cause both 
mechanical and osmotic damage to cells, and the ability to control this process by 
using ice recrystallisation inhibitors has been shown to result in enhanced 
cryopreservation outcomes. A variety of antifreeze proteins (AFPs) and antifreeze 
glycoproteins (AFGPs) have been identified in organisms, of which all are ice-
binding proteins that are crucial for the species survival. Three different 
macromolecular cryoprotectants are evaluated: poly(vinyl alcohol) (PVA) due to 
its high ice recrystallisation inhibition activity, polyproline as a possible AF(G)P 
mimic, and a polyampholyte due to its scalable synthesis and precise 1:1 ratio of 
cationic/anionic groups. We also evaluated three potential osmoprotectants: 
alanine due to the heavy alanine rich regions of AF(G)Ps, betaine for its 
osmoprotecting properties, and proline due to its previous use as a 
cryoprotectant and its implications as an osmoprotectant. The macromolecular 
cryoprotectants and small molecule osmolytes were examined for their physical 
interactions with ice (Chapter 2), toxicity and proliferation impacts (Chapter 3), 
the ability to successfully cryopreserve mammalian cells along with post-freeze 
viability (Chapter 4), and finally, the membrane permeability at various steps 
throughout the freezing processes was evaluated (Chapter 5). Only PVA was 
found to have strong ice activity, minimal toxicity was found and proline was 
shown to down-regulate growth, osmolytes plus PVA or polyproline, and 
polyampholyte alone, were found to cryopreserve cell monolayers, and 
polyampholyte showed improved membrane permeability post-freeze. The 
application of these approaches could provide next generation cryopreservation 
strategies for many different cell types. 
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1.1 THE GOAL OF CRYOPRESERVATION 
According to data from the United Network for Organ Sharing (UNOS), as of April 
2020 there are 67,517 people in the United States on the active waiting list for an 
organ.1 The average wait time for a deceased donor kidney transplant is 3-5 
years, and that for heart transplants is 9 months. Each year, more patients are 
placed on waiting lists than receive transplants (about one every 10 minutes), 
causing the wait time to increase. The major limitation of organ transplantation 
involves the organs themselves, as there is a narrow window of time for the safe 
transport of live organs. There is currently no process to indefinitely store organs 
for future use and if a donor cannot be reached in time, the organs will be unable 
to be used. The ability to store organs in a frozen state (cryostorage) would 
mitigate many of the current limitations in organ transplantation. Preservation of 
tissue, the next level of organisation below organs, impacts numerous areas of 
life, such as fertility, biomedical treatment, and forensic analysis, along with 
medical and laboratory research. The effects of successful tissue preservation 
are too vast to list, however one major area of impact, outside the monumental 
medical impact, is animal research. Currently, molecular studies of experimental 
animal tissues must be conducted immediately, resulting in long days with limited 
results per sample, until the tissue is no longer viable.  The ability to preserve all 
the tissue from an animal subject would ease the burden on the researcher along 
with allowing more samples to be obtained from a single subject, resulting in 
fewer animals needed per study. Organisationally below tissues, cells are the 
1 - Introduction 
 2 
chief currency of biological research, with primary cells being the most 
rare/valuable due to their short lifespan, and stem cells are currently emerging as 
the backbone for many revolutionary personalised medical treatments due to 
their programmability. Cell storage currently results in mixed success, with the 
phenotypic impact of frozen/thawed cells still mostly unknown. A method to 
reproducibly and unalterably store cells would result in a reliable and robust 
starting material for an enormous number of bio-medical and research fields. We 
believe a bottom-up approach is the most beneficial to this field; starting with 
methods to reliably store cells and then extrapolate those methods and findings 
to scale up to the more complex networks involved with tissues and then finally, 
potentially organs. 
Temperature is a main focus when talking about cryopreservation and Clark et al. 
succinctly explained the temperature limits for life2 (Fig 1.1), with emphasis on the 
fact that the lower limits for life are essentially unknown.3 Concisely restated from 
their article, all organisms have an optimal temperature (Topt). On either side of 
that temperature, is a temperature for completion of the life cycle (TL), beyond 
that is a temperature for metabolism (TM), and at the ends there exists a 
temperature for survival (TS). Cryobiologists are attempting to move through 
lower temperatures such that we stop the life cycle and metabolism while 
remaining inside the threshold for survival, holding the cells in stasis, yet an 
undamaged and reversible stasis, such that as the temperature is increased, 
each of these functions are wholly recovered. 
 




1.2 CRYOPRESERVATION STATE-OF-THE-ART 
The general principles of organ preservation, static cold storage in a solution to 
reduce metabolic activity,4 were developed over 30 years ago and are still 
standard protocol today. Developed in the 1980s, University of Wisconsin (UW) 
solution remains the gold standard in organ preservation fluid.5 The principal 
components of the UW solution are lactobionate, a large molecular weight anion 
impermeable to most membranes and thought to suppress hypothermia-induced 
cell swelling, raffinose, a trisaccharide, and dexamethasone, a corticosteroid.  
However, UW solution has limitations, principally its incomplete cell protection.6 
The limitations of organ preservation are also seen on lower levels of cell 
organisation, such as tissues. Tissues are more challenging to cryopreserve than 
cells because both cellular integrity and the structure of the extracellular matrix 
must be preserved, which is complicated by the intimate relationship between 
both.7 There is evidence that the core response of cells to cryopreservation is 
different if the cells are part of a tissue and the scale-up of procedures from a 
microscopic cellular level to a macroscopic tissue scale will introduce new modes 
of injury specific to tissue freezing.8 Most studies of freezing injury have been 
Figure. 1.1. Temperature limits for life. TL: temperature limit for completion of 
the life cycle, TM: temperature limit for metabolism, TS: temperature limit for 
survival. Note that TS can be above, at, or below TM. The shaded area shows 
temperature range over which the organism can complete its life cycle, and the 
white areas show the temperature range (upper and lower) for survival. Topt is 
the temperature at which growth rate is maximal, which is typically closer to the 
upper TL than the lower TL. Reprinted from Clarke (2013).2 
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carried out with fairly dilute cell suspensions, whereas densely packed cells, such 
as those seen in tissues, are more likely to be damaged by mechanical stresses 
due to the space within which they are sequestered changing shape as a result of 
recrystallisation of the ice that forms their boundaries.9   
Furthermore, preservation limitations also exist at the cellular level. For the 
cryopreservation of cells, the standard protocol calls for freezing in a solution 
containing 5-10% of the cryoprotective agent (CPA) dimethyl sulfoxide (DMSO), 
which is able to enter cells and at least partly reduce injury by moderating the 
increase in solute concentration during freezing.6,10,11 DMSO, discovered in 1959 
for its cryoprotective properties,12 is a small amphiphilic molecule with a 
hydrophilic sulfoxide and two hydrophobic methyl groups (Fig 1.2). It has been 
shown that a hydrogen bond between DMSO and water is about 30% stronger 
than that between two water molecules13 and this strong hydrogen bonding with 
water is believed to impart its antifreeze characteristics.14 Additionally, it has been 
reported that DMSO reduces membrane rigidity and induces pore formation, a 
process thought to contribute to reduction of mechanical and osmotic stresses 
during cellular swelling and shrinking, as well as during ice formation.15 While 
suspension freezing in DMSO works for most cell lines, certain cells, such as 
macrophage-like, Abelson leukaemia virus transformed cells (RAW 264.7) are 
highly-sensitive to DMSO.16 These cells are commonly used for the study of 
cellular responses to microbes and their products, therefore, the ability to reliably 
store these cells through the use of lower concentrations of DMSO would greatly 
aid the field of immunology. Additionally, there is a universal concern with using 
DMSO due to its toxicity at high concentrations and/or room temperature17–21 as 
well as the potential for osmotic injuries incurred when loading and unloading 
cells in the concentrations required for cryopreservation (frequently at levels of 
10% w/v).22 
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While cells are typically frozen in cryovials, this format has several 
disadvantages. Most notably, the need for the cells to be propagated forward 
through several passages before they are stable enough to be used for 
reproducible assays.  Another disadvantage is that since any in vitro culture will 
undergo phenotypic and genetic changes when propagated for long periods of 
time, it is neither possible nor practical to maintain a constantly growing culture of 
cells in order to supply material reproducibly.23 One answer to this problem is to 
preserve cells as attached monolayers such that all the required cells for an 
assay can be frozen from the same cell passage number and thawed as needed. 
Freezing with just DMSO often protects cells in solution but this method alone 
does not work well for cell monolayers,24 typically resulting in only around 20 – 
35% recovery25,26 and adherent attached human embryonic stem cells yield 
extremely low survival rates of < 5%, which has been shown to be due to 
apoptosis rather than necrosis from freeze-thaw injury.24,25 The ability to 
cryopreserve monolayered cells would facilitate drug development by providing 
phenotypically identical cells for assays as well as provide insights into the 
cryopreservation of more complex biological material such as spheroids or 
tissues. Compared to cryopreservation of suspended cells, protocols for adherent 
cell monolayers are significantly lacking. To date, there have been few studies on 
the cryopreservation of monolayered cells that look at recovery post-thaw (Table 
1.1). Note in the table that recovery is evaluated in different ways and those 
which report the highest levels are typically evaluated immediately after freezing, 
which is not rigorous. At least 24 hours is required to determine if the cells have 
Figure. 1.2. Dimethyl sulfoxide (DMSO) structure. 
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functionally recovered25 and if cells are evaluated before apoptotic processes 
have had a chance to complete, false positives can be obtained. 
 
 
Cell Line Freezing Rate Condition 
DMSO 
% 
Time After Thawing 
to Assessment  Recovery 
HepG227 1 °C·min-1  Trehalose Pre-Incubation 10 24 h 42% 
Primary 
Hepatocytes28 1.2 °C·min
-1  90% (v/v) FCS  10 48 h 79% 
Porcine Aortic 
Endothelial29 0.1 °C·min
-1  TiProtec 10 3 h 38% 
Porcine Aortic 
Endothelial29 0.1 °C·min
-1  Modified TiProtec 10 3 h 50% 
Neuro-2a26 1 °C·min-1  Trehalose + Proline Pre-Incubation 10 24 h 53% 
HeLa30 Directional - 10 5 h 90% 
Caco-230 Directional - 10 5 h 60% 




1 °C·min-1 Virtogel collagen plates 10 6 h 44% 
HUVEC33 Step-graded 2% Chondroitin Sulfate and 6% HES 5 Immediate 97% 
Keratinocytes34 3 °C·min-1  10 wt% HES 0 24 h 29% 
Keratinocytes35 3.3 °C·min-1  10 wt% HES 0 Immediate 80% 




There are two main conventional methods for cryopreservation: vitrification and 
slow cooling (Fig 1.3). Vitrification uses a high concentration of solutes which 
become viscous through the ultra-rapid lowering of temperature and becomes a 
glassy solid while avoiding ice nucleation.36,37 The high CPA concentration results 
in dehydration of the cells and the potential for extreme ice crystal growth exists 
upon thawing.38,39 Additionally, the high concentration of CPA must be quickly 
removed to prevent toxicity,19,40 which can involve challenging and complex 
processes. Due to the high rate of freezing, along with the high CPA 
concentration required to reach a glassy state, vitrification is not wholly practical 
for everyday lab use.41 Slow cooling involves freezing at a controlled rate of 1 
Table 1.1. Cell monolayer cryopreservation publications. 
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°C·min-1 in the presence of a CPA which promotes dehydration to avoid 
intracellular ice formation.42 Cells can be stored short term at -80 °C or moved to 
liquid nitrogen for long-term storage at -196 °C. For both methods, upon thawing, 
ice recrystallisation can damage the cells through the growth of larger ice 
crystals, at the expense of smaller ones, at temperatures close to the freezing 
point of the cryoprotectant solution. This crystal growth can cause both 
mechanical and osmotic damage to cells, and being able to control this process 
by using ice recrystallisation inhibitors has been shown to result in enhanced 
post-thaw recovery43 (further discussed in Section 1.4). In either method, 
membrane damage can occur at any point where there is molecular movement (> 
-80 °C).   
 




1.3 BIOLOGICAL LIMITATIONS 
According to Mazur’s widely accepted two-factor hypothesis, the main limitations 
in cryopreservation are ice formation and osmotic stress due to the addition of 
cryoprotective agents and the increasing concentration of solutes in the 
remaining water phase during the freezing process.44 Extensive evidence 
indicates that ice-formation inside and/or outside of the cell leads to the damage 
that cells experience when exposed to freezing temperatures, and not the cold 
temperature itself.37 Intracellular ice can form when the cooling rate is 
intermediately high and the cell cannot maintain osmotic equilibrium with the 
environment.45 This formation of intracellular ice is almost always lethal. 
Figure 1.3. Schematic showing conventional cryopreservation processes and 
sites of damage. Pathways for vitrification (purple) and slow cooling (black) 
processes are indicated.  
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Intracellular ice formation (IIF) may occur when rates are substantially higher 
than 1 °C·min-1 but are lower than those seen in the ultra-rapid rates used in 
vitirification.45,46 A highly controlled rate of freezing is essential to ensure 
movement of water across the plasma membrane in order for osmotic 
dehydration to reach equilibrium with intracellular and extracellular contents to 
prevent IIF.23,47 It has been demonstrated that the formation of intracellular ice 
may be less harmful to cells in monolayers than for cells frozen in suspension48 
and IIF may be preceded by damage to the plasma membrane thus IIF could be 
a result of cell injury and not the cause.49 Nevertheless, extracellular ice always 
forms prior to intracellular ice10 and as extracellular ice forms, a significant 
increase in the concentration of solutes occurs in the remaining liquid water 
fraction (Fig 1.4A). If the cooling rate is too low, this can lead to extreme 
dehydration that may result in irreversible membrane alterations and cell death 
(Fig 1.4B). However, the optimal cooling rate can vary substantially among cell 
types and depends on the water permeability of the plasma membrane.37  
 




Even with an ideal cooling rate, the formation of extracellular ice results in 
increased extracellular osmotic pressure that creates an osmotic gradient across 
the plasma membrane, which provides the driving force for an efflux of water 
from the cell.49 There must exist a limit to cell dehydration, as a defining feature of 
Figure. 1.4. Temperature impact on cells. A) Schematic of temperature, water, 
and osmolarity of cells. As temperature drops, extracellular water content is 
reduced as ice forms, the cells experience hyperosmotic conditions, which further 
draws water out of the cell. B) Effect of cooling rate on ice formation and 
osmolarity during cellular freezing. Reprinted from Mazur128 Copyright (1977), with 
permission from Elsevier. 
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apoptosis in cells is the apoptotic volume decrease (AVD), which has been 
considered a passive component of the cell death process. Most cells have 
inherent volume regulatory increase (RVI) mechanisms to contest an imposed 
loss in cell size, thus cells exposed to severe shrinkage during freezing will have 
their apoptotic pathways turned on when thawed.50 Autophagy, as well as 
apoptosis, was observed in Chinese hamster ovary (CHO) cells subjected to 
hyperosmolality and additionally induced apoptosis and tau phosphorylation in 
human neuroblastoma cells.51,52 Hyperosmotic stress has been shown to induce 
metacaspase- and mitochondria-dependent apoptosis in Saccharomyces 
cerevisiae and is thought to kills cells by triggering different molecular pathways, 
which converge at the mitochondria where pro- and anti-apoptotic members of 
the Bcl-2 family exert their control.53,54 Additionally, hyperosmotic stress has also 
been implicated in cell cycle arrest, DNA damage, oxidative stress, inhibition of 
transcription and translation, and mitochondrial depolarisation.55 Conversely, 
hyperosmotic treatment has been shown to osmotically precondition 
cardiomyocytes against apoptosis, necrosis,56 and for an ischemic insult.57 It 
appears that hyperosmotic stress has different outcomes based on time 
experienced and to what extreme, as a tolerable amount of hyperosmotic stress 
could be beneficial to cells prior to being exposed to stressful conditions.  
Temperature also has a strong effect on the physical properties of membrane 
lipids. Cellular membranes function universally as barriers between the 
environment, as well as individual cellular components, and play a major role in 
molecule transport and bioenergetics, and are of critical importance in cell 
signalling processes. The bilayer typically exists in what is commonly termed a 
liquid-crystalline phase (a balance between flexibility and order) and at sufficiently 
low temperatures the regions of the bilayer enter what is termed a gel phase. 
However, due the heterogeneity of the bilayer, liquid- and gel-phase regions may 
coexist in the membrane throughout the cooling process, which results in phase 
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separation58 (Fig 1.5). Phase separated membranes have been shown to have an 
increased permeability at the interface of the two regions59 and upon reheating, 
phase separated membranes can form non-bilayer lipid structures, due to lipid 




Cells at low temperatures must also cope with the reduced molecular kinetic 
energy of the environment and the consequent lower rate of many physical 
processes.2 This reduced kinetic energy can limit processes such as ion pumps, 
as dissipation of ion gradients may occur when energy flow is restricted to the 
point that ion transport cannot keep up with passive ion leak. This is known to 
unavoidably trigger the initiation of apoptosis in mammalian species.61   
Temperature reduction also has an impact on the individual proteins within a cell.  
Proteins denature at high (∼60 °C) and low (∼−20 °C) temperatures62–64 and 
when a protein experiences this structural instability it loses its functionality. 
Clathrate cages (particularly ordered structures of water molecules) around non-
polar residues were identified as the crucial structure leading to both types of 
denaturation.65,66 The hydrophobic effect is one of the main driving forces for the 
formation of self-assembled biological structures such as lipid membranes and 
proteins67 and the strength of the hydrophobic interaction decreases with 
decreasing temperature. However, proteins have been shown to quickly refold 
Figure. 1.5. Membrane phase behaviour. Adapted with permission from 
Wolkers et al.129 Copyright (2018) American Chemical Society. 
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following a cold denatured temperature jump as opposed to the slower rate 
following heat denaturation.68,69 
We have presented many avenues for a cell to become damaged during the 
cryopreservation process. From extracellular and intracellular ice, hyperosmotic 
stress, osmotically-triggered apoptosis, membrane disruptions or damage, 
reduced energy production, and protein damage. This seems like an 
overwhelming amount of possibilities to manage and control, however, we have a 
good starting point for how to protect biological materials during freezing from 
extremophiles found in nature.  
 
1.4 NATURE’S PROTECTION 
Organisms in nature have evolved mechanisms to survive desiccation, exposure 
to sub-zero temperatures, or both. Nature employs a variety of compounds and 
strategies to enhance the survival of ectothermic animals during extreme 
environmental conditions.70 There are many strategies found in nature for the 
survival of freezing which are not useful to us, for example, blubber, feathers, 
blood shunting, and metabolic heating are not feasible for the protection of 
isolated cells in a lab environment. There are, however, a few which can be 
easily exploited to work in a lab setting. 
In 1957, Scholander and colleagues observed that marine teleost fish did not 
freeze during the winter despite the water temperature being over a degree below 
the freezing point of their blood serum, which they attributed to osmoadaptation 
induced by temperature.71 In 1967, DeVries found that these three species of 
Antarctic fish could survive temperatures of -2.5 °C72 and upon further 
investigation found that a freezing point depression was responsible which could 
not be due to colligative properties alone, but was owed to carbohydrate 
containing protein (glycoproteins) (later termed antifreeze glycoproteins (AFGP)), 
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in the serum.73,74 Since then, a variety of non-carbohydrate containing antifreeze 
proteins (AFPs) and AFGPs have since been identified in a number of different 
fish, insects, plants, and bacteria and they are all ice-binding proteins that are 
crucial for the species survival in the harsh cold environments to which they are 




AF(G)Ps have three main activities in regard to freezing: thermal hysteresis (TH), 
dynamic ice shaping (DIS), and ice recrystallisation inhibition (IRI). Thermal 
hysteresis refers to the non-colligative lowering of freezing temperature while the 
melting temperature remains unchanged.75 TH and DIS are interlinked such that, 
when the supercooling temperature of the solutions exceeds the level of freezing 
temperature suppression, growth morphology differs significantly from that of ice 
growth in pure water with bipyramidal crystallites and columnal spicules forming 
instead of sheets75 (Fig 1.7) and both TH and DIS are linked to concentration and 
protein length.76,77 The mechanism for DIS has recently been attributed to a semi-
clathrate water network on the protein, similar to what was discussed previously 
in Section 1.3, which merges with, and freezes to, a disordered water layer 
constructing the ice crystal surface,78 however, there is still much discussion on 
Figure 1.6. Classification and structural differences between fish antifreeze 
proteins (AFPs) and antifreeze glycoproteins (AFGPs). Adapted from Capicciotti.81  
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the exact mechanism and a unifying hypothesis has not been adopted. Most 
notably for us, this bipyramidal ice can lead to mechanical damage of cell 





The third property of antifreeze proteins, IRI, appears to operate independently, 
with little or no correlation to the magnitude of TH activity,79 such that proteins 
with high TH activity show relatively low IRI activity, with the opposite being true 
as well, with proteins showing moderate TH activity showing high IRI.80 Ice 
recrystallisation is thought to occur through either grain boundary migration or 
Ostwald ripening.81 Grain boundary migration is a phenomenon where large ice 
grains grow even larger at the expense of small ice grains as individual 
molecules transfer from unfavourably oriented ice grains to favourably oriented 
ice grains.82,83 For the Ostwald ripening process, a constant ice volume is 
Figure 1.7. Relationship between the morphology of a single ice crystal and AFP 
concentration. A) The crystal forms a round disk without AFP (i), while its six prism 
planes become visible by AFP-binding to form a hexagonal plate (ii). Further additions of 
AFP generate a new disk on the hexagonal plate (iii), leading to the formation of a barrel-
like ice crystal composed of hexagonal ice layers (iv), and ultimately create a bipyramidal 
ice crystal (v). B) Morphology of ice crystals observed for AFPI-III, at concentrations 
lower than their IRI endpoint. The hexagonal ice plate is created in the solutions of AFPI-
AFPIII and similarly for the solvent (40% sucrose). Adapted from Rahman.77 
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maintained and water molecules transfer from the surface of smaller ice crystals 
to bulk-water and then are transferred onto the surface of larger ice crystals. This 
results in an increase in the average ice crystal size and a decrease in the total 
number of ice crystals at a constant total ice volume.84–86 Through either process, 
the development of these large ice crystals during the thawing process has been 
shown to mechanically damage cells during cryopreservation.37,87–90 Antifreeze 
proteins have the ability to limit this ice recrystallisation so the ice crystals remain 
small, which results in significantly less damage to membranes91,92 (Fig 1.8), and 
this property also appears to be dependent on concentration.93 However, as 
stated previously, the DIS properties of AF(G)Ps prohibit their use in applications 
where IRI activity is highly desirable and attempts at cryopreserving cells with 




Another approach to cell protection is to view freezing as simply a loss of water 
event. Cells almost universally respond to the stress of long-term 
hyperosmolality, such as those seen during freezing, by accumulating compatible 
organic osmolytes.100 The major osmolytes in water-stressed eukaryotes are 
restricted to a few classes of low molecular weight metabolic products: polyhydric 
alcohols (polyols), such as glycerol and sucrose; free amino acids and amino 
acid derivatives (taurine and β-alanine); and urea and methylamines, such as 
Figure 1.8. Photomicroscope snapshots of ice grains picked up from 40 min 
videos that recorded the ice recrystallisation process. Photo examples of time-
dependent changes in the ice grains in solvent (40% sucrose) and 1.5 µM solutions of 
AFPIII at −6 °C, taken from the last 20 min. The scale bars represent 50 µm. Adapted 
from Rahman.77 
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tri-methylamine-N-oxide (TMAO), betaine, and sarcosine.101 Probably the most 
universally adopted 'compatible' solutes are the N-substituted amino acids, 
particularly betaine and proline.102 When the freshwater prawn Macrobrachium 
rosenbergii was subjected to a hyperosmotic environment there was shown to be 
an increase in proline synthesis.103 Additionally, Escherichia coli cells synthesise 
the osmoprotectant betaine by oxidation of choline when osmotically 
stressed.104,105 These strategies could be useful in preconditioning our cells for 
the stress associated with cryopreservation by simply incubating the cells in 
these known osmoprotectants.  
Another protective mechanism used by natural systems that undergo seasonal 
exposure to environmental stresses include downregulation of metabolism to 
enter a hypometabolic state (diapause)45 and metabolic depression and cell 
stasis are often prerequisites to survival for animals whose evolutionary history 
has provided natural adaptations to desiccation, freezing temperatures, and 
anoxia106.  As such, a requirement for freezing survival in both Caenorhabditis 
elegans107 and Drosophila melanogaster108 was a reduction in metabolic 
activity.109 Given that there are distinct threshold limits for life, TM (threshold for 
metabolism) and TS (threshold for survival), between TM and TS the organism is in 
a state of suspended animation,2 it is therefore possible that a reduction in 
metabolism could be a necessary and inherent step for the suspension of life 
processes. 
 
1.5 Aims and Objectives 
Utilising inspiration obtained from organisms in nature, as well as previous 
research, there are several novel avenues to be investigated in this work for the 
successful cryopreservation of biological materials, including explorations into the 
mechanisms of protection.   
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We know that AF(G)Ps have a detrimental ice shaping effect which makes their 
use in cryopreservation difficult. In addition to that, there are also immunogenic 
and toxicity issues with using these proteins,110 immense effort required for 
synthetic production, along with the inherent difficulty of obtaining large quantities 
of this protein from a source, as it is only produced by extremophiles, usually in 
specific remote locations.111 We propose utilising AF(G)P IRI polymer mimics, 
which allows for tunability of the polymer’s properties, such as DIS and IRI since 
both of the properties are dependent on concentration and protein length, and 
these polymer mimics mitigate many of the toxicity and immunogenic issues. By 
using readily available starting materials, we can also ensure the availability of 
these products for the scale-up to large batch storage. There has previously been 
success with IRI polymer mimics of AF(G)Ps for freezing cells in suspension,112–
114 but not for cells in a monolayer format.  Therefore, we will probe the 
cryoprotectant properties of these AF(G)P polymer mimics in relation to their 
protection of cell monolayers. We will additionally investigate non-IRI polymers 
for the storage of cells, which have been used in the vitrification of cells.36,115 We 
will also evaluate the use of osmotic preconditioning compounds with and without 
our polymer mimics to explore if we can enhance cryopreservation recovery, as 
this has previously been partially successful in monolayer cryopreservation.26 
We will primarily use three immortalised cell lines throughout this work; A549, 
MC-3T3 and Neuro-2a. The human lung adenocarcinoma cell line A549 was 
established by D.J. Giard in 1972 through an explant culture of a carcinomatous 
tissue from a 48 year-old Caucasian male116 and deposited in the American Type 
Culture Collection (ATCC) bank (CCL-185TM) by M. Lieber.117 The A549 cells are 
characterised as hypotriploid human alveolar basal epithelial cells and are widely 
used as an in vitro model for type II pulmonary epithelial cells as well as a model 
of lung adenocarcinoma.117 These cells grow adherently as monolayers and are 
suitable as a transfection host.118 A549 cells were selected as they have been 
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previously assayed for suspension freezing in the presence of poly(vinyl 
alcohol)119 and will allow for comparisons for monolayer freezing. MC3T3 is an 
osteoblast precursor cell line derived from Mus musculus (mouse) calvaria in 
1981 by Hiro-aki Kodama120 and further characterised into the MC3T3-E1 
subclone (MC-3T3) by Hiroko Sudo.121 These cells have been used extensively to 
define pathways of osteoblast differentiation and equate each stage of 
differentiation and its gene expression profiles with some function in bone.122 The 
cells grow as adherent monolayers and are suitable for in vitro osteoblast 
differentiation. MC-3T3 cells were chosen as they have difficulty attaching and 
serve as a harsh experiment for  cryopreservation outcomes as well as the fact 
that DMSO has been shown to induce differentiation123 and thus it would be 
beneficial to reduce the DMSO exposure of these cells. Gabriella Augusti-Tocco 
established clonal lines of neurons (Neuro-2a) from mouse neuroblastoma 
(C1300) for growth in tissue culture in 1969124 and these cells were further shown 
to be inducible for in vitro differentiation into mature neurons.125 This mouse 
neural crest-derived cell line has been extensively used to study neuronal 
differentiation, axonal growth and signalling pathways126 and they grow as 
adherent monolayers. Neuro-2a cells were chosen as they have previously been 
used for monolayer cryopreservation after exposure to pre-conditioning 
osmolytes,127 a strategy explored in this work. 
In addition to finding novel methods and compounds that are successful in 
cryopreservation, we will also attempt to understand the ways in which these 
compounds are affording their cryoprotection. This is often not heavily 
investigated, so we will attempt to scrutinise different avenues involved in the 
mechanisms of protection. We will assess the compounds’ impacts on ice as a 
mechanism via ice recrystallisation assays and differential scanning calorimetry. 
We will investigate membrane permeability as a mechanism via calein-AM uptake 
and retention along with calcein-AM/EthD-1 uptake. As a baseline for the 
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compound interactions under physiological conditions with the cells we will 
evaluate the toxicity of the compounds via alamarBlue reduction along with the 
proliferation impacts of all compounds used via long-term growth assays, in order 
to assess the impact to the cells of simply being in contact with these 
compounds.  We will additionally assess how well our cells proliferate following 
cryopreservation via long-term growth assays as a measure of overall cell health. 
By evaluating cryopreservation outcomes along with cell impacts and 
mechanisms of protection, we will attempt to identify patterns of protection for 
cells during cryopreservation.  
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CHAPTER 2 
 
2. BIOPHYSICAL EFFECTS OF 
MACROMOLECULAR AND SMALL 
MOLECULAR CRYOPROTECTANTS  
 
2.1 DECLARATIONS 
All polyampholyte polymers were synthesised and functionally analysed by Dr 
Christopher Stubbs and all polyproline polymers were synthesised and 
characterised by Dr Ben Graham, both under the supervision of Prof Matthew 
Gibson. 
 
2.2 CHAPTER SUMMARY  
Ice recrystallisation upon thawing is a major contributor to cell death, which is not 
controlled by traditional cryoprotective agents. We evaluated the ice 
recrystallisation inhibition capabilities of several compounds in two different 
solvents. We additionally assessed the enthalpy of crystallisation and melting 
temperature of our compounds. We observed that poly(vinyl alcohol) retained its 
inhibition properties regardless of solvent or the presence of compatible 
osmolytes and our polymers of polyproline and polyampholyte had weak 
inhibition capabilities. We further observed no significant non-colligative 
deviations for the enthalpy of crystallisation or melting temperature for our 
solutions. 
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2.3 INTRODUCTION 
2.3.1 Synthetic Polymers 
Antifreeze (glyco)proteins (AF(G)Ps) are potent ice recrystallisation inhibitors 
(IRIs), but are typically unsuitable for cryopreservation applications due to their 
potential toxicity/immunogenicity and their secondary effect of dynamic ice 
shaping (DIS), which leads to ‘needle like’ ice crystals that pierce cell 
membranes.1 Due to this, chemical synthesis of biologically and chemically stable 
AF(G)P analogues (as they are structurally simpler than exact AF(G)P structures) 
is a growing research field. This approach started with Eniade et al. discovering a 
short glycopeptide with moderate IRI activity but little to no thermal hysteresis 
(TH) activity,2 which is necessary for DIS, therefore showing that these properties 
could be decoupled in an advantageous way.1,3 Since then, synthetic polymers 
with potent IRI have emerged as a new paradigm for controlling ice growth.4 In 
this work, we started by investigating the IRI properties of several chemically 
distinct polymers which have been suggested as potential CPAs to determine 
what level of IRI activity they possess, if any. 
2.3.1.1 Poly(vinyl alcohol) 
The most studied IRI active synthetic polymer is poly(vinyl alcohol) (PVA), (Fig 
2.1). PVA is a simple, scalable and biocompatible polymer which has potent IRI 
activity, shown by the ability to inhibit ice growth at less than 1 mg·mL-1, and has 




Figure 2.1. Structure of PVA.   
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It was first suggested that the presentation of hydrophobic domains, without the 
onset of self-assembly, contributed to PVA’s high IRI activity,8 however, more 
recently it has been ascribed to the ability to hydrogen bond with the planes of 
ice.9,10 Chain length has also been shown to be important, with a longer chain 
length corresponding to stronger IRI activity, though the stronger IRI activity is 
offset by a reduction in solubility, thereby lowering the final usable concentration. 
The IRI activity of PVA has also been shown to be strongly concentration 
dependent (Fig 2.2).11 Simulations show that PVA binds to the prismatic plane of 
ice via direct hydrogen bonding with two out of every three hydroxyl groups 
hydrogen bonded to the ice parallel to the c-axis.9  
PVA is an attractive cell additive, as it is known to have minimal toxicity and is 
already approved by the Food and Drug Administration (FDA) for use in dietary 
applications and eyedrops.12 PVA has been shown to moderately enhance the 
cryopreservation of cells in suspension,13-15 but has not been previously used for 




Figure 2.2. Ice recrystallization inhibition activity of PVA homopolymers as 
measured by the splat assay. A) Example micrographs showing ice crystals grown 
in PBS alone (upper) and with PVA351, 1 mg·mL–1). B) IRI activity as a function of 
polymer concentration. MLGS = mean largest grain size relative to a PBS control, 
expressed as %. Error bars represent the standard deviation from at least three 
measurements. Reprinted with permission from (Congdon, 2013).11 Copyright (2013) 
American Chemical Society. 
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2.3.1.2 Polyproline 
There are currently no crystal structures for antifreeze glycoproteins (AFGP)s but 
nuclear magnetic resonance (NMR) and ultra-ultraviolet circular dichroism (CD) 
suggest a polyproline II type helix.16 Synthetic peptides with a polyproline II 
helical topology and proline oligomers have been shown to have IRI activity.17,18 
Polyproline (Fig 2.3) is unique as it has a tertiary amide and cannot form 
intramolecular hydrogen bonds which makes it water soluble despite being 
hydrophobic, similar to antifreeze protein (AFP) I, which is comprised of 70% 
alanine (a hydrophobic amino acid).19 Polyproline has also been confirmed to 
have a PPII helix via circular dichroism spectroscopy (CD).20 PPRO11 (1250 
g·mol-1, Đ = 1.03) is used throughout this work.  
Due to its amphiphilicity and tertiary structure, we believe that polyproline may be 
a minimal AF(G)P mimic, making it an ideal candidate for investigation as a 
monolayer cell cryoprotectant as AF(G)Ps have been shown to be detrimental to 
cells and this mimic has the potential to protect without the damaging side effects 




2.3.1.2.1 Characterisation of polyproline21 – Performed and written solely by 
Dr Ben Graham and included here for completeness 
Following dialysis, polymers were characterised by SEC (size exclusion 
chromatography), Table 2.1. The polymers were less disperse than expected due 
Figure 2.3. Structure of polyproline.  
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to fractionation during dialysis. Table 1 also contains polymers from previous 
work, which are included for later critical IRI activity analysis (vide infra). CD 
confirmed that PPro15 adopted a PPII helix (Figure 2.4)22 with characteristic 
signals present at 207 and 228 nm, whilst a random coli would exhibit slight peak 
shifting, with signals absent in the 220 nm region.23 P(D)Pro15 gave the mirror 






Table 2.1. Polyproline SEC (size exclusion chromatography). [a] Determined by 
SEC; [b] Value from supplier; [c] Mass Spectrometry; [d] Single species; [e] From 
literature.80,81,82 Performed and analysed solely by Dr Ben Graham. 
 
  Mn, 
(g.mol-1) 





PPro11 1300 [a] 1.03 11 
PPII PPro15 1700 [a] 2.12 15 
PPro19 2100 [a] 1.50 19 
P(D)Pro15 1700 [a] 1.01 15 Enantiomeric PPII 
P(DL)Pro21 2400 [a] 1.01 21 Random coil 
PPro10-100 1 – 10k [b] - 10-100 PPII [e] 
PPro10 900 [c] [d] 10 PPII [e] 
PPro10-25 1 – 3k 1.01 – 1.03 10 - 25 PPII [e] 
PPro20 2000 [c] [d] 20 PPII [e] 
 
Figure 2.4. Polyproline circular dichroism spectra. A) Spectra of synthesised 
polyproline polymers. B) Spectra of synthesised proline polypeptides compared to a 
polyproline II helical reference (PPro (II) Helix)2 not corrected for concentration to 
enable comparison against reference standard. Performed and analysed solely by 
Dr Ben Graham. 
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2.3.1.3 Polyampholyte 
Synthetic poly(ampholyte)s bearing mixed positive and negative charges have 
been evaluated in cryopreservation. Carboxylated poly(lysine) (PLL) has shown 
good recovery in the slow freezing of suspended cells in vials 6h after thawing 
and the degree of carboxylation was shown to have an impact on both cell 
recovery and IRI, with COOH fractions between 50 and 75% giving the best cell 
recovery and IRI.24 PLL has also been used for the vitrification of cell 
suspensions and monolayers, but 6.5 M ethylene glycol is needed to provide 
good recovery, which was shown to be toxic in less than three minutes and 
equilibrium solutions are needed to prepare the cells for the addition of PLL.25,26 
The mechanism of PLL’s protection is thought to be either through membrane 
interaction, reduction of cytotoxicity or devitrification, or the prevention of 
overexpansion osmotic injury, and not IRI, due to its weak activity.24–26 
Our polyampholyte of interest (Fig 2.5) utilised a poly(methyl vinyl ether-alt-
maleic anhydride) precursor since this precursor is produced on a multi-ton scale, 
is safe as both a food additive and a bioadhesive,27 and the use of an anhydride 
precursor guarantees a 1:1 ratio of cationic/anionic groups. As the distribution of 
carboxylation has been shown to be important and ampholytes have been 
demonstrated to provide cryoprotection, we believe our finely tuned polymer will 
provide interesting insights into the cryoprotection of monolayered cells. 
 




2.3.1.3.1 Characterisation of Polyampholyte28 – Performed and written 
solely by Dr Christopher Stubbs and included here for completeness 
The initial precursor polymer of gantrez was not characterised as it is an 
industrial polymer with relatively poor quality control for molecular weight and 
dispersity, therefore, the exact characterisation becomes difficult. Dimethyl 
aminoethanol functionalised polyampholyte was characterised by 1H NMR and 
infrared spectroscopy (IR) (Figure 2.6). 
 
Figure 2.5. Structure of polyampholyte.  




2.3.2 Osmotic Preconditioning 
Cells in freeze-tolerant organisms experience dehydration in highly organised 
tissues and cells almost universally respond to the stress of long-term 
hyperosmolality (such as those seen during freezing) by accumulating compatible 
organic osmolytes.29 Therefore, we hypothesised that the osmolytes of alanine, 
betaine, and proline (Fig 2.7) might be useful in the cryopreservation of cell 
monolayers. 
Figure 2.6. Characterisation of polyampholyte. A) Annotated 1H NMR of dimethyl 
aminoethanol functionalised polyampholyte. B) Infrared spectra of the poly(methyl 
vinyl ether-alt-maleic anhydride) precursor (black) and the aminoethanol functionalised 
polyampholyte (red), the anhydride peak at ca. 1750 cm-1 is removed, and the new 
carboxylate and ester stretches produced. C) 1H NMR spectra of the poly(methyl vinyl 
ether-alt-maleic anhydride) precursor (black) and the aminoethanol functionalised 
polyampholyte (red). Performed and analysed solely by Dr Christopher Stubbs. 
 




Alanine is a simple nonpolar aliphatic amino acid that is zwitterionic under 
biological conditions. Alanine is the second most prevalent amino acid occurring 
in proteins and is therefore used heavily for protein synthesis. Even though 
alanine is a zwitterion, it has not been used extensively in cryopreservation. 
Alanine was shown to have a detrimental effect on ram semen during 
cryopreservation30 and only marginally increased the post-thaw motility of striped 
bass (Morone saxatilis) spermatozoa.31  
Alanine is an interesting supplement for cryopreservation investigation due to the 
alanine-heavy regions of many AF(G)Ps32 and will allow us to investigate if the 
presence of alanine is a contributing protective factor for native proteins.  
2.3.2.2 Betaine 
Glycine betaine (referred to in this text as simply “betaine”) is an amino acid 
derivative that was originally discovered in beets that required osmolytes in order 
to survive in the salty soils of coastal areas. Betaine is an N-trimethylated amino 
acid, and the quaternary ammonium exists as a zwitterion at neutral pH. 
Betaine’s osmoprotection is thought to be attributed to the osmoregulated 
betaine/GABA transporter (BGT1) which couples the transport of betaine to Cl- 
and Na+ across the cell membrane.33 These ion gradients strengthen the 
transport of betaine, providing a driving force that can raise betaine from 
Figure 2.7. Structure of osmolytes.  A) Structure of L-alanine. B) Structure of 
betaine. C) Structure of L-proline.  
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micromolar levels to millimolar levels within the plasma of the cells. Hypertonicity 
has also been shown to increase the transcription of the BGT1 gene, followed by 
a rise in its mRNA and transport activity.34 Thus, tonicity controls betaine 
transporter activity by affecting BGT1 transcription. BGT1 is regulated not only by 
transcription, but also by insertion into the plasma membrane.35 The small 
amount of BGT1 that exists under normal conditions is mainly located in the 
cytoplasm and following hypertonicity, BGT1 is seen mainly within membranes. 
This transport is upregulated without change in the total abundance of BGT1, 
only its location.36 In addition to its osmoprotectant role, betaine has also been 
implicated to have a role in cellular metabolism and DNA methylation.37 Betaine’s 
osmoprotection is found throughout nature, as one example, when the dogfish 
shark Squalus acanthias was exposed to hypotonic conditions, there was an 
efflux of betaine and this efflux was shown to be responsible for the loss of 
osmotically obliged water during regulatory volume decrease.38 Within the 
laboratory, renomedullary cells grown in hyperosmotic media contained higher 
concentrations of betaine than cells grown in isotonic media39 and simian-virus-
40-transformed Balb/c 3T3 (SV-3T3) cells were resistant to osmotic stress, which 
typically resulted in inhibition of protein synthesis and decreased proliferation, 
when treated exogenously with betaine.40 Betaine has been shown to reduce 
leakage from frozen multilamellar liposomes,41 and significantly enhance the 
vitrification of mammalian cells in suspension.42 
Betaine, due to its osmoprotectant role, could provide the necessary 
preconditioning and/or protections to aid cells through the harsh event of 
cryopreservation, as the freezing process consists of a loss of water from the 
cells.   
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2.3.2.3 Proline 
Proline is a proteinogenic amino acid that contains a side chain pyrrolidine, 
classifying it as a nonpolar aliphatic amino acid and it is the only proteinogenic 
amino acid with a secondary amine. Proline is membrane permeable regardless 
of pH,43 and transfer may also occur by either a classical sodium-dependent A-
type system with a wide substrate specificity or by the combination of sodium-
dependent PHE (phenylalanine preferring) and IMINO (proline, alpha-
methylaminoisobutyric acid preferring) systems.44 Proline has also been 
implicated as a survival factor that protects the cell against apoptosis and 
maintains the progression of the cell cycle through a signal recognition function of 
the transporters that may take part in the control of cell cycle progression and 
programmed cell death.45 In biological organisms, proline utilisation 
(PUT1)-disrupted Saccharomyces cerevisiae, supplemented with external 
proline, accumulated higher levels of proline in cells and conferred a higher 
tolerance to freezing and desiccation stresses.46 Further, increased proline 
transport is also suggested to generate or maintain an osmoprotective 
transmembrane proline gradient in the bacterium Escherichia coli.47 Even more 
striking, when a high level of proline was incorporated into the tissues of 
Drosophila melanogaster, a chill susceptible insect, it was able to survive with 
50% of its total water volume frozen.48 Proline has been used with success to 
cryopreserve mouse oocytes,49 vitrify red blood cells (RBCs) and mammalian 
cells,50 and has shown moderate protection for mammalian cell monolayers.51 
Proline, similar to betaine above, has been chosen for its potential 
osmoprotective role, however, proline also has implications in protection from 
apoptosis which could be very beneficial to cells following the harsh event of 
cryopreservation.  
The first aim of this thesis was to examine the physical properties on ice of our 
potential cryoprotective agents. This will be accomplished via ice recrystallisation 
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assays, to determine if our compounds alter ice growth upon melting and 
differential scanning calorimetry of the compounds to evaluate ice crystal 
fractions and melting temperatures. This will allow us a first look as to how our 
compounds may be affording their protection, if any exists, either through 
interaction with and influence on the ice, allowing us to begin to classify our 
compounds. We wanted to specifically address if: (i) our compounds effected the 
recrystallisation of ice, (ii) the solvent affected the results, (iii) compatible 
osmolytes affected the properties of ice or (iv) compatible osmolytes affected 
another compound’s interaction with ice, and (v) any of the compounds induced 
vitrification or affect melting temperature.  Should we find large variances in our 
physical assays, we can propose a mechanism of action via ice influence or 
interaction. 
 
2.4 RESULTS AND DISCUSSION 
2.4.1 Ice Recrystallisation Inhibition (IRI) 
Ice recrystallisation is a major problem in cell and tissue cryopreservation1,52,53 
and we will start our investigation by assaying our compounds’ ability to inhibit ice 
recrystallisation, as this will allow us to identify a potential protective mechanism. 
IRI is routinely evaluated by using an assay developed by Knight et al., typically 
referred to as the “splat test”, which addressed the difficulties of previous assays 
in inconsistent nucleation and grain growth.54 The splat test involves a small (10 
µL) droplet released from a height of ~2 m onto a pre-cooled aluminium plate 
sitting atop dry ice (~ -70 °C). This impact causes an instantaneous phase 
change that results in the formation of a single layer of ice crystals. The layer is 
then annealed at -8 °C for 30 min on a cryostage, which allows for ice crystal 
growth due to melting. The ice crystals themselves are transparent and a 
polariser sits between the light source and the crystal specimen causing a 
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change in the brightness and/or the colour of the crystals being examined. 
Polarisation colours result from the interference of the two components of light 
split by the anisotropic specimen and is a result of white light minus those colours 
that are interfering destructively, our resultant images appear to be in the sixth 
order wavelength in the pink field. The orientation and thickness of the ice will 
have an impact on the observed colour. Images are taken after 30 min and 
crystals are then counted using imageJ software. The overall size of the picture 
capture area is 652.22 µm x 434.81 µm (at 7.2859 pixels·µm-1) for a total area of 
271851.908 µm2, therefore using the crystal counts and the known area we can 
calculate the average crystal size. Values are reported as true averages for the 
solvent (control) and experimental samples to allow for statistical analysis. 
Smaller ice crystals indicate IRI properties for the compound tested, while larger 
ice crystals reflect little to no IRI activity.   
2.4.1.1 PVA IRI 
We first wanted to test and compare the IRI activity of both phosphate buffered 
saline (PBS) and cell culture media (Ham's F-12K (Kaighn's) Medium (F-12K)), 
as the cell media contains proteins and additives which are typically not taken 
into account when translating results in PBS to a more complex solution.  We 
saw no significant difference in the average crystal sizes between PBS and F-
12K (Fig 2.8), suggesting the cell culture media (F-12K) was not affecting the 
assay. Following our solvent tests, we wanted to evaluate the IRI activity of PVA 
in both PBS and F-12K to note any differences cell media may have on the IRI 
ability of PVA. As expected, PVA had significantly higher IRI activity than either 
solvent tested, but we saw no significant difference in the ice crystal sizes of PVA 
when dissolved in either PBS or F-12K (Fig 2.8, n = 3, P = 0.000003). PVA is 
known to have potent IRI activity in the ranges of 1 - 10 mg·mL-1 when dissolved 
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in PBS13 and our results demonstrate that PVA retains its strong IRI activity when 
dissolved in completed cell media (F-12K).  
 
 
2.4.1.2 Polyproline IRI 
We next evaluated the IRI activity of our polyproline polymer in both PBS and 
F-12K. We found that 5 and 20 mg·mL-1 polyproline had significantly smaller 
crystals than PBS alone, but significantly larger crystals than 5 mg·mL-1 PVA 
(Fig 2.9, n = 3, P = 0.00000002). We additionally saw that 20 mg·mL-1 polyproline 
in F-12K was statistically similar to 5 mg·mL-1 PVA in F-12K (Fig 2.25, n = 3, P = 
0.00004). While we do see a reduction in ice crystal size, due to the dissimilarity 
to PVA and the concentration needed to be statistically similar, for the samples in 
F-12K, our results show that polyproline would be considered a “weak inhibitor” of 
ice recrystallisation.55 Poly(hydroxyl proline) has previously been shown to also 
have moderate IRI activity, which was thought to be due to the spacing of the 
Figure 2.8. Splat of PVA solutions.  A) Splat micrograph of PBS. B) Splat 
micrograph of F-12K. C) Splat micrograph of 5 mg·mL-1 PVA in PBS. D) Splat 
micrograph of 5 mg·mL-1 PVA in F-12K.  Scale bar = 100 µm. E) Average ice crystal 
size of solutions calculated from splat wafers. * P < 0.001 from PBS, ** P < 0.001 from 
F-12K. Error bars represent ± SEM of 3 independent experiments. 
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hydroxyl groups.7 Whilst we haven’t tested poly(hydroxyl proline), our results 
suggest that the moderate activity of both polyproline and poly(hydroxyl proline) 
is due to the polyproline II type helix,16 rather than the hydroxyl groups, and that 




2.4.1.3 Polyampholyte IRI 
We next evaluated the IRI activity of our novel polyampholyte polymer (which is 
shown in later chapters to be a potent cryoprotectant) at an average Mn value of 
80 kDa (P2). We saw that 5 and 40 mg·mL-1 P2 had smaller crystals than PBS, 
suggesting both samples were more IRI active than PBS alone. However, 
5 mg·mL-1 P2 had significantly larger crystals than 5 mg·mL-1 PVA (Fig 2.10, n = 
3, P = 0.00003), indicating it was far less IRI active than PVA. Similar to 
Figure 2.9. Splat of polyproline and PVA solutions in PBS.  A) Splat micrograph 
of PBS. B) Splat micrograph of 5 mg·mL-1 PVA in PBS. C) Splat micrograph of 5 
mg·mL-1 polyproline in PBS. D) Splat micrograph of 20 mg·mL-1 polyproline in PBS. 
Scale bar = 100 µm. E) Average ice crystal size of solutions calculated from splat 
wafers. * P < 0.001 from PBS, ** P < 0.001 from 5 mg·mL-1 PVA in PBS. Error bars 
represent ± SEM of 3 independent experiments. 
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polyproline in F-12K, the high concentration of 40 mg·mL-1 P2 in PBS was 
statistically similar to 5 mg·mL-1 PVA in PBS, however, the concentration of P2 
needed to achieve IRI activity similar to PVA, while also showing larger crystals, 
would result in P2 being considered a “weak inhibitor” of ice recrystallisation.55 




2.4.1.4 Compatible Osmolyte IRI 
We next wanted to evaluate the IRI properties of alanine, betaine, and proline. 
Our osmolytes were tested individually in both PBS and F-12K and the individual 
results are shown in Figures 2.27-2.32. Osmolyte concentrations were chosen 
based on the best cryopreservation conditions used later (Section 4.4.1.2). 
Combining the results for comparison, 100 mM alanine, 100 mM betaine, and 
Figure 2.10. Splat of polyampholyte P2 and PVA solutions in PBS.  A) Splat 
micrograph of PBS. B) Splat micrograph of 5 mg·mL-1 PVA in PBS. C) Splat 
micrograph of 5 mg·mL-1 P2 in PBS. D) Splat micrograph of 40 mg·mL-1 P2 in PBS. 
Scale bar = 100 µm. E) Average ice crystal size of solutions calculated from splat 
wafers. * P < 0.0001 from PBS, ** P < 0.0001 from 5 mg·mL-1 PVA in PBS. Error bars 
represent ± SEM of 3 independent experiments. 
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200 mM proline had statistically significant smaller crystal sizes than PBS alone, 
yet all also had statistically significant larger crystal sizes than 5 mg·mL-1 PVA in 
PBS (Fig 2.11, n = 3, P = 0.0000000001), suggesting that while the osmolytes 
may have some IRI activity compared to PBS, the osmolytes alone would not be 
considered IRI active compounds, as their activity is well below that needed to 
even be considered “weak inhibitors” of ice recrystallisation.55 It is emerging that 
IRI is very dependent not only on the IRI active compound, but also any ions that 
may be present, with the concentration and type of ion presenting variable results 
in IRI activity,58,59 yet we did not see statistically significant effects with the 
addition of our osmolytes. All osmolyte solutions containing PVA had statistically 
significant smaller ice crystals than PBS but were not statistically significantly 
different from PVA alone, showing that the osmolytes neither inhibited nor 
enhanced PVA’s IRI activity. While alanine showed the most reduction in mean 
grain size, it was still statistically significantly higher than the IRI active PVA. 
Although alanine is found predominantly in AFPs, it is believed that there is a 
strong hydrogen bond interaction with the threonine-hydroxyl groups of these 
AFPs and that the methyl groups of threonine and alanine do not bind water but 
instead insert into the cavity of ice.60 Our results show that free alanine is not a 
potent IRI active compound. Betaine is well known for its hydrophilic property of 
strongly binding water molecules, via ionic solvation effects due to its charged 
groups.61 However, it had the largest mean grain size of our three osmolytes and 
its IRI activity is more comparable to PBS than PVA, thus we would not consider 
it’s mechanism to consist of ice inhibition. Proline showed statistically significantly 
smaller ice crystals than PBS and it has been hypothesised that water-proline 
hydrogen bonding is significant, and upon cooling becomes stronger, which 
affects the rate of crystallisation.62 However, again, it is statistically significantly 
higher than PVA, and thus would not be considered an IRI active substance. 
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These results establish that our osmolytes have no impact on the IRI activity of 




Figure 2.11. Splat of osmolyte solutions in PBS. A) Splat of PBS. B) Splat of 100 
mM alanine in PBS. C) Splat of 100 mM betaine in PBS. D) Splat of 200 mM proline 
in PBS. E) Splat of 5 mg·mL-1 PVA in PBS. F) Splat of 100 mM alanine + 5 mg·mL-1 
PVA in PBS. G) Splat of 100 mM betaine + 5 mg·mL-1 PVA in PBS. H) Splat of 200 
mM proline + 5 mg·mL-1 PVA in PBS. Scale bar = 100 µm. I) Average crystal size of 
solutions calculated from splat ice wafers. * P < 0.0001 from PBS, ** P < 0.0001 from 
5 mg·mL-1 PVA in PBS. Error bars represent ± SEM of 3 independent experiments. 
(NP = no polymer). 
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This section has demonstrated that PVA has high IRI activity regardless of 
utilising either PBS or F-12K as a solvent and hence we can be confident that IRI 
activity is retained under cell culture conditions. We have additionally 
demonstrated the moderate IRI activity of polyproline and a statistically relevant, 
but rather weak, IRI of polyampholyte. We have further shown that compatible 
osmolytes do not possess strong IRI activity but also do not hinder the IRI activity 
of PVA. These results allow a starting point for the classification of these 
macromolecular and molecular compounds. 
 
2.4.2 Differential Scanning Calorimetry (DSC) 
We next wanted to evaluate the phase transitions of our solutions during freezing, 
along with the melting point. We primarily sought to verify that our solutions were 
indeed freezing and not vitrifying (ice-free phase). We utilised differential 
scanning calorimetry (DSC), a thermo-analytical technique that can precisely 
measure the differences in energy required between a reference and sample to 
detect exothermic and endothermic events (presented as peaks) and therefore 
phase transitions. If our solutions were freezing, we would expect to see a 
crystallisation peak where heat is released during the formation of ice crystals. If 
vitrification was occurring, we would expect to see a step bump resulting in a 
baseline shift. Both of these curves are represented in Figure 2.12 (adapted from 
Schawe and Löffler63) from the cooling of metallic alloy, with freezing curves 
illustrated at ≤ 200	K·s-1 and vitrification curves illustrated at ≥ 500 K·s-1.  
 




By measuring the enthalpy of crystallisation (obtained by taking the area under 
the curve of each crystallisation peak in the DSC trace), we were able to evaluate 
any non-colligative properties of the solutions. By heating our solutions after 
cooling, we could also evaluate the onset of the melting point to identify changes 
in the solid to liquid phase transition upon heating. We also looked at peak shifts 
from the effects of the added solutes to our standards, for both heating and 
cooling, as we would expect small scale changes, since solutes are known to 
result in freezing point depression.64,65   
 
2.4.2.1 PVA DSC 
Similar to our IRI assessment, we first evaluated the phase transition and melting 
temperature of both PBS and F-12K, followed by 5 mg·mL-1 PVA and 10% 
Figure 2.12. DSC phase transformations upon cooling. Adapted with permission 
under a Creative Commons Attribution 4.0 International License from Schawe and 
Löffler63 (2019). The green, blue, gold, red, and grey lines show clear crystallisation 
peaks, whereas the pink, black, and cyan show no peaks and indicate vitrification. 
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dimethyl sulfoxide (DMSO) in both PBS and F-12K, and then finally, the 
combination of PVA + DMSO in both PBS and F-12K to note any differences cell 
media may have on the assessed properties. Evaluating the DSC freezing traces 
for solutions in PBS (Fig 2.13A) and F-12K (Fig 2.13B) we saw subtle differences 
between two solutions that we analysed further by measuring the area under the 
curve of each of the peaks to find the average ice crystallisation enthalpy. We 
saw no differences in enthalpy between PBS and F-12K, or for PVA in either 
solvent (Fig 2.13C, n = 3, P = 0.00000004), which was anticipated as PVA has 
been shown not to greatly alter the ice content, even in a concentration 
dependent manner.13 We saw a statistically significant difference in the ice 
crystallisation enthalpy of solutions containing DMSO, which was expected as the 
viscosity increase of DMSO is thought to decrease molecular mobility and hence 
crystallisation.66 None of the solutions containing DMSO significantly differed from 
each other statistically, showing that neither the solvent used, nor the presence of 
PVA, affected the crystallisation enthalpy of DMSO. 
 




Assessing the DSC melting traces for PBS (Fig 2.14A) we can see two distinctive 
peaks in the PBS sample and upon zooming into the -30 ˚C region we can see 
there are a total of four unique peaks, three small peaks (labelled antemelting 
(AM), incipient melting (IM), and eutectic melting (EM)) followed a large melting 
Figure 2.13. DSC cooling of PVA solutions. A) DSC trace of PBS solutions cooling 
to -150 °C at 10 °C·min-1. B) DSC trace of F-12K solutions cooling to -150 °C at 10 
°C·min-1. C) Average enthalpy of ice crystallisation of solutions calculated from area 
under curve on DSC trace. Error bars represent ± SEM of 3 independent experiments. 
* P < 0.001 from PBS, ** P < 0.001 from F-12K, $ P < 0.001 from 5 mg·mL-1 PVA in 
PBS, $$ P < 0.001 from 5 mg·mL-1 PVA in F-12K. 
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peak. Slow freezing causes ice to separate and the exothermic peak AM might 
be the result of the unfrozen water fraction freezing upon warming,67,68 with the IM 
peak relating to a grain boundary melting phase directly prior to the EM peak. 
The endothermic peak (labelled (EM)) is thought to be the melting of the 
equilibrium eutectic phase due to the crystal phase of the unfrozen water 
fraction69 and previous EM values of -25 ˚C have been reported70 which align with 
our reported values here. Eutectic crystallisation has been shown to occur only 
with supercooling during freezing but melting occurred at the thermodynamic 
equilibrium eutectic temperatures.70  In the samples containing DMSO, we see no 
AM, IM, or EM peak, suggesting an amorphous state for the unfrozen fraction 
and this has been previously demonstrated as glycerol and DMSO have been 
shown to prevent eutectic formation.71 In the samples with F-12K (Fig 2.14B) 
there was a larger AM peak with a smaller EM peak. The disappearance of 
eutectic formation has been observed for more complex mixtures72 with cell 
media eutectic values of ~ -30 ˚C,70 however our cell media is complete in this 
solution, so we have the additional impacts of the heavy protein content of the 
foetal bovine serum and we see that the further addition of PVA fully removes the 
eutectic peak from the F-12K solution, which speaks more to complexity of the 
solution and not the IRI activity of the polymer as AFPs have been shown not to 
alter premelting peaks.73 While eutectic crystallization is thought to directly injure 
cells during freezing,70 all of our solutions used as CPAs contain DMSO, which 
eliminate the eutectic melting peak, therefore we can disregard the influence of 
the eutectic melting as a mode of damage in our later cryopreservation studies. 
We saw no differences in melting temperature between PBS and F-12K, or for 
PVA in either solvent (Fig 2.14C, n = 3, P = 0.000002). We did see a statistically 
significant difference in the melting temperature of solutions containing DMSO, 
which was expected as DMSO has been shown to decrease the melting 
temperature.66,74 None of the solutions containing DMSO significantly differed 
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from each other statistically, showing that neither the solvent used, nor the 
presence of PVA, affected the melting temperature of DMSO. This mirrored our 




Figure 2.14. DSC heating of PVA solutions. A) DSC trace of warming PBS 
solutions from -150 °C to 25 °C at 10 °C·min-1. B) DSC trace of warming F-12K 
solutions from -150 °C to 25 °C at 10 °C·min-1. C) Average melting temperature 
calculated from onset of DSC exothermic drop. Error bars represent ± SEM of 3 
independent. * P < 0.001 from PBS, ** P < 0.001 from F-12K, $ P < 0.001 from 5 
mg·mL-1 PVA in PBS, $$ P < 0.001 from 5 mg·mL-1 PVA in F-12K. 
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These results have shown that PVA does not alter the ice crystallisation enthalpy 
or melting temperature compared to the standards of PBS/F-12K or 10% DMSO 
in either PBS or F-12K. 
2.4.2.2 Polyproline Proline DSC 
In evaluating the phase transition and melting temperatures of polyproline we 
saw that all combinations of our solutions were freezing and not vitrifying (Fig 
2.15A). Looking at the enthalpy of crystallisation, there were no statistically 
significant differences among any of solutions, most likely due to the high 
variability of the polyproline solutions (Fig 2.15B, n = 3). We did observe a 
statistically significant lower enthalpy for 200 mM proline + 5 mg·mL-1 polyproline 
both with and without 10% DMSO in F-12K compared to F-12K alone (Fig 2.33B, 
n = 3, P = 0.01), we believe this is due to colligative effects due to the high 
concentration of proline used (explored more in Section 2.4.2.4). 
 




From the heating curves, there are not large peak shifts from controls with 
polyproline suggesting the polymer is not affecting the ice fraction (Fig 2.16A). 
Antemelting and eutectic melt peaks were observed for PBS and also for 
polyproline. Upon the addition of proline, the peak was no longer observed, which 
aligns with previous research demonstrating the disappearance of the eutectic 
peak in the presence of proline.69 
Obtaining the melting point from the onset of the exothermic peak, we saw no 
statistically significant differences in melting temperature for polyproline 
compared to the standards of solutions containing either PBS or 10% DMSO, 
with all solutions containing 10% DMSO statistically significantly different to 
Figure 2.15. DSC cooling of polyproline solutions in PBS. A) DSC trace of 
polyproline solutions cooled to -150 °C at 10 °C·min-1. B) Average enthalpy of ice 
crystallisation of solutions calculated from area under curve on DSC trace. Error bars 
represent ± SEM of 3 independent experiments.  
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solutions containing only PBS (Fig 2.16B, n = 3, P = 0.00005). For solutions in F-
12K, we saw a statistically significant lower melting temperature for 5 mg·mL-1 
polyproline + 200 mM proline + 10% DMSO, again most likely due to colligative 




2.4.2.3 Polyampholyte DSC 
In evaluating the phase transition of our polyampholyte solutions, we saw that all 
molecular weights of our polymer (Mn = 20 kDa (P1), 80 kDa (P2), and 311 kDa 
(P3)) were freezing and not vitrifying (Fig 2.17A). Looking at the enthalpy of 
Figure 2.16. DSC heating of polyproline solutions in PBS. A) DSC trace of 
warming polyproline solutions from -150 °C to 25 °C at 10 °C·min-1. B) Average 
melting temperature calculated from onset of DSC exothermic drop. Error bars 
represent ± SEM of 3 independent experiments. * P < 0.0001 from PBS, ** P < 
0.0001 from 10% DMSO in PBS. 
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crystallisation, we saw only statistically significant differences from F-12K for 
solutions containing 10% DMSO (Fig 2.17B, n = 3 (5 mg·mL-1 P3 (No DMSO and 




From our heating curves, we saw that our peak shifts aligned with the presence 
of DMSO (Fig 2.18A) and premelting peaks only exist in the F-12K solution, most 
likely due to the increased complexity of complete F-12K as a base solution. 
Obtaining the melting point from the onset of the exothermic peak, we saw 
statistically significant differences in melting temperature only for solutions 
Figure 2.17. DSC cooling of polyampholyte MW solutions in F-12K. A) DSC 
trace of P1-P3 solutions cooled to -150 °C at 10 °C·min-1. B) Average enthalpy of ice 
crystallisation of solutions calculated from area under curve on DSC trace. Error bars 
represent ± SEM of 3 independent experiments (5 mg·mL-1 P3 (No DMSO and 10% 
DMSO) N=2). * P < 0.0001 from F-12K. 
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containing 10% DMSO compared to F-12K (Fig 2.18B, n = 3 (5 mg·mL-1 P3 (No 





A single molecular weight (P2, Mn = 80 kDa) was selected for further analysis. In 
evaluating the phase transition of the concentration effects of P2 we saw that all 
combinations of our solutions in PBS were freezing and not vitrifying (Fig 2.19A). 
Looking at the enthalpy of crystallisation, we saw only statistically significant 
differences for solutions containing DMSO (Fig 2.19B, n = 3, P = 0.000003). We 
Figure 2.18. DSC heating of polyampholyte MW solutions in F-12K.  A) DSC 
trace of warming P1-P3 solutions from -150 °C to 25 °C at 10 °C·min-1. B) Average 
melting temperature calculated from onset of DSC exothermic drop.  Error bars 
represent ± SEM of 3 independent experiments (5 mg·mL-1 P3 (No DMSO and 10% 
DMSO) N=2). * P < 0.0001 from F-12K. 
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From our heating curves, we saw that our small peak shifts aligned with the 
DMSO concentration (Fig 2.20A) and eutectic peaks exist for PBS and 5 mg·mL-1 
P2 but disappear upon higher concentrations/more complex mixtures. Obtaining 
the melting point from the onset of the exothermic peak, we saw statistically 
significant differences in melting temperature for solutions containing 5 and 10% 
DMSO compared to PBS along with a statistically significant lower melting 
Figure 2.19. DSC cooling of polyampholyte P2 solutions in PBS. A) DSC trace of 
P2 solutions cooled to -150 °C at 10 °C·min-1. B) Average enthalpy of ice 
crystallisation of solutions calculated from area under curve on DSC trace. Error bars 
represent ± SEM of 3 independent experiments. * P < 0.0001 from PBS. 
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temperature for 40 mg·mL-1 P2 + 10% DMSO compared to 10% DMSO, similar to 
the concentration effects we have seen previously (Fig 2.20B, n = 3, P = 
0.00000003). For solutions in F-12K, we saw statistically significant differences 
only for solutions containing 10% DMSO, as well as a statistically significant 
lower melting temperature for 40 mg·mL-1 P2 + 10% DMSO compared to 10% 




None of our macromolecular cryoprotectants significantly altered the ice 
crystallisation enthalpy or the melting temperature compared to standards. We 
Figure 2.20. DSC heating of polyampholyte P2 solutions in PBS.  A) DSC trace of 
warming P2 solutions from -150 °C to 25 °C at 10 °C·min-1. B) Average melting 
temperature calculated from onset of DSC exothermic drop.  Error bars represent ± 
SEM of 3 independent experiments. * P < 0.0001 from PBS, ** P < 0.0001 from 10% 
DMSO in PBS. 
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did see significant differences for high concentration solutions, owing to 
colligative effects rather than inherent properties of the compounds themselves. 
We have additionally shown that all of our macromolecular cryoprotectant 
solutions are freezing and not vitrifying.  
 
 2.4.2.4 Combined Osmolyte PVA DSC 
Although osmolytes have not been reported to heavily influence the ice fraction, 
we wanted to extensively test these compounds, on their own and in combination 
with PVA, to ensure there were no agonistic/antagonistic interactions or 
alterations of phase transitions that could be attributed to any cryoprotection 
these small molecule osmolytes may afford. We measured the phase transition 
and melting temperatures of our individual osmolyte solutions in both PBS and F-
12K, followed by combinations in solution of 5 mg·mL-1 PVA and 10% DMSO in 
both PBS and F-12K, and then finally, the combination of PVA + DMSO in both 
PBS and F-12K (Fig 2.37-2.48). Combining the data for comparison, we can see 
that with the addition of osmolytes, our solutions are freezing and not vitrifying 
(Fig 2.21). Looking at the enthalpy of crystallisation, there were no significant 
differences among our solutions which contained DMSO, showing that our 
osmolytes in combination with PVA did not induce vitrification (Fig 2.22, n = 3, P 
= 0.0000004). We did observe a lower enthalpy for both alanine and proline 
(+PVA+DMSO) solutions. There exists very little literature on alanine’s interaction 
with ice and we believe that alanine may be affecting ice nucleation in some way, 
however, this requires further study. Proline has been shown to reduce the glass 
transition temperature at high concentrations,75 however, for 100 mM proline 
(+PVA+DMSO) we saw no change in the ice crystallisation enthalpy or a phase 
change from freezing to vitrification. Similar to our results, proline-fed larvae of 
two Drosophilia melanogaster flies (resulting in cold-acclimation76) showed 
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relatively small differences in ice fraction dynamics.77 This suggests that the lower 
ice crystal enthalpy for 200 mM proline (+PVA+DMSO) is due to concentration 
colligative effects. 
 




Figure 2.21. DSC cooling of osmolyte solutions to -150 °C at 10 °C·min-1. A) 
Solutions in PBS. B) Solutions with 5 mg·mL-1 PVA in PBS.  C) Solutions with 5 
mg·mL-1 PVA + 10% DMSO in PBS.  




From our heating curves, we saw that we did not have large peak shifts with the 
addition of our osmolytes (Fig 2.23), suggesting there were no large freezing 
point depression alterations and we observed no premelting peaks for any of the 
osmolyte solutions. Obtaining the melting point from the onset of the exothermic 
peak, we saw no significant differences in melting temperature for our osmolyte 
solutions containing PVA+DMSO (Fig 2.24, n = 3, P = 0.0000002). Betaine has 
been shown to slightly increase the melting temperature42 but we did not see any 
difference for the concentration tested. We did see a slightly lower melting 
temperature for 200 mM proline (+PVA+DMSO), however it was not observed 
with 100 mM proline so we believe this is also a concentration colligative effect. 
 
Figure 2.22. Average enthalpy of ice crystallisation for osmolyte solutions.  
Average enthalpy of ice crystallisation of solutions calculated from area under curve 
on DSC trace. Error bars represent ± SEM of 3 independent experiments (100 mM 
proline in PBS (standards) N=2 and was not included in statistical analyses). * P < 
0.001 from PBS. ** P < 0.001 from 10% DMSO. 





Figure 2.23. DSC heating of osmolyte solutions warmed from -150 °C to 25 
°C at 10 °C·min-1. A) Solutions in PBS. B) Solutions with 5 mg·mL-1 PVA in PBS. 
C) Solutions with 5 mg·mL-1 PVA + 10% DMSO in PBS. 




We saw no significant changes for the addition of osmolytes in our solutions and 
are confident that phase change alterations are not responsible for 
cryopreservation outcomes. Our results thus far have shown that PVA, 
osmolytes, or a combination of both do not alter the phase transitions of ice. 
There may be aspirations to extrapolate data from our two physical assays, IRI 
and DSC, to explain the results of each other. However, our conditions and 
assays are not wholly comparable. The IRI assay is an artificial environment 
which allows us to observe crystallisation. Our solutions of interest are usually 
quenched at CO2(s) temperatures and this deep supercooling can give rise to the 
small ice crystals seen.78 Therefore, ice grains within the DSC pans are unlikely 
to ever be as small as those seen in the splat assays. Additionally, the DSC 
cooling rates are slow cooling rates with variable temperatures and that results in 
a much different environment than those used for the IRI assay which are held at 
one single temperature. These assays independently explore the potential for ice 
recrystallisation inhibition along with the enthalpy of crystallisation and melting 
Figure 2.24. Melting temperature for osmolyte solutions. Average melting 
temperature of solutions calculated from onset of exothermic drop on DSC trace.  
Error bars represent ± SEM of 3 independent experiments (100 mM proline in PBS 
(standards) N=2 and was not included in statistical analyses). * P < 0.0001 from PBS. 
** P< 0.0001 from 10% DMSO. 
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temperatures, which allows us to answer questions as to the ice interactions and 
influences of these compounds. 
2.5 Conclusion 
In this chapter our aim was to assess the IRI activity of our macromolecular and 
molecular compounds along with any influence on the enthalpy of crystallisation 
and melting temperature. We found that PVA is a potent IRI polymer, regardless 
of solvent (PBS or cell media) and polyproline and polyampholyte showed weak 
IRI activity in comparison. The osmolytes themselves showed weak IRI activity 
yet did not inhibit PVA’s high IRI activity. All solutions containing macromolecular 
cryoprotectants, osmolytes, DMSO, or a combination of, have been shown to 
freeze and not vitrify and the polymers and osmolytes did not affect DMSO’s 
phase transitions. Our results have been summarised in Table 2.2. The results of 
this chapter have shown that PVA would be considered to have a large impact on 
the physical properties of the ice as a potential mechanism via ice 
recrystallisation inhibition, while the polymers of polyproline and polyampholyte, 
along with the osmolytes of alanine, betaine, and proline, have only a minimal 
influence on the physical properties of ice for the IRI. This is most likely due to 
the orientation and spacing of the hydroxyl groups of PVA, which allow it to bind 
to and inhibit the recrystallisation of ice upon thawing, and therefore, it would 
follow that the rest of our compounds do not have the necessary groups and/or a 
favourable orientation of those groups to influence ice recrystallisation in the 
same manner as PVA. An interesting next step would be to assay the phase 
transitions of the solutions via DSC in the presence of cells attached as a 
monolayer as we don’t know how the presence of cells influences the phase 
transitions of the solutions. Additionally, Raman spectroscopy of the solutions on 
their own and in the presence of cells could also provide further insights into the 
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shape and size of the ice fractions, allowing a baseline of starting fraction sizes 










  (µm2) (J·g-1) (˚C) 
Target ↓ - - 
Control 4519.59a 157.65c -13.68c 
5 mg·mL-1 
PVA  365.87 158.54 -15.05 
100 mM 
Alanine 2326.05
b − − 
Alanine + PVA 117.9 112.13 -15.09 
100 mM 
Betaine 3641.71
b − − 
Betaine + PVA 354.71 170.03 -13.49 
200 mM  
Proline 2657.67
b − − 
Proline + PVA 344.34 75.54 -20.82 
5 mg·mL-1 
Polyproline 1323.41
b 169.78d -14.65d 
5 mg·mL-1 P2 
Polyampholyte 2622.38
b 168.33 -14.40 
 
 
2.6 Materials and Methods 
2.6.1 Chemical structures 
All structures were drawn with ChemDraw 19.0 (PerkinElmer, Waltham, MA). 
2.6.2 Reagents and solutions 
PVA (Mw 9,000-10,000, 80% hydrolysed, CAS Number: 9002-89-5) was obtained 
from Sigma Aldrich Co Ltd, (Irvine, UK). Standard cell culture medium was 
composed of Ham's F-12K (Kaighn's) Medium (F-12K) (Gibco, Paisley, UK) 
supplemented with 10% USA-origin foetal bovine serum (FBS) purchased from 
Table 2.2. Chapter 2 Results Summary.  Control = aPBS, b5 mg·mL-1 PVA in PBS, 
c10% DMSO in PBS, d+200 mM proline. Significantly higher than control, significant 
from control and indicated solution, significantly lower than control. 
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Sigma Aldrich (Dorset, UK) and 100 units·mL-1 penicillin, 100 µg·mL-1 
streptomycin, and 250 ng·mL-1 amphotericin B (PSA) (HyClone, Cramlington, 
UK). Solutions for experiments were prepared by dissolving the individual 
compounds in PBS or base cell media supplemented with 10% FBS and 1x PSA 
(solutions to be used as CPAs did not contain PSA) and sterile filtering prior to 
use.  
2.6.2.1 Synthesis of polyproline 
Performed and written by Dr Ben Graham from the University of Warwick 
and reproduced here for completeness. EDCI (0.50 g, 2.60 mmol) was 
dissolved in dry DCM (20 mL) and stirred at room temperature under a flow of 
nitrogen for 20 minutes, followed by cooling to 0 ºC. Within 5 minutes of cooling, 
L-proline (0.30 g, 2.60 mmol, 1 eqv) and OxymaPureTM (0.37 g, 2.60 mmol, 1 
eqv) were added together to the reaction mixture, resulting in an instantaneous 
colour change to yellow. The mixture was stirred on ice under nitrogen for 1 
further hour, and then warmed to RT with stirring overnight. The dark yellow 
solution was condensed in vacuo, dissolved in Milli-Q water (10 mL) acidified to 
pH 3-4 with 3M HCl, and a minimum volume of methanol added until residual 
solids dissolved. Dialysis (> 1 kDa) for 48 hours was subsequently performed 
with regular water changes. The resulting solution was freeze dried, yielding an 
offwhite solid. 31.4 mg (10.4%). The DL racemate, P(DL)Pron, utilised a 1:1 ratio 
of L- and D-proline (2.60 mmol prolines). 
2.6.2.1.1 Polyproline physical and analytical methods   
Performed and written by Dr Ben Graham and included here for 
completeness. SEC (size exclusion chromatography) was acquired a DMF 
Agilent 390-LC MDS instrument equipped with differential refractive index (DRI), 
viscometry (VS), dual angle light scatter (LS) and dual wavelength UV detectors. 
The system was equipped with 2 x PLgel Mixed D columns (300 x 7.5 mm) and a 
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PLgel 5 µm guard column. The eluent is DMF with 5 mmol NH4BF4 additive. 
Samples were run at 1 mL/min at 50’C. Poly(methyl methacrylate) standards 
(Agilent EasyVials) were used for calibration. Analyte samples were filtered 
through a nylon membrane with 0.22 µm pore size before injection. Respectively, 
experimental molar mass (Mn,SEC) and dispersity (Đ) values of synthesised 
polymers were determined by conventional calibration (relative to poly(methyl 
methacrylate) standards) using Agilent GPC/SEC software. Refractive index 
recorded. 
2.6.2.2 Synthesis of polyampholyte 
Performed and written by Dr Christopher Stubbs and included here for 
completeness. As a representative example, poly(methyl vinyl ether-alt-maleic 
anhydride), average Mn ~80,000 Da, (1 g) was dissolved in tetrahydrofuran (50 
mL) and heated to 50 °C with stirring. After dissolution, dimethylamino ethanol (2 
g) was added in excess, forming a pink waxy solid, which was allowed to stir for 
30 minutes. 50 mL water was added, and the reaction left to stir overnight 
followed by purification in dialysis tubing (Spectrapor, 12 – 14 kDa MWCO) for 48 
hours with 7 water changes. The resulting solution was freeze-dried to evolve a 
white solid. 
2.6.2.2.1 Polyampholyte physical and analytical methods   
Performed and written by Dr Christopher Stubbs, from the University of 
Warwick and included here for completeness. 1H and 13C NMR spectra were 
recorded on Bruker Avance III HD 300 MHz, HD 400 MHz or HD 500 MHz 
spectrometers using deuterated solvents obtained from Sigma-Aldrich. Chemical 
shifts are reported relative to residual non-deuterated solvent.  
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2.6.3 Splat Assays 
A 10 µL droplet of compound in solution was dropped using a Hamilton gastight 
1750 syringe (Hamilton Bonaduz AG, GR, Switzerland) coupled with a BD 
microlance 3 21G needle (BD, Oxfordshire, UK) from a fixed height of 1.4 m onto 
a 22x22 mm no.1 glass cover slip (Fisher Scientific UK Ltd, Leicestershire, UK) 
placed on a CO2(s) cooled aluminium plate (~ -70 °C). The droplet froze instantly 
upon impact with the plate, spread out, and formed a thin wafer of ice. This wafer 
was then placed on a liquid nitrogen cooled BCS196 cryostage (Linkam 
Scientific, Surrey, UK) and held at -8 °C to anneal for 30 min using the LNP96 
cooling system (Linkam Scientific). Photographs were taken using a Canon EOS 
500D SLR digital camera (Canon (UK) Ltd, Surrey, UK) after 0 and 30 minutes 
coupled to an Olympus CX41 microscope (Olympus, Southend-on-Sea, UK) 
equipped with UIS-2 20x/0.45/∞/0-2/FN22, UIS-2 4x/0.1/∞/-/FN22 and UIS-2 
10x/0.2/∞/-/FN22 lenses (Olympus Ltd, Essex, UK) through cross polarisers.  The 
number of crystals in the image were counted using ImageJ (version 1.52a)79 and 
the area of the field of view divided by the number of crystals gave the average 
crystal size per wafer. 
2.6.4 Differential Scanning Calorimetry 
Samples were prepared by weighing standard 40 µL aluminium crucibles (Mettler 
Toledo, Leicestershire, UK) and adding 15 µL of analyte before sealing 
(hermetically) and reweighing in order to quantify the exact mass of sample.  
Each sample was then transferred to a liquid nitrogen cooled DSC 1 STAR® 
system (Mettler Toledo, Leicestershire, UK) differential scanning calorimeter. The 
mass of the aluminium crucible and sample mass was input into the 
complimentary STARe thermal analysis software to retain a digital record and aid 
analysis. Each DSC sample was individually cooled from +25 ºC to -150 ºC at a 
rate of 10 ºC·min-1 whilst concurrently monitoring the heat flow (mW) of the 
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system to detect any endothermic or exothermic transitions. When samples were 
cooled to -150 ºC, each sample was held for 10 min and then warmed at a rate of 
10 ºC·min-1 from -150 ºC to +25 ºC. Raw data from each experiment was 
exported and plotted in R (R Foundation for Statistical Computing, Vienna, 
Austria) and individual peaks highlighted for comparison using the STARe 
thermal analysis software built-in modelling functions for linear curve fitting and 
area under the curve when required. 
2.6.5 Statistical Analysis 
Data were analysed with a one-way analysis of variance (ANOVA) on ranks 
followed by comparison of experimental groups with the appropriate control group 
(Holm–Sidak method) followed by Tukey’s post hoc test. Excel 2013 (Microsoft, 
Redmond, WA) and R were used for the analyses and graphs. Data sets are 
presented as mean ± (SEM).   
 





Figure 2.25. Splat of polyproline and PVA solutions in F-12K.  A) Splat micrograph 
of F-12K. B) Splat micrograph of 5 mg·mL-1 PVA in F-12K. C) Splat micrograph of 5 
mg·mL-1 polyproline in F-12K. D) Splat micrograph of 20 mg·mL-1 polyproline in F-12K. 
Scale bar = 100 µm. E) Average ice crystal size of solutions calculated from splat 
wafers. * P < 0.001 from F-12K, ** P < 0.001 from 5 mg·mL-1 PVA in F-12K. Error bars 
represent ± SEM of 3 independent experiments. 




Figure 2.26. Splat of polyampholyte P2 and PVA solutions in F-12K.  A) Splat 
micrograph of F-12K. B) Splat micrograph of 5 mg·mL-1 PVA in F-12K. C) Splat 
micrograph of 5 mg·mL-1 P2 in F-12K. D) Splat micrograph of 40 mg·mL-1 P2 in F-12K. 
Scale bar = 100 µm. E) Average ice crystal size of solutions calculated from splat 
wafers. * P < 0.001 from F-12K, ** P < 0.001 from 5 mg·mL-1 PVA in F-12K. Error bars 
represent ± SEM of 3 independent experiments. 







Figure 2.27. Splat of proline solutions in PBS.  A) Splat of PBS. B) Splat of 200 
mM proline in PBS. C) Splat of 5 mg·mL-1 PVA in PBS. D) Splat of 200 mM proline + 
5 mg·mL-1 PVA in PBS. E) Average crystal size of solutions calculated from splat ice 
wafers.  * P < 0.0001 from PBS, ** P < 0.0001 from 5 mg·mL-1 PVA in PBS, *** P < 
0.0001 from 200 mM proline in PBS. Error bars represent ± SEM of 3 independent 
experiments. Scale bar = 100 µm (NP=No polymer). 
Figure 2.28. Splat of proline solutions in F-12K.  A) Splat of F-12K. B) Splat of 200 
mM proline in F-12K. C) Splat of 5 mg·mL-1 PVA in F-12K. D) Splat of 200 mM proline 
+ 5 mg·mL-1 PVA in F-12K. E) Average crystal size of solutions calculated from splat 
ice wafers.  * P < 0.0001 from F-12K, ** P < 0.0001 from 5 mg·mL-1 PVA in F-12K, 
*** P < 0.0001 from 200 mM proline in F-12K. Error bars represent ± SEM of 3 
independent experiments. Scale bar = 100 µm (NP=No polymer). 






Figure 2.29. Splat of betaine solutions in PBS.  A) Splat of PBS. B) Splat of 100 
mM betaine in PBS. C) Splat of 5 mg·mL-1 PVA in PBS. D) Splat of 100 mM betaine + 
5 mg·mL-1 PVA in PBS. E) Average crystal size of solutions calculated from splat ice 
wafers.  * P < 0.0001 from PBS, ** P < 0.0001 from 5 mg·mL-1 PVA in PBS, *** P < 
0.0001 from 100 mM betaine in PBS. Error bars represent ± SEM of 3 independent 
experiments. Scale bar = 100 µm (NP=No polymer). 
Figure 2.30. Splat of betaine solutions in F-12K.  A) Splat of F-12K. B) Splat of 
100 mM betaine in F-12K. C) Splat of 5 mg·mL-1 PVA in F-12K. D) Splat of 100 mM 
betaine + 5 mg·mL-1 PVA in F-12K. E) Average crystal size of solutions calculated 
from splat ice wafers.  * P < 0.0001 from F-12K, ** P < 0.0001 from 5 mg·mL-1 PVA in 
F-12K, *** P < 0.0001 from 100 mM betaine in F-12K. Error bars represent ± SEM of 
3 independent experiments. Scale bar = 100 µm (NP=No polymer). 






Figure 2.31. Splat of alanine solutions in PBS.  A) Splat of PBS. B) Splat of 100 
mM alanine in PBS. C) Splat of 5 mg·mL-1 PVA in PBS. D) Splat of 100 mM alanine + 
5 mg·mL-1 PVA in PBS. E) Average crystal size of solutions calculated from splat ice 
wafers.  * P < 0.0001 from PBS, ** P < 0.0001 from 5 mg·mL-1 PVA in PBS, *** P < 
0.0001 from 100 mM alanine in PBS. Error bars represent ± SEM of 3 independent 
experiments. Scale bar = 100 µm (NP=No polymer). 
Figure 2.32. Splat of alanine solutions in F-12K.  A) Splat of F-12K. B) Splat of 
100 mM alanine in F-12K. C) Splat of 5 mg·mL-1 PVA in F-12K. D) Splat of 100 mM 
alanine + 5 mg·mL-1 PVA in F-12K. E) Average crystal size of solutions calculated 
from splat ice wafers.  * P < 0.0001 from F-12K. Error bars represent ± SEM of 3 
independent experiments. Scale bar = 100 µm (NP=No polymer). 




Figure 2.33. DSC cooling of polyproline solutions in F-12K.  A) DSC trace of 
cooling to -150 °C at 10 °C·min-1. B) Average enthalpy of ice crystallisation of 
solutions calculated from area under curve on DSC trace.  Error bars represent ± 
SEM of 3 independent experiments. * P < 0.0001 from F-12K. 




Figure 2.34. DSC heating of polyproline solutions in F-12K.  A) DSC trace of 
warming polyproline solutions from -150 °C to 25 °C at 10 °C·min-1. B) Average 
melting temperature calculated from onset of DSC exothermic drop.  Error bars 
represent ± SEM of 3 independent. * P < 0.001 from F-12K, ** P < 0.001 from 10% 
DMSO in F-12K. 
 





Figure 2.35. DSC cooling of polyampholyte P2 solutions in F-12K. A) DSC trace 
of P2 solutions cooled to -150 °C at 10 °C·min-1. B) Average enthalpy of ice 
crystallisation of solutions calculated from area under curve on DSC trace. Error bars 
represent ± SEM of 3 independent experiments. * P < 0.0001 from F-12K, ** P < 
0.0001 from 10% DMSO in F-12K. 





Figure 2.36. DSC heating of polyampholyte P2 solutions in F-12K.  A) DSC trace 
of warming P2 solutions from -150 °C to 25 °C at 10 °C·min-1. B) Average melting 
temperature calculated from onset of DSC exothermic drop.  Error bars represent 
± SEM of 3 independent. * P < 0.001 from F-12K, ** P < 0.001 from 10% DMSO in 
F-12K. 





Figure 2.37. DSC cooling of proline solutions in PBS.  A) DSC trace of cooling to -
150 °C at 10 °C·min-1. B) Average enthalpy of ice crystallisation of solutions calculated 
from area under curve on DSC trace.  Error bars represent ± SEM of 3 independent 
experiments. * P < 0.001 from PBS. ** P< 0.001 from 10% DMSO.  (100 mM proline 
N=2 and not included in statistical analysis.) 




Figure 2.38. DSC heating of proline solutions in PBS.  A) DSC trace of warming from -
150 °C to 25 °C at 10 °C·min-1. B) Average melting temperature calculated from onset of 
DSC mW drop.  Error bars represent ± SEM of 3 independent experiments (100 mM 
proline N=2 and not included in statistical analysis). * P < 0.0001 from PBS. ** P < 0.0001 
from 10% DMSO.   




Figure 2.39. DSC cooling of proline solutions in F-12K.  A) DSC trace of cooling to 
-150 °C at 10 °C·min-1. B) Average enthalpy of ice crystallisation of solutions 
calculated from area under curve on DSC trace.  Error bars represent ± SEM of 3 
independent experiments (100 mM proline N=2 and was not included in statistical 
analysis). * P < 0.00001 from F-12K. ** P < 0.00001 from 10% DMSO.   




Figure 2.40. DSC heating of proline solutions in F-12K.  A) DSC trace of warming 
from -150 °C to 25 °C at 10 °C·min-1. B) Average melting temperature calculated from 
onset of DSC mW drop.  Error bars represent ± SEM of 3 independent experiments. * P < 
0.00001 from F-12K.   ** P < 0.0001 from 10% DMSO. (100 mM proline N=2 and was not 
included in statistical analysis.) 




Figure 2.41. DSC cooling of betaine solutions in PBS.  A) DSC trace of cooling 
to -150 °C at 10 °C·min-1. B) Average enthalpy of ice crystallisation of solutions 
calculated from area under curve on DSC trace.  Error bars represent ± SEM of 3 
independent experiments. * P < 0.0001 from PBS. ** P< 0.001 from 10% DMSO. 




Figure 2.42. DSC heating of betaine solutions in PBS.  A) DSC trace of warming 
from -150 °C to 25 °C at 10 °C·min-1. B) Average melting temperature calculated 
from onset of DSC mW drop.  Error bars represent ± SEM of 3 independent 
experiments. * P < 0.00001 from PBS.   ** P < 0.0001 from 10% DMSO.  
 




Figure 2.43. DSC cooling of betaine solutions in F-12K.  A) DSC trace of cooling 
to -150 °C at 10 °C·min-1. B) Average enthalpy of ice crystallisation of solutions 
calculated from area under curve on DSC trace.  Error bars represent ± SEM of 3 
independent experiments. * P < 0.0001 from F-12K. ** P< 0.001 from 10% DMSO. 




Figure 2.44. DSC heating of betaine solutions in F-12K.  A) DSC trace of 
warming from -150 °C to 25 °C at 10 °C·min-1. B) Average melting temperature 
calculated from onset of DSC mW drop.  Error bars represent ± SEM of 3 
independent experiments. * P < 0.00001 from F-12K.   ** P < 0.0001 from 10% 
DMSO.  
 




Figure 2.45. DSC cooling of alanine solutions in PBS.  A) DSC trace of cooling to 
-150 °C at 10 °C·min-1. B) Average enthalpy of ice crystallisation of solutions 
calculated from area under curve on DSC trace.  Error bars represent ± SEM of 3 
independent experiments. * P < 0.0001 from PBS. ** P< 0.001 from 10% DMSO. 




Figure 2.46. DSC heating of alanine solutions in PBS.  A) DSC trace of warming 
from -150 °C to 25 °C at 10 °C·min-1. B) Average melting temperature calculated 
from onset of DSC mW drop.  Error bars represent ± SEM of 3 independent 
experiments. * P < 0.00001 from PBS.   ** P < 0.0001 from 10% DMSO.  
 




Figure 2.47. DSC cooling of alanine solutions in F-12K.  A) DSC trace of cooling 
to -150 °C at 10 °C·min-1. B) Average enthalpy of ice crystallisation of solutions 
calculated from area under curve on DSC trace.  Error bars represent ± SEM of 3 
independent experiments. * P < 0.0001 from F-12K. ** P< 0.001 from 10% DMSO. 
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3. BIOCOMPATIBILITY OF 
MOLECULAR AND 
MACROMOLECULAR COMPOUNDS 
ON A549 CELLS 
 
3.1 DECLARATIONS 
All polyampholyte polymers were synthesised by Dr Christopher Stubbs and all 
polyproline polymers were synthesised by Dr Ben Graham, both under the 
supervision of Prof Matthew Gibson. 
 
3.2 CHAPTER SUMMARY  
In examining potential cryoprotective agents, the ability of these compounds to 
provide protection without introducing down-stream ill effects of their own is vital. 
Here we show the compatibility of three macromolecular cryoprotectants that do 
not reduce cell metabolism when used for a CPA exposure time of 10 min, which 
aligns with the cryopreservation conditions used throughout this thesis. We 
additionally show that our small molecule osmolytes do not show cell cytotoxicity 
for incubation times up to 24 h. Only one small molecule, proline, was shown to 
down-regulate cell growth, and growth was shown to be recoverable to normal 
levels when the proline solution was removed, which may help explain its 
cryoprotective benefit. 
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3.3 INTRODUCTION 
The aim of this chapter was to understand how our macromolecular 
cryoprotectants and molecular osmolytes affect cells at physiological conditions 
and to examine cytotoxicity and proliferation. The ideal test for in vitro cytotoxicity 
is a simple, rapid, efficient, reliable, and cost-effective measurement of cell 
viability and additionally should not interfere with the compound being tested. 
AlamarBlue has been widely used over the past 50 years in studies on cell 
viability and cytotoxicity in a range of biological systems and is one of the most 
highly referenced substances used for cytotoxicity and viability assays according 
to PubMed records.1 AlamarBlue monitors the reducing environment of the living 
cell. The active ingredient is resazurin (IUPAC name: 7-hydroxy-10-
oxidophenoxazin-10-ium-3-one), also known as diazo-resorcinol, azoresorcin, 
resazoin, or resazurine, which is water-soluble, stable in culture medium, is non-
toxic, and permeable through cell membranes.1 The oxidised, blue, non-
fluorescent alamarBlue is reduced to a pink fluorescent dye in the medium by cell 
activity (likely by oxygen consumption through metabolism).2 The reduced form, 
resorufin, is pink and highly fluorescent, and the intensity of the pink colour or 
fluorescence produced is proportional to the number of living cells respiring. 
Through detecting the level of reduction during respiration, alamarBlue acts as a 
direct indicator to quantitatively measure cell viability and cytotoxicity. 
Spectrophotometric absorbance is taken at two wavelengths (570 and 600 nm). 
Since organisms that undergo seasonal exposure to environmental stresses 
utilise downregulation of metabolism to enter a hypometabolic state (diapause),3 
it follows that we would want to explore if these processes were taking place due 
to the presence of osmolytes. Metabolic depression and cell stasis are often 
prerequisites to survival for animals whose evolutionary history has provided 
natural adaptations to desiccation, freezing temperatures, and anoxia.4 It has also 
3 – Biocompatibility of Molecular and Macromolecular Compounds on A549 Cells  
 110 
been shown that a requirement for freezing survival in both Caenorhabditis 
elegans5 and Drosophila melanogaster6 is a reduction in metabolic activity. 
Therefore, we wanted to investigate how incubation with compatible osmolytes 
affected the proliferation of cells. This was accomplished by simply counting the 
cells daily throughout a long exposure osmolyte incubation. For a more detailed 
analysis, we conducted cell cycle analysis to determine if down-regulation or 
stasis may be occurring.  
It is important to understand how any compounds used in the presence of cells 
will impact those cells under ideal physiological conditions in order to establish a 
baseline of compound influence. We will evaluate the impact of metabolic activity 
via alamarBlue reduction to evaluate the potential cytotoxicity of our compounds. 
In order to evaluate the proliferation impacts of our compounds, we will conduct 
long-term growth assays of cells incubated in the compounds for the duration of 
the assay. The specific aims of this chapter were to evaluate if (i) any of our 
macromolecular cryoprotectants or molecular osmolytes were inherently toxic to 
our cells and the working ranges thereof, (ii) the osmolytes affected the 
proliferation rate of cells. The results of this chapter will allow us to identify any 
potential downstream issues that may result from the cells being in contact with 
the compound of interest, such as reduced metabolism or up/down-regulation of 
growth. 
 
3.4 RESULTS AND DISCUSSION 
3.4.1 Cytotoxicity 
 In evaluating the impact the compounds had on A549 cell metabolism as a 
means of cytotoxicity screening, it is important to note that DMSO, the most 
common cryoprotective agent (CPA), is cytotoxic at room temperature and high 
concentrations.7 In evaluating the cytotoxicity of our macromolecular 
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cryoprotectants we were not looking to rule out a particular compound but rather 
to understand how these polymers may be interacting with our cells. Since our 
polymers will be functioning in a CPA capacity, we tested two incubation times, 
exposure for 10 min (thereafter replaced with cell media) along with an extreme 
exposure of 24 h. The 10 min exposure was to replicate the CPA exposure time 
in our monolayer protocol with a 24 h extreme exposure to test severe 
responses. The osmolyte compounds will only be utilised for a 24 h incubation 
treatment as CPAs, and were assayed as such. Following the incubation periods, 
cells were treated with a 1% alamarBlue (resazurin) solution. Control cells were 
measured in tandem with experimental cells and values were normalised based 
on control values of 100% reduction. Less reduction represents less metabolism 
and thus suggests cell damage. 
 
3.4.1.1 PVA Cytotoxicity 
We first investigated PVA toxicity on A549 cells for 10 min and 24 h and 
compared these results to cells exposed to 10% DMSO. Normalised alamarBlue 
reduction for all concentrations of PVA was not significantly different from control 
cells (0 mM) after a 10 min incubation, however, 10% DMSO did show 
significantly less reduction following a 10 min exposure (Fig 3.1, n ≥ 3, P = 
0.0000000001). For our 24 h incubation, PVA led to lower alamarBlue reduction 
when treated at 1, 2, and 10 mg·mL-1. However, this 24 h PVA reduction was not 
extreme and was comparable to cells treated with 10% DMSO for 10 min. Cells 
exposed for 24 h to 10% DMSO had a significantly lower alamarBlue reduction of 
only 31.9%. This correlates with previous data showing that PVA is non-toxic at 
up to 20 mg·mL-1 concentrations8 as PVA is regularly utilised in eye drops and is 
FDA approved. We have shown that PVA was non-toxic for the exposure time of 
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a CPA (10 min) and only minimally reduced metabolic activity when incubated for 




3.4.1.2 Polyproline Cytotoxicity 
Following our screen using PVA, we next wanted to understand how polyproline 
may affect cell metabolism. Utilising varying concentrations of poly(L-proline) with 
a 10 min incubation, we did not see significant differences from control cells 
(0 mM). However, we did see significantly less metabolic activity for 
concentrations above 1 mg·mL-1 poly(L-proline) when incubated for 24 h (Fig 3.2, 
n ≥ 3, P = 0.0000000001). To evaluate if poly(L-proline) was causing a specific 
cell response to reduce metabolic activity, we also tested the isomer of poly(L-
proline), poly(D-proline). Similar to poly(L-proline), incubating cells in poly(D-
Figure 3.1. A549 PVA cytotoxicity. Average normalised alamarBlue reduction for 10 
min and 24 h. * P < 0.0001 from control (0 mM). Error bars represent ± SEM of at least 
3 independent experiments.  
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proline) for 24 h showed significantly lower alamarBlue reduction for 
concentrations above 5 mg·mL-1 compared to untreated control cells, suggesting 
the reduction in metabolic activity was not an isomer specific effect. We have 
found that poly(L-proline) was non-toxic for the exposure time of a CPA (10 min) 
and reduced metabolic activity similar to 10% DMSO when incubated for 24 h (an 




3.4.1.3 Polyampholyte Cytotoxicity 
Testing the cytotoxicity of our final novel macromolecular cryoprotectant, 
polyampholyte P2 (Mn = 80 kDa), we saw no difference in reduction for cells 
incubated with varying concentrations of polyampholyte for 10 min compared to 
control cells (0 mM) (Fig 3.3, n ≥ 3, P = 0.0000000003). For our 24 h incubation, 
we saw significant reductions for concentrations higher than 10 mg·mL-1, with 
Figure 3.2. A549 polyproline cytotoxicity. Average normalised alamarBlue reduction 
for 10 min and 24 h. * P < 0.0001 from control (0 mM). Error bars represent ± SEM of at 
least 3 independent experiments.  
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reductions falling midway between reductions seen for 10% DMSO at 10 min and 
24 h. This suggests that polyampholyte P2 is non-toxic for the exposure time of a 
CPA (10 min) and only minimally reduced metabolic activity when incubated for 
24 h at high concentrations.  
 
 
3.4.1.4 Combined Osmolyte Cytotoxicity 
Following analysis of our macromolecular compounds, we next tested the effect 
our small molecular osmolytes had on cell metabolic activity. We first tested our 
osmolyte solutions individually for alamarBlue reduction (Fig 3.10-3.12). F-12K 
media contains 0.2 mM alanine and 0.6 mM proline and the concentrations listed 
in our assays are in addition to the pre-existing osmolytes in the base cell media 
formulation. Combining the individual results for comparison, we saw that 
alamarBlue reduction of A549 cells incubated for 24 h with varying concentrations 
Figure 3.3. A549 polyampholyte P2 cytotoxicity. Average normalised alamarBlue 
reduction for 10 min and 24 h. * P < 0.0001 from control (0 mM). Error bars represent ± 
SEM of at least 3 independent experiments.  
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of osmolytes showed no significant difference in reduction compared to control 
(F-12K 0 mM) (Fig 3.4, n = 3). These results were somewhat unsurprising, as 
compatible solutes are highly soluble organic compounds of low molecular weight 
that maintain osmotic balance (osmoregulation) without interfering with cell 
metabolism.9 We have shown that incubation with osmolytes for 24 h did not alter 
the metabolic capabilities of the cells compared to control and thus appear to be 




This section has demonstrated that our macromolecular cryoprotectants are not 
toxic to A549 cells when used for the CPA duration time of 10 min. PVA showed 
minimal toxicity for longer exposure times, polyproline showed reduced 
reductions similar to 10% DMSO for long exposure, and polyampholyte showed 
Figure 3.4. A549 osmolyte cytotoxicity. Average normalised alamarBlue reduction 
after 24 h incubation. Error bars represent ± SEM of 3 independent experiments. 
3 – Biocompatibility of Molecular and Macromolecular Compounds on A549 Cells  
 116 
lower reduction at high concentrations. It should be noted that DMSO is redox 
reactive, as several DMSO reductases exist,10 however all compounds were 
assayed without cells and no alamarBlue reduction was observed (data not 
shown). Osmolytes showed no significant difference from control cells when 
incubated for 24 h at concentrations up to and including 300 mM. These findings 
illustrate the well-known compatibility of these osmolytes and show the suitability 
of these small molecules for the investigation of their cryoprotective effects. 
 
3.4.2 Growth in the Presence of Osmolytes 
We next evaluated how the cells grew (proliferated) while incubated in the 
osmolyte solutions. Since the cells would be incubated for 24 h in the solutions 
prior to cryopreservation, we wanted to assess if any up- or down-regulation of 
cell growth was taking place during this incubation period and we were 
particularly interested in any down-regulated cell growth, as Chapter 1 explained 
that stasis is a requirement for some organisms to survive extreme conditions.  
To determine cell growth, cells were plated at an identical density and counted 
each day (starting with day 2) to obtain cell numbers. Starting density was 
12.5·103 per well in 6-well plates to allow cells enough room to grow for the 
duration of the experiment and not become confluent but allow enough cells to be 
initially plated as to not cause growth arrest due to a low-density environment. 
Cells were counted using trypan blue exclusion11 with a hemocytometer. Trypan 
blue is impermeable to cells with intact membranes and will only be taken up by 
dead cells with porous membranes, therefore reliable counts of live cells can be 
obtained. Healthy cells grow in an exponential fashion and the formula for this 
growth is listed in Equation 3.1.   
 
 







Since we are interested in the growth rate of our cells, we can solve for r utilising 
Equation 3.2 to establish a rate of growth for each of the incubation conditions. A 
rate of 0 would indicate no change in cell growth from the previous day while a 
rate of 1 would indicated a complete doubling of the cells from the previous day, 





We evaluated the 6-day fold change of our cells in individual osmolyte solutions 
(alanine, betaine and proline) (Fig 3.13-3.15). Combining the results for 
comparison, we found control cells to have a day 6 rate of growth of 0.68 – 0.71 
(Fig 3.5, n = 3, P = 0.00012). Alanine and betaine had comparable rates of 0.62 – 
0.70 and 0.71 – 0.78, respectively. Proline had a significantly lower rate of 0.47 – 
0.54 compared to control cells.  
 
N(t) = number of cells at time (day) 
N(0) = number of cells at time zero (initially plated) 
r = rate of growth 
t = time (day) 
 
Equation 3.1. Equation for exponential cell growth. 
N(t) = number of cells at time (day) 
N(0) = number of cells at time zero (initially plated) 
r = rate of growth 
t = time (day) 
 
Equation 3.2. Equation for cell growth rate. 




We also tested for long term effects, or how recoverable the change in regulation 
would be, if there was one. For this, cells were incubated in the osmolytes for 3 
days and then the osmolyte solution was replaced with complete cell media, then 
cell counts were performed for the subsequent 3 days. We found control cells to 
have a day 6 rate of growth of 0.38 – 0.41 (Fig 3.6, n = 3, P = 0.01). Alanine and 
betaine had comparable rates of 0.42 – 0.44 and 0.40 – 0.46, respectively. 
Proline had a significantly higher rate of 0.45 – 0.52 compared to control cells. 
This shows that the reduced growth seen for the proline incubated cells is 
reversible and cells recovery quickly to proliferate faster than control cells. 
Conducting this experiment in the future, it would be wise to include the previous 
day counts (days 1-3) to analyse trends from when the osmolyte solutions are 
replaced. 
 
Figure 3.5. A549 osmolyte incubation rate of growth. Growth rates after incubation 
with F-12K (black) or osmolyte (alanine=green, betaine=blue, proline=purple) for 6 
days. Error represents ± SEM of 3 independent experiments. 




Alanine has been shown to reduce cell proliferation in epithelial cells,12 yet 
showed increased proliferation in thymocyte lobes,13 however, our cells were not 
effected in either direction as they did not significantly differ from control when 
grown in the presence of alanine. Betaine has been shown to reduce the 
proliferation of HeLa (cervical cancer)14 and DU-145 (prostate cancer)15 cells, and 
most surprising, betaine was shown to suppress tumour formation of A549 cells 
in vivo.16 Our results differ from these, as our cells, in the presence of betaine, 
grew much faster than control cells. Proline has been shown to be essential for 
proliferation in hepatocyte cells in culture17 and increases the proliferation of 
embryonic stem (ES) cells.18 However, proline catabolism effects seem to be 
dependent on metabolic context and the switches for these responses remain 
unknown.19 One explanation for the suppressed growth of our proline-incubated 
cells comes from P493 (B lymphoma) cells incubated in proline which experience 
growth inhibition, and thus, results in the proline biosynthesis (PB) pathway being 
down-regulated with a downstream effect on the glycolytic pathway (Fig 3.7).20 
Figure 3.6. A549 osmolyte recovery growth rates. Growth rates after incubation with 
F-12K for 6 days (black) or osmolyte for 3 days (alanine=green, betaine=blue, 
proline=purple) then F-12K media for 3 days. Error represents ± SEM of 3 independent 
experiments. 
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This suggests that the lower proliferation rate we see may not be the proline 
itself, but rather the effects of the PB pathway not running due to an increase in 






We have shown that none of our macromolecular cryoprotectants were toxic to 
our cells for a 10 min exposure and none of our osmolytes were toxic to the cells 
after 24 hours. This is promising, as these timescales were chosen as they reflect 
those used in monolayer cryopreservation protocols; the intended application for 
our compounds. DMSO was shown to significantly reduce alamarBlue reduction 
following a 24 h exposure and all of our potential cryoprotective agents performed 
better than DMSO. Proline was the only osmolyte to affect the growth of our cells, 
Figure 3.7. Proline biosynthesis from glutamine in cancer cells promotes cell 
growth through interacting with glycolysis and oxidative arm of pentose 
phosphate pathway. P5C, Δ1-pyrroline-5-carboxylate; GSA, glutamic-gamma-
semialdehyde; GLS, glutaminase; GS, glutaminesynthase; P5CS, pyrroline-5-
carboxylatesynthase; P5CDH, pyrroline-5-carboxylatedehydrogenase; PRODH/POX, 
proline dehydrogenase/oxidase; PYCR1/2, pyrroline-5-carboxylatereductase1, and 2; 
PYCRL, pyrroline-5-carboxylatereductase L. oxPPP, oxidative arm of pentose 
phosphate pathway. Reprinted from Liu (2015).20 
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significantly down-regulating growth during incubation, this is most likely due to 
the proline biosynthesis pathway not running due to the excess of available 
proline. Our results have been summarised in Table 3.1. As osmolarity is a key 
area of damage for cells during cryopreservation, the next step in this work would 
be to evaluate the osmotic parameters of the cells in the presence of our 
compounds as well as an osmotic stress assay to evaluate if any of our 
compounds have the ability to protect cells from stressful osmotic conditions. 
Having established the effects of our compounds on cell toxicity and proliferation, 
our next chapter sought to understand how these compounds faired as 















		   (%)     
		 Target ↑     
		 Control 100 0.69 0.39 
		 10% DMSO 31.9     
		
5 mg·mL-1 
PVA  88.3 − − 
		
5 mg·mL-1 
Polyproline 67.5 − − 
		
5 mg·mL-1 P2 
Polyampholyte 79.1 − − 
		
100 mM 
Alanine 93.5 0.66 0.43 
		
100 mM 
Betaine 95.4 0.74 0.43 
		
200 mM  
Proline 82.1 0.51 0.49 
 
 
Table 3.1. Chapter 3 results summary.  Control = F-12K. Significantly higher than 
control, significantly lower than control. 
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3.6 Materials and Methods 
3.6.1 Reagents 
All non-specified chemicals were obtained from Sigma Aldrich Co Ltd, (Irvine, 
UK).   
Polyproline was synthesised as in Section 2.6.1.1. 
Polyampholyte was synthesised as in Section 2.6.1.2. 
3.6.2 A549 Cell Culture 
Human Caucasian lung carcinoma cells (A549) were obtained from the European 
Collection of Authenticated Cell Cultures (ECACC) (Salisbury, UK) and grown in 
175 cm2 cell culture Nunc flasks (Corning Incorporated, Corning, NY). Standard 
cell culture medium was composed of Ham's F-12K (Kaighn's) Medium (F-12K) 
(Gibco, Paisley, UK) supplemented with 10% USA-origin fetal bovine serum 
(FBS) purchased from Sigma Aldrich (Dorset, UK), 100 units·mL-1 penicillin, 100 
µg·mL-1 streptomycin, and 250 ng·mL-1 amphotericin B (PSA) (HyClone, 
Cramlington, UK). F-12K contains 0.2 mM alanine, 0.6 mM proline and has an 
osmolarity of 275 to 357 mOsm·kg-1. A549 cells were maintained in a humidified 
atmosphere of 5% CO2 and 95% air at 37 °C and the culture medium was 
renewed every 3–4 days. The cells were subcultured every 7 days or before 
reaching 90% confluency. To subculture, cells were dissociated using 0.25% 
trypsin plus 1 mM EDTA in balanced salt solution (Gibco) and reseeded at 
1.87·105 cells per 175 cm2 cell culture flasks. 
3.6.3 Solution Preparation 
Solutions for cell experiments were prepared by dissolving the individual 
compounds in base cell media supplemented with 10% FBS and 1x PSA 
(solutions used as CPAs did not contain PSA) and sterile filtering prior to use.  
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3.6.4 Cytotoxicity of Compounds 
A549 cells were seeded at 4·104 cells per well in 200 µL of cell culture medium 
with indicated concentrations of solutions in 96-well plates (ThermoFisher). Cells 
were incubated with solutions for 10 min and exchanged against complete cell 
media or incubated with solutions for 24 h in a humidified atmosphere of 5 % CO2 
and 95 % air at 37 °C. Following the incubation period, resazurin sodium salt 
(Sigma Aldrich) was dissolved in phosphate buffered saline (Sigma Aldrich) and 
added to wells in an amount of 1/10th initial well volume.  Readings were taken 
using a Synergy HTX Multi-Mode Reader (BioTek, Swindon, UK) at 570/600 nm 
absorbance every 30 m until control cells reached ~70% reduction. These 
readings enabled the calculation for the percentage of alamarBlue reduction 
(Equation 3.3). Values were normalised by dividing experimental values by 
control values. Cells were then imaged using a CKX41 microscope (Olympus) 
equipped with the XC30 camera (Olympus). Images were captured and 




3.6.5 Incubation Growth Assay 
Cells were seeded at 12.5·103 per well in 6-well plates (Thermo Fisher) in 2 mL of 
complete cell media or in the indicated solutions. Cells were placed in a 
O1 = molar extinction coefficient (E) of oxidised alamarBlue (blue) at 570 nm 
O2 = E of oxidised alamarBlue at 600 nm 
R1 = E of reduced alamarBlue (red) at 570 nm 
R2 = E of reduced alamarBlue at 600 nm 
A1 = absorbance of test wells at 570 nm 
A2 = absorbance of test wells at 600 nm 
N1 = absorbance of negative control well (media plus alamarBlue but no cells) at 570 nm 
N2 = absorbance of negative control well (media plus alamarBlue but no cells) at 600 nm 
 
Equation 3.3. Equation used for alamarBlue reduction calculation. 
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humidified atmosphere of 5% CO2 and 95% air at 37 °C and allowed to grow, with 
counts starting on day two and commencing on day six.  Cell media was renewed 
on day three. Cells were dissociated using 0.25% trypsin plus 1 mM EDTA in 
balanced salt solution. The number of viable cells was then determined by 
counting with a haemocytometer (Sigma Aldrich) at room temperature after 1:1 
dilution of the sample with 0.4% trypan blue solution (Sigma Aldrich). Fold 
increase of cells was calculated by dividing the number of cells with intact cell 
membranes by the number of cells initially plated.  
3.6.6 Incubation Recovery Growth Assay 
Cells were seeded at 12.5·103 per well in 6-well plates (Thermo Fisher) in 2 mL of 
complete cell media or in the indicated solutions. Cells were placed in a 
humidified atmosphere of 5% CO2 and 95% air at 37 °C and allowed to grow, with 
counts starting on day two and commencing on day six.  Cell media was renewed 
on day three and cells incubated in solutes were switched back to complete cell 
media. Cells were dissociated using 0.25% trypsin plus 1 mM EDTA in balanced 
salt solution. The number of viable cells was then determined by counting with a 
haemocytometer (Sigma Aldrich) at room temperature after 1:1 dilution of the 
sample with 0.4% trypan blue solution (Sigma Aldrich). Fold increase of cells was 
calculated by dividing the number of cells with intact cell membranes by the 
average number of cells on day three.  
3.6.7 Trypan Blue Assay 
50 µL of 0.4% trypan blue was combined with 50 µL cell suspension, mixed, and 
allowed to penetrate for 10 min. After remixing of sample, 10 µL of trypan 
blue/cell sample was added to each side of a haemocytometer. Four squares on 
each side of the haemocytometer were counted for viable (non-blue) cells (Fig 
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3.6.8 Statistical Analysis 
Data were analysed with a one-way analysis of variance (ANOVA) on ranks 
followed by comparison of experimental groups with the appropriate control group 
(Holm–Sidak method) followed by Tukey’s post hoc test. Excel 2013 (Microsoft, 
Redmond, WA) and R were used for the analyses and graphs. Data sets are 
presented as mean ± (SEM).   
 
S = number of squares counted 
DF = dilution factor 
V = volume scale up to mL 
 
Equation 3.4. Equation used for trypan blue viable cell calculation. 
Figure 3.8. Haemocytometer Counting.   




Figure 3.9. A549 proline cytotoxicity. Average normalised alamarBlue reduction 
after 24 h incubation. Error bars represent ± SEM of 3 independent experiments. 
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Figure 3.10. A549 betaine cytotoxicity. Average normalised alamarBlue reduction 
after 24hr incubation. Error bars represent ± SEM of 3 independent experiments. 





Figure 3.11. A549 alanine cytotoxicity. Average normalised alamarBlue reduction 
after 24hr incubation. Error bars represent ± SEM of 3 independent experiments. * P 
< 0.02 from control (0 mM alanine).  
* P < 0.02 from control (0 mM Alanine). 






Figure 3.12. A549 proline incubation and recovery growth rates. Growth rates 
after incubation with F-12K (control) for 6 days (black), 200 mM proline for 6 days 
(red), control recovery cells (grey), or 200 mM proline for 3 days then F-12K media for 
3 days (blue).  Error bars represent ± SEM of 3 independent experiments. 
Figure 3.13. A549 betaine incubation and recovery growth rates. Growth rates 
after incubation with F-12K for 6 days (black), 100 mM betaine for 6 days (red), control 
recovery cells (grey), or 100 mM betaine for 3 days then F-12K media for 3 days 
(blue). Error bars represent ± SEM of 3 independent experiments. 
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CRYOPROTECTANTS AND OSMOTIC 





All polyampholyte polymers were synthesised by Dr Christopher Stubbs and all 
polyproline polymers were synthesised by Dr Ben Graham, both under the 
supervision of Prof Matthew Gibson. 
 
4.2 CHAPTER SUMMARY  
We have demonstrated that osmolytes in combination with the highly active IRI 
polymer PVA, or the moderately IRI active polymer polyproline, and the very low 
IRI active polyampholyte can be used to improve the cryopreservation of cell 
monolayers, with each potentially acting by different mechanisms of action. In 
particular the polyampholyte lead to very large increase in post-thaw cell yield for 
A549 cells, but also moderate increases with harder to freeze MC-3T3 and 
Neuro-2a monolayers. We further demonstrate that cells frozen with the 
combination of osmolytes, plus PVA or polyproline, grow better post-thaw than 
cells frozen with just 10% DMSO, osmolytes alone, or PVA/polyproline alone. 
Similarly, cells frozen with a low concentration of polyampholyte P2 were shown 
to grow better post-freeze than cells frozen with just 10% DMSO. Taken together, 
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this shows that macromolecular cryoprotectants increase cell yield and health, 
post-thaw. 
4.3 INTRODUCTION 
As discussed in Chapter 1, there are only a few studies on monolayer 
cryopreservation and they often involve complicated processes, such as solvent 
equilibration steps or specialised freezing processes. For example, Matsumura et 
al. used slow vitrification (10.8 ˚C·min-1) in the cryopreservation of monolayered 
mesenchymal stem cells.1 Their CPA solutions included a vitrification solution 
(VS) comprising 6.5 M ethylene glycol (EG) and 0.75 M sucrose or a polymer 
vitrification solution (P-VS) comprised of the VS plus 10% carboxylated poly-L-
lysine (COOH-PLL) – a polyampholyte which we hypothesise has similar 
functions to the one used in this thesis. Their process involved treating the cells 
with an equilibrium solution (ES) comprised of 15% EG for 10 min, a CPA 
exposure of 5 min, slow vitrification utilising N2(l) (distance from the surface 
dictated the freezing rate) for 20 min, then soaking the plate in N2(l). Plates were 
then warmed with rewarming solution (RS), comprised of 1M sucrose, for 1 min 
then treated with dilution solution (DS), a 0.5 M sucrose solution, for 3 min, then 
washed twice with cell media to ensure all treatment solutions were removed. 
Cells were assayed immediately after freezing, using trypan blue exclusion, with 
the cells still attached to the plate, and a 90% recovery for cells frozen with VS 
and a 95% recovery for cells frozen with P-VS was found. Repeating the trypan 
blue assay 24 h later found a 50% recovery for cells frozen with VS and a 90% 
recovery for cells frozen with P-VS, showing a substantial 40% drop in recovery 
for VS cells from the 90% reported immediately post-thaw. Bahari et al. utilised 
directional freezing, where the monolayers were individually frozen on a 
cryostage; following nucleation, the slides were moved linearly from hot to cold at 
variable speeds.2 The monolayers were assayed 5 h post-thaw via fluorescent 
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microscopy, with HeLa cells showing a 90% recovery and Caco-2 cells showing 
at 60% recovery. A study by Pless-Petig et al. investigated porcine aortic 
endothelial cells, utilising a slow freezing rate of 0.1 ˚C·min-1 and a proprietary 
TiProtec® solution containing iron chelators, glycine, alanine, and high chloride 
and potassium, along with 10% DMSO.3 Their freezing process involved 
incubating the cells at 4 °C for 10 min, then transferring to a pre-cooled (4°C) 
cooling chamber of a controlled-rate freezer and cooled at a linear temperature 
gradient to -4 °C, followed by a short, rapid temperature drop to -40 °C then 
immediately back to the approximate sample temperature to initialise 
crystallisation, and then a linear decrease to -80 °C at the initial cooling rate. The 
cells were evaluated 3 h post-thaw, with a maximum recovery rate of 50%. The 
cells were then examined after 24 h re-culture via assessment of intracellular 
LDH and trends were found to match the 3 h post-thaw assessments. All of these 
studies provide valuable insights into how cryoprotectants and freezing conditions 
affect the freezing of monolayers but the scale up of these procedures would be 
laborious, expensive, and time consuming.  
Additionally, there is no universal method or procedure for assessment, which 
makes comparing studies and results especially difficult. Time from thawing to 
assessment introduces a large variable for comparability. For example, in 2009, a 
study by Miyamoto et al. used vitrogel collagen matrices in combination with 10% 
DMSO to cryopreserve primary hepatocytes and mouse embryonic stem cells.4 
The assessment was conducted 3 h post-thaw with the cells attached to the 
plates via live/dead staining and fluorescent microscopy. They found a 36% 
recovery for hepatocytes and a 44% recovery for embryonic stem cells. 
Conversely, Stevenson et al. also examined primary rat hepatocytes, utilising a 
90% foetal calf serum (FCS) and 10% DMSO solution, the cryopreserved cells 
were assayed 48 h post-thaw to allow repair to damaged plasma membranes,5 
the cells were not removed from the plates and assessed via carboxyfluorescein 
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and measured with confocal laser scanning microscopy (CLSM) to find a 79% 
recovery rate. It is difficult to assess whether the greater recovery value reported 
in the latter study is due to a superior cryoprotectant or the increased post-thaw 
incubation time which may allow for cell proliferation to occur.  
Another variable for comparability in cryopreservation outcomes is trypsinisation. 
None of the studies mentioned previously removed their cells from the attached 
substrate for analysis. In 1999, Pasch et al. examined keratinocyte monolayers 
and found a 29% recovery for cells frozen with 10% hydroxyethyl starch 24 h 
after thawing.6 They additionally found that 65% of their cells were damaged 
during the trypsinisation process. In 2000, they repeated the experiment but 
assayed the cells immediately after thawing, without removal from the plate, and 
found an 80% recovery rate for monolayers frozen with 10% hydroxyethyl starch.7 
This shows that the trypsinisation process introduces stress to the cells, and 
studies that do not remove the cells from the plates may overstate the membrane 
health of cryopreservation outcomes.   
Studies that allow 24 h recovery and removal of cells from the substrate, 
compared to immediate post-thaw analysis conducted with cells attached, report 
moderate cell recoveries. Stokich et al. incubated hepatocyte cell (HepG2) 
monolayers in 100 mM trehalose, followed by freezing with 10% DMSO, to 
achieve a 42% recovery 24 h post thaw and trypsinisation.8 Bailey et al. found 
that incubating neuronal cell (Neuro-2a) monolayers in 112.5 mM proline and 
trehalose, followed by freezing with 112.5 mM proline and trehalose plus 10% 
DMSO resulted in 53% recovery 24 h post-thaw and trypsinisation.9 Finally, 
Tomás et al. found a 60% recovery for A549 monolayers frozen with 0.8 mg·mL-1 
AFPIII and 10% DMSO 24 h post-thaw and trypsinisation.10 With these studies, 
the results appear to be directly accountable to the cryopreservation processes 
themselves, as time between thawing and the assay has allowed apoptosis 
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processes to complete and cells have been removed from the substrate, a 
rigorous test of cell membrane integrity. 
The highest recovery seen for monolayer cryopreservation was the Eskandaria et 
al. study utilising cryopreserved human umbilical vein endothelial cell monolayers 
with a solution of 2% chondroitin sulfate, 6% hydroxyethyl starch, and 5% 
DMSO.11 The cells were measured for viability immediately post-thaw without 
removal from the substrate via staining with SYTO 13/GelRed, imaging with 
fluorescent microscopy, and analysis using the Viability3 program to find 97% 
recovery, with no longevity studies conducted. It is difficult to determine if this 
high recovery rate was due to the cryoprotectants themselves, the immediate 
assay time, leaving the cells attached to the substrate, or combinations of, which 
may be affording the reported protections. 
These examples demonstrate that while assessing cells too early can potentially 
give false positives as apoptotic processes have not had time to complete,12 
assessing later than 24 h post-thaw can potentially allow the cells to repair 
damage and proliferate.13,14  
We hoped to find a simple, streamlined approach for freezing cell monolayers 
that would be researcher and lab-friendly. For the monolayer freezing in this 
work, we utilised an efficient slow-freezing methodology,9 which ensured proper 
recovery time to evaluation (Fig 4.1). We allowed the cells to attach for 2 h, 
media was then exchanged and cells were incubated for 24 h, and then treated 
with a CPA for 10 min. In order to freeze the cells in a semi-dry state and allow 
for a faster thawing process, we then fully removed the CPA from the cells. Cells 
were frozen at 1 °C·min-1 to -80 °C for 24 h and then thawed using 37 °C cell 
media. We utilised a cooling rate of 1 °C·min-1 which allowed the cells to 
dehydrate so there was less chance of intracellular ice while still retaining a 
recoverable water content (enough water within the cell to avoid triggering 
apoptotic processes due to water loss) upon rewarming. The rationale for a 24 h 
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frozen storage time was due to evidence that post-thaw function is independent 
of storage time at -80 ˚C, in particular, rat hepatocytes cryopreserved as 
monolayer cultures for 28 days at -80 ˚C showed no significant differences in 
cytochrome P-450 activity from those cultures stored for 1 day.15 The cells were 
then incubated for 24 h prior to recovery assays. 
   
 
 
Following cryopreservation and our recovery assessment, cells were also plated 
at equal starting numbers to evaluate growth rates over six days to determine 
post-freeze viability.          
And now, the main event, to evaluate if these compounds are useful in the 
cryopreservation of monolayered cells. We will evaluate cryopreservation 
outcomes via our previously outlined cell cryopreservation methodology. In 
addition to cryopreservation outcomes, we will also assess the proliferation 
capabilities of cryopreserved cells via long-term growth assays. The main 
objectives of this chapter were to evaluate (i) if our molecular osmolytes and/or 
macromolecular polymers were able to successfully cryopreserve mammalian 
cells, and (ii) how viable the cells were post-freeze when our molecular osmolytes 
and/or macromolecular polymers were included. The results of this chapter will 
allow us to identify potentially protective compounds for the cryopreservation of 
attached monolayered cells while also assessing the downstream effects of the 
cells several days post-thaw.  
 
Figure 4.1. Monolayer cell cryopreservation methodology. 
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4.4 RESULTS AND DISCUSSION 
4.4.1 Cell Cryopreservation 
Our monolayer method involved plating the cells with a 24 h incubation period 
(with or without osmolytes as indicated in figures) to allow time for any pre-
conditioning. This was followed by a 10 min CPA application, removal of the 
CPA, controlled rate freezing of 1 °C·min-1 to -80 °C for 24 h, and then quickly 
thawing with 37 °C media, followed by a post-thaw incubation of 24 h, and finally 
counting with trypan blue to evaluate cell recovery. Since cells have been 
successfully cryopreserved with PVA utilising suspension freezing16 (cells 
suspended in solution and frozen in vials), our first experiment was to evaluate if 
similar results could be obtained with monolayer freezing. In these assays we 
were looking for a high percentage of cells recovered after freezing, significantly 
higher than 10% DMSO on its own.   
 
4.4.1.1 PVA Monolayer Freezing 
A549 cells frozen as monolayers with a CPA of only 10% DMSO resulted in a 
16.9% (± 3.2) recovery (Fig 4.2, n = 3). We next tested cell recovery with different 
concentrations, from 1 to 10 mg⋅mL-1 PVA, added to the CPA solution. Cells 
frozen with 5 mg·mL-1 PVA inclusion in the CPA (along with 10% DMSO) gave 
the highest recovery of 23.7% (± 2.8), however, this is still considered to be a 
very low recovery. These results highlight the difficulty in moving from suspension 
freezing to freezing cells as a monolayer, as A549 cells frozen in suspension with 
10% DMSO resulted in ~ 60% recovery.17 Cells in solution have free movement 
and are able to adjust to ice engulfment and often avoid growing ice by moving 
into the non-frozen solution between crystals,18 whereas monolayer cells are 
attached to a substrate and cannot adjust their position throughout the freezing 
process. While PVA has been successfully utilised in suspension 
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4.4.1.2 Combined Osmolyte PVA A549 Monolayer Freezing 
In Chapter 1 we hypothesised that incubation with osmolytes may precondition 
the cells to improve cryopreservation outcomes, potentially by modifying 
metabolic or other processes, to ‘prepare’ them for cold stress. Therefore, we 
next combined an osmolyte incubation with PVA to assess if cryoprotection could 
be enhanced with this combination for monolayered cells as well as primary 
human cells in solution. We first tested our cells using a PVA concentration of 1 
mg·mL-1 with variable proline (the osmolyte) incubation conditions to assess the 
optimal proline concentration (Fig 4.16). We next took our best performing proline 
Figure 4.2. A549 PVA monolayer freezing. Cells recovered after freezing to -80 °C.  
Error bars represent ± SEM of 3 independent experiments with 2 nested replicates. 
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concentration and tested different PVA concentrations (Fig 4.17). The best 
performing PVA concentration from this assay (5 mg·mL-1 PVA) was then tested 
against variable concentrations of betaine (Fig 4.18) and alanine (Fig 4.19). 
Combining a uniform PVA concentration of 5 mg·mL-1 with the best performing 
concentration of each osmolyte for comparison, we saw a significant increase in 
recovery when cells were incubated in osmolyte solutions and cryopreserved in 
the presence of PVA (Fig 4.3, n ≥ 3, P = 0.0000005). Cells frozen with no 
incubation and 10% DMSO resulted in only 16.9% (± 3.2) average recovery. The 
addition of 5 mg·mL-1 PVA to 10% DMSO resulted in 23.7% (± 2.8) recovery. 
Incubating cells in either 100 mM alanine or 100 mM betaine, and freezing with 
10% DMSO, resulted in 24.1% (± 3.7) and 30% (± 3.7) recovery respectively and 
was not significantly higher than 10% DMSO or 5 mg·mL-1 PVA + 10% DMSO. 
Adding 5 mg·mL-1 PVA to both of these solutions resulted in a significant increase 
in recovery to 56.6% (± 1.8) for betaine incubated cells, yet had only a minimal 
effect on the alanine-treated cells. Incubating the cells in 200 mM proline and 
freezing with 10% DMSO resulted in a significant increase to 45.7% (± 5.2) 
recovery, and incubation of cells in 200 mM proline with a CPA of 5 mg·mL-1 PVA 
+ 10% DMSO resulted in our highest recovery of 62.7% (± 4.2). Incubation in 
proline and betaine significantly increased the post-thaw recovery of our A549 
monolayers. We believe this is due to directly affecting cell processes, as we 
have shown these osmolytes do not have an impact on ice within our system. 
These interactions could be in the form of membrane protection (explored in 
Chapter 5), osmoregulation, metabolic preconditioning (as shown for proline in 
Section 3.4.2), protein regulation, or perhaps the mitigation of apoptotic 
processes.  
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This section has shown that pre-incubation of A549 cells with an osmolyte of 
proline or betaine and frozen in the presence of PVA + 10% DMSO significantly 
increased the post-thaw recovery of cells frozen as monolayers and shows that 
recrystallisation inhibitors can increase post-thaw cell recovery in pre-conditioned 
cells showing that combinations of cryoprotectants may be a viable strategy to 
enhance post-thaw outcomes.  
 
4.4.1.3 Primary Endometrial Proline/PVA Suspension Freezing 
Due to the high post-thaw recovery seen with the A549 monolayer cells, we next 
moved to test primary cells. Primary human cells are more sensitive and 
Figure 4.3. A549 osmolyte PVA monolayer freezing. Cells recovered after freezing 
to -80 °C. Error bars represent ± SEM of at least 3 independent experiments with two 
nested repeats. * P < 0.0001 from F-12K with 10% DMSO. ** P < 0.0001 from F-12K 
with 5 mg·mL-1 PVA + 10% DMSO.    
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challenging to cryopreserve and are less straightforward to culture, hence 
maximising their recovery is essential19,20 as these cells are limited by the 
availability of donors and reduced cell counts post-thaw cannot be overcome by 
proliferation due to the short time span of primary cell growth. For this work we 
used human endometrial cells obtained from consenting donors via Dr Brosens’ 
Implantation Clinic. The tissue was dissociated and two cells types were 
subsequently collected: endometrial stromal cells (ESC) and endometrial 
epithelial cells (EEC). Primary cells are usually cryopreserved in vials using 
standard methods, including slow cooling rates in combination with 5 – 10% 
DMSO supplemented with varying concentrations of foetal serum.21–24 These 
cells were frozen in a suspension format, rather than a monolayer format, as the 
recovery of ESC/EEC frozen in suspension result in a low recovery, along with 
limited space available for sample storage. We first wanted to attempt to increase 
the recovery of these cells in suspension before moving on to a more challenging 
format. The cryopreservation protocol in the Brosens lab was 90% dextran-
coated charcoal foetal calf serum (DCC) with 10% DMSO. DCC is very expensive 
and has been shown to stabilise bio-membranes and adjust osmotic pressure but 
it also contains a number of proteins and peptides which can cause an immune 
reaction after reinfusion.25 Therefore, we wanted to start by selecting the proper 
base freezing media for primary endometrial cells, testing 90% DCC against 
completed cell media (DMEM) containing only 10% DCC for both cell types. We 
saw no significant difference between DCC and DMEM (supplemented with 10% 
DMSO) with or without 5 mg·mL-1 PVA for either ESC cells (Fig 4.4A) or EEC 
cells (Fig 4.4B). The recoveries of the ESC cells were very similar across all 
conditions, while the EEC cells recovered much better when frozen in DMEM 
rather than in DCC. From this, we selected DMEM as our base freezing media 
due to the higher recovery and the lower cost of the formula. 
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Now with the base freezing media set, we next wanted to see if proline could 
increase our post-thaw recovery with primary endothelial cells. In the previous 
experiments our monolayer cells were incubated in proline for 24 h. However, we 
wanted to work within the bounds of the Brosens’ cryopreservation protocol, 
which involved freezing the cells immediately after dissociation and cell 
separation. This gave us two options for proline inclusion: adding the proline 
Figure 4.4. Media selection for primary human endometrial vial freezing. A) ESC 
cells recovered after freezing to -196 °C. B) EEC cells recovered after freezing to -196 
°C. Error bars represent ± SEM of 3 independent experiments.  
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directly into the freezing media or adding the proline to the 1 h digestion media. 
We saw no improvement in recovery for cells frozen with or without an incubation 
period for proline and with or without 5 mg·mL-1 PVA for ESC cells (Fig 4.5A) or 
for EEC cells (Fig 4.5B). There are several potential factors responsible for the 
lower recovery of our primary cells, most notably, the high variability of the 
results. This variation could be attributed to slight time-to-freeze disparities. This 
experiment was conducted within the large sample processing of the Brosens lab 
and the cells that were ready to freeze would often be held until the freezing 
container was full or all samples had been collected. This highlights the transition 
from lab setting to real-world application, as all factors, which may impact the 
outcome, cannot always be controlled. The high variability also speaks to the 
imperfect cryopreservation conditions for these cells as we see imprecise results 
in all conditions tested. There is much room for improvement in the storage of 
these cells, from adjusting the concentration and incubation time of the osmotic 
pre-conditioner, the concentration of the IRI compound, the concentration of 
DMSO, the number of cells frozen, and even the time to freeze. 
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In this section we have shown that DMEM works better than DCC for primary 
human endometrial cell (ESC and EEC) vial cryopreservation. PVA or proline 
with PVA did not improve cryopreservation outcome for ESC or EEC cells frozen 
in suspension. We believe there is a large area for improvement in the 
Figure 4.5. Primary endometrial epithelial proline/PVA vial freezing.  Cells 
recovered after freezing to -196 °C. A) ESC cells frozen with 5 mg·mL-1 PVA, 200 mM 
proline, or a combination of proline and PVA. B) EEC cells frozen with 5 mg·mL-1 PVA, 
200 mM proline, or a combination of proline and PVA. Error bars represent ± SEM of 
at least 3 independent experiments.  
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cryopreservation of primary human endometrial cells and optimisation of this 
protocol could vastly increase the recovery of these cells post-thaw. 
 
4.4.1.4 Additional Immortalised Cell Monolayer Proline PVA Variable 
Concentration Freezing 
Due to the poor recovery seen with human primary cells, we next wanted to test 
other immortalised cell lines in a monolayer format to see how our proline results 
would compare to those seen with A549 cells. We looked at two different cell 
lines: mouse calvarial osteoblastic (MC-3T3) and mouse brain neuroblastoma 
(Neuro-2a) cells.  
 
4.4.1.4.1 MC-3T3 Proline PVA Variable Concentration Monolayer Freezing 
Freezing monolayered MC-3T3 cells with 10% DMSO resulted in 11.8% (± 1.8) 
recovery (Fig 4.6A) and our largest improvement was with a 200 mM proline 
incubation in combination with 5 mg·mL-1 PVA + 10% DMSO, resulting in 27.7% 
(± 1.1) recovery. As MC-3T3 cells are known to have some attachment 
preferences, we also evaluated MC-3T3 cells frozen on collagen coated plates 
with 10% DMSO, which resulted in 9.5% (± 0.2) recovery (Fig 4.6B) and the 
inclusion of 200 mM proline and 5 mg·mL-1 PVA + 10% DMSO resulted in only 
25.1% (± 7.3) recovery. While we did see some improvement in post-freeze 
recovery when proline and PVA were used, the recovery was not significantly 
different from cells frozen with only 10% DMSO. It has been shown that both the 
selection of an attachment substrate26 and the pore size of substrate itself27 
effects adhesion, so it follows that collagen coating may not be a suitable 
substrate to retain cell attachment during the harsh event of monolayer freezing, 
which is reliant on attachment for cell retainability/recovery. MC-3T3 cells are 
also a contact inhibited cell line so we may have inadvertently programed them to 
arrest by simply creating a confluent monolayer. The lack of significant 
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improvement could also be due to the need for a different proline concentration, 
as MC-3T3 cells are considerably larger (20–50 µm)28 than A549 cells (~15 µm)29 
and it would follow that ice would have more interaction with the larger 
membranes of these cells, especially if they haven’t suitably shrunk prior to 
freezing. An additional mechanism may be through differentiation, as MC-3T3 
confluent monolayers treated with 1% DMSO resulted in MC-3T3 differentiation 
and increased alkaline phosphatase (ALP) production,30 as did simple 
mechanical strain,31 and our cells are exposed to both of these throughout the 
cryopreservation process. 
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4.4.1.4.2 Neuro-2a Proline PVA Variable Concentration Monolayer Freezing 
Freezing Neuro-2a monolayer cells on collagen-coated plates with 10% DMSO 
resulted in only an 18.9% (± 5.6) recovery (Fig 4.7) and our highest recovery was 
seen with a 200 mM proline incubation combined with 18 mg·mL-1 PVA, resulting 
in 37.5% (± 8.2) recovery.  We saw no significant improvement for the monolayer 
freezing of Neuro-2a cells incubated in 200 mM proline and frozen with varying 
Figure 4.6. MC-3T3 proline PVA variable concentration monolayer freezing.  Cells 
recovered after freezing to -80 °C. A) MC-3T3 cells frozen on bare plates. B) MC-3T3 
cells frozen on collagen coated plates. Error bars represent ± SEM of 3 independent 
experiments with two nested repeats.  
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concentrations of PVA on collagen coated plates. While our Neuro-2a cells were 
similar in size (10-14 µm)32 to our A549 cells, neuronal cells are very sensitive to 
hypotonic conditions33 so these cells may be much more sensitive to the harsh 
event of cryopreservation, thus a higher concentration of proline may be needed.  
We did see a somewhat PVA concentration-dependent increase in recovery, so it 
may also be that a higher concentration of IRI polymer is needed for these cells, 




In this section we attempted to improve the post-freeze recovery of MC-3T3 and 
Neuro-2a cells. While we did see some improvement with our solutions, we did 
not see any significant increases in recovery. We believe the formulation and 
process can be further optimised to provide increased recovery for these delicate 
Figure 4.7. Neuro-2a proline PVA variable concentration monolayer freezing. 
Cells recovered after freezing to -80 °C. Error bars represent ± SEM of 3 independent 
experiments with two nested repeats. 
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cell lines. These results further demonstrate how cryopreservation processes can 
be very cell-line dependent as different cell types will respond differently to 
particular treatments.  
 
4.4.1.5 A549 Polyproline Monolayer Freezing 
Having tested PVA as a cryoprotectant for several cell types, we next wanted to 
understand whether other macromolecular compounds had any cryoprotective 
benefit, either alone or in combination with osmolyte pre-conditioning. Addition of 
poly(L-proline) (which has moderate IRI activity) alone to 10% DMSO failed to 
give any significant increase in cell recovery, however, cells which were pre-
conditioned with 200 mM proline for 24 h then treated with 10 mg·mL-1 polyproline 
+ 10% DMSO doubled cell recovery to 53% compared to 10% DMSO alone (Fig 
4.8, n ≥ 3, P = 0.000002). Increasing the concentration of polyproline beyond 10 
mg·mL-1 did not increase recovery further suggesting the additive benefits 
plateaued at 10 mg·mL-1. The highest recovery seen with proline + polyproline 
was 10% less than that seen with proline + PVA and this might be due to the 
differences in IRI activity, considering PVA is a highly active IRI polymer and 
polyproline showed only moderate IRI activity. These data suggest that in 
addition to IRI, other effects of polymers can lead to cryopreservation 
improvements, such as membrane interaction and/or protection.  
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This section has shown that pre-incubation of A549 cells with proline and frozen 
in the presence of polyproline + 10% DMSO significantly increased the post-thaw 
recovery of cells frozen as monolayers. 
 
4.4.1.6 Polyampholyte Monolayer Cryopreservation 
4.4.1.6.1 A549 Polyampholyte Molecular Weight Variable Concentration Monolayer 
Freezing 
We next sought to understand if polyampholyte had any cryoprotective benefits. 
As the start of our polyampholyte investigation, molecular weight effects of the 
polymer were screened (Mn = 20 kDa (P1), 80 kDa (P2), and 311 kDa (P3)). We 
found that all three molecular weights at 20 mg·mL-1 (in combination with 10% 
Figure 4.8. A549 proline polyproline variable concentration monolayer freezing. 
Cells recovered after freezing to -80 °C. Error bars represent ± SEM of at least 3 
independent experiments with two nested repeats. * P < 0.0001 from 0 mg·mL-1 
F-12K, ** P < 0.0001 from 0 mg·mL-1 200 mM proline. 
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DMSO) significantly improved the cryopreservation outcomes compared to cells 
frozen only with DMSO (Fig 4.9, n ≥ 3, P = 0.000006). We further saw that P2 
significantly protected cells at concentrations as low as 1 mg·mL-1. While all three 
weights can be considered very potent cryoprotectants, we moved forward with 
our experiments utilising only P2 as the most promising candidate due to its 




4.4.1.6.2 A549 Polyampholyte P2 Variable Concentration Proline Monolayer 
Freezing  
We next tested a concentration range for P2 along with a proline incubation in 
combination with P2 to see how much protection we could afford our monolayers. 
We saw significant increases in cell recovery for all combinations tested (Fig 
Figure 4.9. A549 polyampholyte molecular weight variable concentration 
monolayer freezing. Cells recovered after freezing to -80 °C. Error bars represent ± 
SEM of at least 3 independent experiments with two nested repeats. * P < 0.0001 
from 0 mg·mL-1 NP (no polymer). 
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4.10, n ≥ 3, P = 0.000000004). The highest recovery was seen with 30 mg·mL-1 
for a recovery of 89.1% (±11.5%), however concentrations as low as 5 mg·mL-1 
still provided a high recovery of 80.8% (±10.2%). Most surprisingly, we did not 
see any further increases in cell recovery for cells incubated with 200 mM proline 
and in most cases P2 actually performed better on its own. This could be due to 
proline and P2 sharing a protective mechanism to the point of a slight detrimental 




4.4.1.6.3 A549 Polyampholyte P2 Reduced DMSO Monolayer Freezing 
Due to the high recovery seen with P2 combined with 10% DMSO, we next 
tested to see if we could reduce the percentage of DMSO used during 
Figure 4.10. A549 polyampholyte P2 variable concentration monolayer freezing. 
Cells recovered after freezing to -80 °C. Error bars represent ± SEM of at least 3 
independent experiments with two nested repeats. * P < 0.0001 from 0 mg·mL-1 F-
12K. 
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cryopreservation. We tested three different polymer concentrations against five 
different DMSO percentages. We found that cells frozen with 40 mg·mL-1 and 5% 
DMSO had significantly higher recoveries than cells frozen with 10% DMSO 
alone (Fig 4.11, n = 3, P = 0.0000000001). We additionally observed that cells 
frozen with 10 mg·mL-1 and 5% DMSO along with 40 mg·mL-1 and 2% DMSO 
showed recoveries similar to cells frozen with 10% DMSO alone. The ability to 
lower the DMSO percentage while retaining recoveries similar to 10% DMSO 




Figure 4.11. A549 polyampholyte P2 DMSO percentage monolayer freezing. 
Cells recovered after freezing to -80 °C. Error bars represent ± SEM of 3 independent 
experiments with two nested repeats. * P < 0.0001 from 10% DMSO NP (NP = no 
polymer). 
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4.4.1.6.4 MC-3T3 and Neuro-2a Polyampholyte P2 Variable Concentration 
Monolayer Freezing 
As a final investigation into the cryoprotection of P2 polyampholyte, we tested the 
more sensitive immortalised cell lines of MC-3T3 and Neuro-2a. For MC-3T3 
cells we saw that 5 and 30 mg·mL-1 resulted in significant increases from cells 
frozen with only 10% DMSO and for Neuro-2a cells we saw that 10, 20, and 30 
mg·mL-1 resulted in significantly higher recovery than cells frozen with only 10% 




This section has shown that the polyampholyte P2 is a powerful cryoprotectant 
not only for the robust A549 cell line but also the more delicate cells lines of MC-
3T3 and Neuro-2a frozen as attached monolayers. These results indicate that P2 
Figure 4.12. MC-3T3 and Neuro-2a polyampholyte P2 variable concentration 
monolayer freezing. Cells recovered after freezing to -80 °C. Error bars represent ± 
SEM of 3 independent experiments with two nested repeats. * P < 0.05 from 
0 mg·mL-1 (of the same cell type). 
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could be a universal cryoprotectant for many different cell types. We also 
demonstrated the ability to reduce the concentration of DMSO used while 
retaining recoveries similar to 10% DMSO. The ability to lower the DMSO 
concentration could dramatically increase the availability of cells that could 
otherwise not be used due to downstream DMSO toxicity issues.  
4.4.2 Post-Freeze Viability 
In order to assess the health of our cells post-freeze, utilising A549 cells, we 
conducted a growth viability assay of the cells after thawing. Typically with 
cryopreservation studies, either post-thaw recovery (how many cells are 
recovered after freezing) or post-thaw viability (how well the cells metabolise, 
grow, or behave after freezing) are reported, not always both. These are two 
independent measurements on the success of cryopreservation, and we feel both 
assays should be conducted to understand the full breadth of protection for the 
compound being tested. Our post-freeze viability assay was conducted in a 
similar manner as the growth assay in Section 3.4.2. Following a 24 h post-thaw 
incubation, the cells were detached and plated at identical densities, then 
assessed daily via the trypan blue exclusion assay to determine cell growth over 
6 days. We were again looking for growth rates comparable to unfrozen controls. 
4.4.2.1 Osmolyte PVA Post-Freeze Growth Rates 
We conducted a 6-day post-freeze viability on cells frozen with 5 mg⋅mL-1 PVA, 
with or without a 24 h pre-incubation with our individual osmolyte compounds 
(Fig 4.20-4.23). Combining these results for rate of growth analysis, we found 
unfrozen control cells to have a day 6 rate of growth of 0.68 – 0.74 while cells 
frozen with 10% DMSO had a day 6 rate of 0.52 – 0.65 (Fig 4.13A, n = 3). 
Alanine (N = 2) had rates of 0.71 – 0.76, betaine showed rates of 0.59 – 0.71 and 
proline had rates of 0.53 – 0.65, respectively. These results were highly variable 
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and none of the conditions differed significantly from unfrozen control cells. 
Increasing the sample size may allow for more precise statistical analysis to 
determine significant differences in post-freeze growth rates for cells frozen with 
osmolyte pre-treatments. For cells frozen with 5 mg⋅mL-1 PVA included in the 
CPA we found a significantly lower rate of 0.55 – 0.60 compared to unfrozen 
control cells (Fig 4.13B, n = 3, P = 0.026), with this data set also showing 10% 
DMSO to have a significantly lower growth rate. For cells pre-incubated in 
osmolyte solutions and then frozen with PVA we found that alanine+PVA had a 
rate of 0.61 – 0.66, betaine+PVA showed a rate of 0.62 – 0.73 and proline+PVA 
had rates of 0.62 – 0.66. All cells with an osmolyte pre-incubation and frozen with 
PVA in the CPA had post-freeze rates of growth comparable to unfrozen control 
cells. 
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Overall, these results have shown that cells frozen in osmolyte solutions or an 
osmolyte solution with 5 mg·mL-1 PVA + 10% DMSO grew better than cells frozen 
Figure 4.13. A549 osmolyte post-freeze growth rates. Rate of growth after 
freezing to -80 °C. A) Rate of growth following freezing with osmolyte solutions (100 
mM alanine N=2; 10% DMSO and 100 mM betaine day 2 had no cells thus resulting 
in an ‘undefined’ rate for one data point each). B) Rate of growth following freezing 
with osmolyte solutions and PVA (10% DMSO-day 2 had no cells thus resulting in 
an ‘undefined’ rate for one data point, * P < 0.03 from control cells). Error represents 
± SEM of 3 independent experiments 
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in just 10% DMSO or 5 mg·mL-1 PVA + 10% DMSO, highlighting the long term 
effect of the protective osmolytes of betaine and proline. This further shows that if 
post-thaw growth was our only post-freeze assessment, alanine would look like a 
suitable osmotic cryoprotectant, even though it resulted in much lower post-
freeze cell recovery. 
4.4.2.2 Polyproline Proline Post-Freeze Growth Rates 
Monitoring the growth of the cells frozen with polyproline or 200 mM proline + 
polyproline revealed cells frozen with just 10 mg·mL-1 polyproline + 10% DMSO 
had a rate of growth of 0.60 – 0.66 (Fig 4.14, n = 3). Cells incubated in proline for 
24 h then frozen with 10 mg·mL-1 polyproline + 10% DMSO had a rate of growth 




Figure 4.14. A549 polyproline post-freeze growth rates. Fold change after freezing 
to -80 °C. (10% DMSO-day 2 and 10 mg·mL-1 polyproline-day 3 had no cells thus 
resulting in an ‘undefined’ rate for one data point each). Error represents ± SEM of 3 
independent experiments. 
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4.4.2.3 Polyampholyte Post-Freeze Growth Rates 
Monitoring the growth of the cells frozen with polyampholyte revealed cells frozen 
with 10 mg·mL-1 P2 + 10% DMSO had a rate of growth of 0.57 – 0.64 (Fig 4.15, n 
= 3). All conditions frozen with 40 mg·mL-1 P2, regardless of DMSO 
concentration, showed lower growth rates than cells frozen with just 10% DMSO. 
We found that 40 mg·mL-1 P2 frozen with 2% DMSO had rates of 0.47 – 0.59, 40 
mg·mL-1 P2 frozen with 5% DMSO had rates of 0.35 – 0.57, and 40 mg·mL-1 P2 
frozen with 10% DMSO had rates of 0.49 – 0.59. All conditions were statistically 
similar to control cells, as there is large variability in this data set. Regardless, we 
believe that 10 mg·mL-1 P2 is the optimum concentration of for A549 cells and the 
trade-off between slower growth rates for higher concentrations/lower DMSO 
percentages should be considered based on the limiting factors of the cells (such 
as DMSO sensitivity). 
 
 
Figure 4.15. A549 polyampholyte P2 post-freeze growth rates. Fold change after 
freezing to -80 °C (10% DMSO-day 2 had no cells thus resulting in an ‘undefined’ rate for 
one data point). Error represents ± SEM of 3 independent experiments. 
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4.5 Conclusion 
We have shown that combination of betaine or proline with PVA resulted in a 
significantly higher post-thaw recovery of A549 monolayers but the combination 
of proline with PVA was not successful for the cryopreservation of suspension 
human endometrial cells, MC-3T3 monolayers, or Neuro-2a monolayers. All A549 
monolayers frozen with osmolytes and PVA grew better than cells frozen with 
only 10% DMSO. These results suggest that PVA’s IRI (as demonstrated in 
Chapter 2) on its own is not sufficient for the cryopreservation of cell monolayers 
and that the extra necessary component for successful cryopreservation is seen 
in the preconditioning with betaine and proline, perhaps through osmo-protection 
or membrane protection. Polyproline, in combination with proline incubation, 
resulted in significantly higher recoveries for A549 cells frozen as monolayers 
compared to cells frozen with 10% DMSO. The combination of polyproline and 
proline also resulted in higher post-thaw growth rates. These results, correlated 
with our PVA results suggest that perhaps there is only a minimal amount of IRI 
necessary for the increased protection of cell monolayers. Polyproline was shown 
to have minimal IRI activity in Chapter 2 and yet, it performs similarly to the highly 
active IRI polymer PVA, both in its inability to provide protection on its own and in 
the presence of betaine or proline polyproline provides enhanced cryoprotection. 
This suggests that only a small amount of IRI may be necessary to provide 
improved cryoprotection. The polyampholyte P2 resulted in significantly higher 
post-thaw recoveries at all concentrations tested and the inclusion of proline did 
not further increase the recoveries seen for A549 monolayers. P2 also protected 
Neuro-2a and MC-3T3 cells, and also allowed for the lowering of DMSO down to 
2% with recoveries comparable to 10% DMSO alone. Cells frozen with 10 mg·mL-
1 P2 also grew better post-freeze compared to cells frozen with only 10% DMSO. 
Similar to polyproline, P2 showed minimal IRI activity in Chapter 2, however the 
added protection provided by proline was not necessary for improved 
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cryopreservation outcomes with P2. This suggest that P2 has a dual action of 
minimal IRI and membrane or osmo-protection, or that it acts in a singular fashion 
such that the membrane or osmo-protection is great enough that IRI does not 
damage the cells, or that proline and P2 have overlapping mechanisms to the 
point of being detrimental. Our results with PVA highlight how different cell types 
respond differently to CPA treatments, however, the apparent universal 
protection offered by P2 shows exciting potential as a powerful new 
cryoprotectant. Our results have been summarised in Table 4.1. There are 
several exciting avenues to follow up the questions remaining in this work. Since 
PVA’s IRI activity has been linked to concentration and polymer length, it is 
possible to engineer a polymer with the same IRI activity as P2 to test if the same 
cryoprotection is observed with the less active IRI PVA (in the presence of a 
protective osmolyte), potentially demonstrating an IRI minimal threshold for 
cryoprotection. Another area for investigation would be to cryopreserve cells in 
the presence of PVA and P2 to evaluate if any further protection is gained, which 
would help to delineate the role of IRI as a mechanism of P2 if increased post-
thaw viability is observed, it could be that P2 has a minimal role as an IRI active 
polymer and further protection can be obtained by the combination of the two 
polymers.  
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		 Target ↑   
		
Unfrozen 
Control - 0.70 
		 10% DMSO 16.9 0.58 
		
5 mg·mL-1 
PVA  23.7 0.58 
		
100 mM 
Alanine 24.1 0.74 
		 Alanine + PVA 38.7 0.64 
		
100 mM 
Betaine 30.0 0.64 
		 Betaine + PVA 56.7 0.67 
		
200 mM 
Proline 45.7 0.61 
		 Proline + PVA 62.7 0.64 
		
10 mg·mL-1 
Polyproline 20.3 0.63 
		
Proline + 
Polyproline 47.6 0.68 
		
10 mg·mL-1 P2 
Polyampholyte 71.2 0.61 
 
4.6 Materials and Methods 
4.6.1 Reagents 
All non-specified chemicals were obtained from Sigma Aldrich Co Ltd, (Irvine, 
UK).   
Polyproline was synthesised as in Section 2.6.1.1. 
Polyampholyte was synthesised as in Section 2.6.1.2. 
4.6.2 A549 Cell Culture 
A549 cells were cultured as per Section 3.6.2. 
Table 4.1. Chapter 4 results summary.  Significantly higher than control, significantly 
lower than control (*N=2). 
4 – Macromolecular Cryoprotectants and Osmotic Preconditioning for Enhanced 
Mammalian Cell Cryopreservation 
 165 
4.6.3 Neuro-2a Cell Culture 
Mouse brain neuroblastoma cells (Neuro-2a) were obtained from American 
Tissue Culture Collection (ATCC) (Middlesex, UK) and grown in 75 cm2 cell 
culture Nunc flasks.  Standard cell culture medium was composed of Eagle’s 
Minimum Essential Media (EMEM) (Gibco) supplemented with 10 % USA-origin 
foetal bovine serum (FBS), 100 units·mL-1 penicillin, 100 µg·mL-1 streptomycin, 
and 250 ng·mL-1 amphotericin B (PSA).  Neuro-2a cells were maintained in a 
humidified atmosphere of 5% CO2 and 95% air at 37 °C and the culture medium 
was renewed every 3 - 4 days. The cells were subcultured every 7 days or before 
reaching 90% confluency. To subculture, cells were dissociated using 0.25% 
trypsin plus 1 mM EDTA in balanced salt solution (Gibco) and reseeded at 
7.5·104 cells per 75 cm2 cell culture flasks. 
4.6.4 MC-3T3 Cell Culture 
Mouse calvarial osteoblastic cells (MC-3T3-E1) were obtained from ECACC and 
grown in 75 cm2 cell culture Nunc flasks.  Standard cell culture medium was 
composed of Minimum Essential Medium α (MEM-Alpha) (Gibco) supplemented 
with 10 % USA-origin foetal bovine serum (FBS), 100 units·mL-1 penicillin, 100 
µg·mL-1 streptomycin, and 250 ng·mL-1 amphotericin B (PSA). MC-3T3 cells were 
maintained in a humidified atmosphere of 5% CO2 and 95% air at 37 °C and the 
culture medium was renewed every 3–4 days. The cells were subcultured every 7 
days or before reaching 90% confluency. To subculture, cells were dissociated 
using 0.25% trypsin plus 1 mM EDTA in balanced salt solution (Gibco) and 
reseeded at 1.87·105 cells per 75 cm2 cell culture flasks. 
4.6.5 Primary Endothelial Cell Culture 
Methods adapted from Barros (2016)34. Endometrial biopsies were obtained by 
Dr Jan Brosens from women attending the Implantation Clinic, a dedicated 
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research clinic at University Hospitals Coventry and Warwickshire National 
Health Service Trust. All research was undertaken with full ethical approval and 
with written informed consent obtained from all participants in accordance with 
the guidelines in The Declaration of Helsinki 2000. Biopsies were taken during 
the secretory phase of the menstrual cycle using an Endocell cannula, starting 
from the uterine fundus and moving downward to the internal cervical ostium. The 
endometrial biopsy was placed in a labelled Bijoux tube containing 5 ml cell 
culture media and processed immediately. 
Tissue was diced for 5 min with a scalpel to dissociate the tissue. Sample was 
then incubated in digestion media containing additive-free Dulbecco’s minimum 
essential media (DMEM) (Gibco), 0.5 mg·mL-1 collagenase (Sigma-Aldrich), and 
0.1 mg·mL-1 DNase I (Roche Diagnostics) for 1 h to promote further dissociation; 
sample was shaken every 15 minutes. Sample was then passed through a 0.2 
µm membrane to allow endometrial stromal cells (ESC) and red blood cells to 
pass through. The membrane was then back washed to collect endometrial 
epithelial cells (EEC). Samples were spun at 2 g for 5 min, supernatant removed, 
and cells were resuspended in DMEM containing 10% dextran-coated charcoal 
FCS (DCC) (Gibco).   
4.6.6 Solution Preparation 
Solutions for cell experiments were prepared by dissolving the individual 
compounds in base cell media supplemented with 10% FBS and 1x PSA 
(solutions used as freezing buffers did not contain PSA) and sterile filtering prior 
to use.  
4.6.7 Monolayer plate collagen coating 
As indicated in experiments, to promote attachment of cells, collagen I from rat 
tail (Sigma-Aldrich) was diluted to 50 µg·mL-1 in 200 mM acetic acid (Sigma) and 
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added to each well of a 24-well cell culture plate at 5 µg collagen·cm-2. Plates 
were incubated with the dissolved collagen for 1 h at room temperature. After this 
incubation period the collagen solution was removed and the plates were rinsed 
three times with 200 µL Dulbecco’s phosphate buffered saline (Thermo Fisher) to 
remove any residual acetic acid solution. The collagen treated plates were 
allowed to dry for 1 h in a laminar flow hood and stored for less than 1 week at 4 
°C prior to use. 
4.6.8 Cryopreservation of Cell Monolayers 
Methods adapted from Bailey.9 Cells to be frozen in monolayer format were 
seeded at 0.4·106 (A549) or 0.5·106 (Neuro-2a, MC-3T3) cells per well in 500 µL 
of cell culture medium in 24-well plates (Corning Incorporated, Corning, NY). 
Plates had a total available volume of 3.4 mL with an approximate growth area of 
1.9 cm2, no coverslips were used and plates were used with the accompanying 
lid. Cells were allowed to attach to the entire free surface of the bottom of the well 
and formed a confluent layer not greater in height than one cell. Before 
experimental treatments, cells were allowed to attach for 2 h to the plates in a 
humidified atmosphere of 5% CO2 and 95% air at 37 °C. The medium was 
exchanged against medium that was or was not supplemented with solutes as 
indicated in the figures. Control cells received no additional solutes and 
experimental cells were incubated in indicated solutions for 24 h in a humidified 
atmosphere of 5% CO2 and 95% air at 37 °C. Following the incubation period, the 
culture medium was removed and cells were exposed for 10 min at room 
temperature to different concentrations of solutes dissolved in base media 
supplemented with 10% FBS and indicated concentrations of DMSO.  After 10 
min, the freezing solutions were removed and the plate placed inside a CoolCell® 
MP plate (BioCision, LLC, Larkspur, CA), transferred to a -80 °C freezer and 
frozen at a rate of 1 °C·min-1. After 24 h at -80 °C, cells were rapidly thawed by 
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addition of 500 µL complete cell culture medium warmed to 37 °C.  Cells were 
placed in a humidified atmosphere for 24 h and then dissociated using 0.25% 
trypsin plus 1 mM EDTA in balanced salt solution. The number of viable cells was 
then determined by counting with a hemocytometer (Sigma Aldrich) at room 
temperature after 1:1 dilution of the sample with 0.4% trypan blue solution (Sigma 
Aldrich). The initial cell medium was discarded such that any non-attached cells 
were not included in the assessment. The percentage of recovered cells was 
calculated by dividing the number of cells with intact membranes after freezing 
and thawing by the number of cells present prior to freezing (i.e. after application 
of pre-treatments), multiplied by 100. 
4.6.9 Primary Endothelial Suspension Freezing 
Cells were counted to determine starting number and diluted such that 500 µL of 
cell solution was placed into cryovials with 500 µL of different freezing mediums 
containing 10% DMSO. Cryovials were placed in a Mr. Frosty (Nalgene) and 
placed inside a -80 °C freezer for 24 h. Samples were then moved into liquid 
nitrogen (-196 °C) for 6 days.  Samples were thawed by placing them in a 37 °C 
water bath. Post-thaw cells were plated in T-25 flasks (Thermo Fisher) in DMEM 
containing 10% DCC for 24 h. ESCs were dissociated using 0.25% trypsin plus 
1mM EDTA in balanced salt solution. EECs were not attached and were simply 
washed off the flask and collected. The number of viable cells was determined by 
counting with a hemocytometer after 1:1 dilution of the sample with 0.4% trypan 
blue solution. 
4.6.10 Post-freezing Cell Viability Assay 
Cells were frozen as indicated in Section 4.6.8. Cells were then seeded at 
12.5·103 per well in 6-well plates in 2 mL of complete cell media. Cells were 
placed in a humidified atmosphere of 5% CO2 and 95% air at 37 °C and allowed 
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to grow, with counts starting on day two and commencing on day six. Cell media 
was renewed on day three. Cells were dissociated using 0.25% trypsin plus 1 
mM EDTA in balanced salt solution. The number of viable cells was then 
determined by counting with a hemocytometer at room temperature after 1:1 
dilution of the sample with 0.4% trypan blue solution. Fold increase of cells was 
calculated by dividing the number of cells with intact cell membranes by the 
number of cells initially plated.  
4.6.11 Statistical Analysis 
Data were analysed with a one-way analysis of variance (ANOVA) on ranks 
followed by comparison of experimental groups with the appropriate control group 
(Holm–Sidak method) followed by Tukey’s post hoc test. Excel 2013 (Microsoft, 
Redmond, WA) and R were used for the analyses and graphs. Data sets are 
presented as mean ± (SEM).   
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Figure 4.16. A549 proline concentration monolayer freezing.  Cells recovered after 
freezing to -80 °C. Error bars represent ± SEM of 3 independent experiments with two 
nested replicates. 
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Figure 4.17. A549 proline PVA concentration monolayer freezing. Cells recovered 
after freezing to -80 °C. Error bars represent ± SEM of 3 independent experiments with 
two nested replicates. * P < 0.00001 from control (0 mg·mL-1 in F-12K).  
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Figure 4.18. A549 betaine concentration monolayer freezing. Cells recovered after 
freezing to -80 °C. Error bars represent ± SEM of 3 independent experiments with two 
nested replicates. * P < 0.00001 from control (0 mM no PVA). ** P < 0.0001 from 
control with 5 mg·mL-1 PVA.   
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Figure 4.19. A549 alanine concentration monolayer freezing. Cells recovered after 
freezing to -80 °C. Error bars represent ± SEM of 3 independent experiments with two 
nested replicates.     
Figure 4.20. A549 PVA post-freeze growth rates. Growth rates after freezing 
to -80 °C. Error bars represent ± SEM of 3 independent experiments. 
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Figure 4.21. A549 proline post-freeze growth rates. Growth rates after freezing 
to -80 °C. Error bars represent ± SEM of 3 independent experiments. 
Figure 4.22. A549 betaine post-freeze growth rates. Growth rates after freezing 
to -80 °C. Error bars represent ± SEM of 3 independent experiments. 
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5. IMPACT OF MOLECULAR AND 
MACROMOLECULAR 
CRYOPROTECTANTS ON 
MEMBRANE INTEGRITY BEFORE 
AND AFTER CRYOPRESERVATION 
 
5.1 DECLARATIONS 
All polyampholyte polymers were synthesised by Dr Christopher Stubbs and 
polyproline polymers were synthesised by Dr Ben Graham under the supervision 
of Prof Matthew Gibson. Confocal imaging assistance was provided by Ruben 
Tomás and confocal images were processed solely by Ruben Tomás under the 
supervision of Prof Matthew Gibson. 
 
5.2 CHAPTER SUMMARY 
Cell membranes are an integral component of cell survival; irreversible damage 
to a membrane is considered a catastrophic event. Dehydration during the 
freezing process is essential to prevent intracellular ice, and thus ultimately, cell 
recovery, and the integrity of the membrane is a determinant for this process. In 
this chapter we examine the effect of our molecular and macromolecular 
cryoprotectants on the cell membrane. We found that the macromolecular 
cryoprotectants of PVA, polyproline, and polyampholyte did not have an impact 
on membrane permeability during short exposures at room temperature and the 
osmolytes of alanine, betaine, or proline did not affect permeability for long 
exposures at physiological temperatures. Following cryopreservation, we 
5 – Impact of Molecular and Macromolecular Cryoprotectants on Membrane Integrity 
Before and After Cryopreservation 
 181 
discovered that cell permeability after storage with our cryoprotectants were 
comparable to those seen with 10% DMSO, with the exception of polyampholyte 
treatment, which showed significantly lower permeability. Additionally, the 
polyampholyte induced a unique phenotype not observed in our other 
macromolecular cryoprotectants and was investigated to rule out the cause as 
lipid bodies, polymer aggregation, phagocytes, or membrane poration.  
 
5.3 INTRODUCTION 
Cell membranes are large flexible bilayers that serve as the boundaries of cells 
and their intracellular organelles. Membranes literally define what a cell is (the 
outer membrane and the contents contained within) and what is not. Membranes 
are assembled by the non-covalent association of their components, the primary 
building blocks being phospholipids consisting of two long-chain, nonpolar fatty 
acid groups linked (usually by an ester bond) to small, highly polar groups, 
including a phosphor-glycerol unit. The plasma membrane serves as both a 
permeability barrier and a conduit, allowing the import of essential nutrients, 
ensuring that metabolic intermediates remain in the cells, and enabling waste 
products to leave the cell, while also permitting the selective transport of material 
and information between the cell’s exterior and interior spaces.  
Maximov suggested in 1929 that disruption of the plasma membrane was the 
primary cause of freezing injury1 and in 1938 Siminovitch & Scarth concluded that 
both intracellular and extracellular ice formation resulted in damage to the plasma 
membrane, for separate reasons,2 and this went on to help shape Mazur’s two-
factor hypothesis of freezing injury.3 For cells in a partially frozen solution, the 
intracellular solution must come into equilibrium with the extracellular ice, either 
by intracellular ice formation or cell dehydration4 and the plasma membrane plays 
a central role in determining the manner of this equilibrium. This is due to two 
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factors: the first is that the intact membrane acts as an effective barrier to 
extracellular ice5,6 along with a lack of effective intracellular ice nucleators,6 the 
intracellular solution will remain unfrozen. Secondly, due to the semipermeable 
nature of the plasma membrane, the cell will dehydrate in response to the lower 
potential of the extracellular solution.7 Whether the cell achieves equilibrium by 
dehydration or intracellular ice formation is ultimately a consequence of the 
stability of the plasma membrane.4 This emphasises how important the stability of 
the cell membrane is, even if all other mechanisms of damage are mitigated, 
irreparable damage to the cell membrane is not recoverable regardless of how 
well other factors are managed.  
Cellular plasma membranes are selectively permeable such that only small 
hydrophobic or non-charged molecules, along with water, can pass through the 
membrane quickly without assistance (Fig 5.1). We can exploit this characteristic 
to probe membrane health; by using markers of either permeable or non-





Figure 5.1. Selective membrane permeability. Bidirectional membrane permeability 
parameters. 
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DMSO is thought to introduce transient pores into the membrane during the 
freezing process, therefore we wanted to evaluate the membrane permeability of 
our compounds under physiological conditions to determine if there was any 
alteration in permeability that may be affording protection. This will be 
accomplished via a calcein-AM retention kinetic assay to measure any 
permeability as it happens in real time. Additionally, permeability after 
cryopreservation is a commonly used means of assessment in cell 
cryopreservation so we will evaluate post-freeze permeability via calcein-
AM/EthD-1 retention and uptake prior to removing the cells from the plate through 
the damaging trypsinisation process. In this chapter, the membrane permeability 
at various steps throughout our freezing processes was assessed to determine if, 
(i) our macromolecules used as cryoprotective agents (CPAs) altered the 
membrane permeability under normal conditions, (ii) small molecule osmolyte 
incubation altered the membrane permeability under normal conditions, and (iii) 
the membrane permeability was altered after freezing in each of our conditions. 
The results of this chapter will allow us to evaluate if there is any impact on the 
permeability of the cell membrane due to our cells being in the presence of our 
compounds. Additionally, we will be able to evaluate potential cell damage of our 
cryopreserved monolayers before any outside manipulation occurs to remove 
them from the plate. This will help us to identify potential areas of cell damage 
during the cryopreservation process.  
 
5.4 RESULTS AND DISCUSSION 
5.4.1 Permeability Kinetics 
We first wanted to look at the membrane impacts of our macromolecules being 
used as CPAs. As demonstrated in Chapter 4, our macromolecular CPAs are in 
contact with our cells for a relatively short period of time in the monolayer format. 
5 – Impact of Molecular and Macromolecular Cryoprotectants on Membrane Integrity 
Before and After Cryopreservation 
 184 
They experience a 10 min CPA incubation prior to freezing, the CPA solution is 
then removed (some will remain behind at the cell surface) and the cells are then 
frozen at a rate of 1 °C·min-1 down to -80 °C (~103 min). Therefore, we needed 
an assay that would quickly capture any impacts our CPAs were having on cell 
membranes in less than 2 h. One method to quickly evaluate the stability of a cell 
membrane is through the uptake of a retained fluorescent molecule such as 
calcein-AM. Calcein-AM is freely permeable to the cell and can also be 
transported out via the P-glycoprotein (P-gp) transporter. Once inside the cells, 
calcein-AM is hydrolysed by endogenous esterases into the negatively charged 
green fluorescent calcein, which is retained in the cytoplasm. Calcein is not cell 
permeable and is not effluxed by P-gp. One limitation to this assay is in the event 
of a loss of membrane stability, such that the fluorescent calcein is released into 
the solution, which can result in inaccurate fluorescent readings. Fortunately, this 
problem has a solution. Utilising a membrane flux assay modified from Su et al.,8 
the calcein quencher trypan blue was exogenously added, allowing membrane 
flux to be continuously monitored by a reduction in retained calcein-associated 
fluorescence (Fig 5.2). The exogenously added trypan blue will quench any lost 
fluorescence from calcein which has leached from the cell (as well as permeate 
damaged membranes) and allow accurate readings of cell-retained calcein. For 
this assay, cells were loaded with calcein-AM then plated and exposed to the 
CPAs for 4 h at 37 ˚C, with readings taken every 10 min. Lower fluorescent 
values indicate cell leakage, and therefore membrane permeability. A slight 
increase in cell permeability could be beneficial to our cells during the freezing 
process, allowing them to dehydrate faster, but a large increase in permeability 
would be fatal if the integrity of the bilayer was lost. 
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5.4.1.1 Standard Membrane Permeability Kinetics 
We first tested the permeability kinetics for our standards of cell media (Ham's 
F-12K (Kaighn's) Medium (F-12K)) and the standard cryoprotectant of dimethyl 
sulfoxide (DMSO). Control cells were incubated in complete cell media (F-12K) 
and experimental cells (10 and 20% DMSO) were incubated in the indicated 
solutions for the duration of the experiment (4 h). Control cells showed the 
expected exponential decay of the fluorophore, with 10% DMSO exhibiting the 
same decay trend, although with a slightly higher initial fluorescence retention 
(Fig 5.3, n = 3). The higher retention for 10% DMSO may be due to DMSO 
increasing cell permeability or inducing water pores,9 thereby allowing more 
calcein-AM to enter. We saw that cells treated with 20% DMSO showed a large 
decrease in fluorescence over a short period of time (45 minutes), suggesting 
that 20% DMSO caused the cell membranes to become very permeable resulting 
in a loss of structural integrity. However, DMSO is known to be toxic at room 
temperature10 so these results were not overall unexpected for the high 
concentration of DMSO used. 
Figure 5.2. Schematic representation of membrane permeability kinetics assay.   
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These results show that this assay is a useful indicator of membrane permeability 
and provides a fast and reliable reporting method. We have additionally 
demonstrated that 20% DMSO results in catastrophic membrane permeability 
leading to a fatal loss of membrane integrity at room temperature in less than 45 
minutes.   
 
5.4.1.2 PVA and Polyproline Membrane Permeability Kinetics 
We next looked at the membrane permeability of two of our macromolecular CPA 
compounds, PVA and polyproline. Neither of these compounds are highly 
soluble, with a max solubility of approximately 20 mg·mL-1 (for the molecular 
weight used here). Due to the nature of this assay, such as the timing and the 
Figure 5.3. Permeability kinetics of control cells and DMSO.  A) Plate readings of 
calcein fluorescence. B) Bright-field images of cells at 4 h (460 nmλ illumination). 
Scale bar = 200 µm. 
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volumes used, a 4X experimental solution is required, therefore the highest 
concentration tested for PVA and polyproline was 5 mg·mL-1. We saw no 
significant change in permeability for either PVA or polyproline, with values below 




PVA is not considered to be highly membrane active, for example, when used as 
a hydrogel it has poor cell attachment due to its highly hydrophilic nature.11 
Additionally, polyproline showed no inherent membrane permeability when tested 
against red blood cells for hemolysis,12 also aligning with our results. From this 
we can conclude that the macromolecular CPA agents of PVA and polyproline do 
Figure 5.4. Permeability kinetics of PVA and polyproline.  A) Plate readings of 
calcein fluorescence. B) Bright-field images of cells at 4 h (460 nmλ illumination). 
Scale bar = 200 µm. 
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not inherently induce cell permeation at room temperature for the concentrations 
tested. 
 
5.4.1.3 Polyampholyte Membrane Permeability Kinetics 
We next tested the membrane permeability of polyampholyte, which is highly 
soluble, allowing us to test concentrations from 1 to 40 mg·mL-1. We saw 
fluorescence retention values higher than control cells but comparable to values 
obtained with 10% DMSO (Fig 5.5, n = 3).  
 
5 – Impact of Molecular and Macromolecular Cryoprotectants on Membrane Integrity 




Cells incubated with varying concentrations of polyampholyte had retention 
values comparable to 10% DMSO and we saw no reduction in fluorescence 
retention, demonstrating that polyampholyte does not increase permeability at 
room temperature over 4 h. Polyampholytes have been shown to interact with the 
membrane and protect it from freezing-induced damage;13 our results suggest no 
loss of membrane stability when cells are incubated with polyampholytes. 
Figure 5.5. Permeability kinetics of polyampholyte.  A) Plate readings of calcein 
fluorescence. B) Bright-field images of cells at 4 h (460 nmλ illumination). Scale bar = 
200 µm. 
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These results show that our additives used as macromolecular CPAs do not 
affect the membrane permeability at room temperature. It would be interesting to 
test the stability of our additives in combination with 20% DMSO, to assess if our 
macromolecular CPAs could mitigate the membrane damage from high 
concentration DMSO exposure. 
 
5.4.2 Osmolyte Incubation Pre-Freezing Membrane Permeability 
After evaluating the membrane permeability of short exposure macromolecular 
CPAs, we next wanted to assay the permeability impact of the osmolytes of 
alanine, betaine, and proline. These compounds are incubated with cells for 24 h 
prior to cryopreservation, since as we established in Chapter 4, this pre-
incubation period dramatically improves post-thaw recoveries for betaine and 
proline. Therefore, due to the 24 h exposure time, permeability kinetics would 
only be useful to pinpoint the time at which permeability may happen, assuming it 
does it all. With that in mind, we conducted a static permeability assay following 
osmolyte incubations at 24 h. For this assay, we utilised the well-established 
calcein-AM/ethidium homodimer-1 (EthD-1) assay, commonly known as the 
LIVE/DEAD assay. This assay works similar to the calcein-AM assay in Section 
5.4.1, where healthy cells convert calcein-AM to calcein. In addition, EthD-1 is not 
freely permeable and cannot enter cells unless the membrane is damaged, once 
EthD-1 enters the cells, it binds to nucleic acids and its fluorescence is increased 
40 fold. In this assay, the cells are incubated in the osmolyte compounds for 24 h, 
then treated with calcein-AM/EthD-1 for 45 min at room temperature, rinsed, 
analysed on a plate reader, and then imaged. Healthy cells will have a higher 
reading on the calcein channel (green) and damaged cells will have a higher 
reading on the EthD-1 channel (red) (Fig 5.6). 
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Incubating cells in osmolyte solutions for 24 h did not significantly change their 
permeability relative to control cells (F-12K) (Fig 5.7). There was no significant 
difference in calcein fluorescence (green) for cells incubated in osmolyte 
solutions (Fig 5.8A) and cells incubated in 200 mM proline had significantly lower 
EthD-1 fluorescence (red) compared to 100 mM alanine and 100 mM betaine (Fig 
5.8B, n = 3, P = 0.02) but all conditions were comparable to control cells. 
Incubating cells in osmolyte solutions for 24 h did not significantly alter the 
permeability of the cells relative to control cells.  
 
Figure 5.6. Schematic representation of calcein/ethidium homodimer-1 
membrane permeability assay.   
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Figure 5.7. Calcein/EthD-1 bright-field images of A549 cells incubated in osmolyte 
solutions for 24 h.  (Green = 460 nmλ illumination, red = 525-660 nmλ illumination) 
Scale bar = 50 µm. 
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These results are not unsurprising, as these compounds are compatible 
osmolytes, which means they typically do not act in detrimental ways, and the 
stabilising ability of these compounds appear to be used only when there are 
stressors that destabilise membranes.14 
 
5.4.3 Post-Freeze Membrane Permeability 
Since we didn’t see any significant membrane permeability with either 
macromolecular CPAs or osmolyte compounds under normal conditions, we next 
wanted to evaluate the permeability of the membrane after freezing and thawing 
Figure 5.8. Calcein/EthD-1 fluorescent readings of A549 cells incubated in 
osmolyte solutions for 24 h.  A) Calcein readings.  B) Ethidium homodimer-1 
readings. * P < 0.03 from 200 mM proline. 
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our cells with our various treatments. This section utilises the same assay as in 
Section 5.4.2, except in this experiment the cells have been frozen and thawed 
as in Section 4.6.8 prior to calcein-AM/EthD-1 treatment.  
 
5.4.3.1 Osmolyte PVA Post-Freeze Membrane Permeability  
Cells were incubated in osmolyte pre-treatments for 24 h (as indicated) then 
treated with the specified CPA for 10 min, frozen for 24 h to -80 °C, thawed with 
37 °C cell media (F-12K) and incubated for 24 h, then treated with calcein-AM 
and EthD-1 (Fig 5.9). Cells frozen with osmolyte pre-incubation and with or 
without PVA did not significantly differ in their calcein-AM or EthD-1 uptake from 
10% DMSO, with the exception of 100 mM alanine which had significantly higher 
EthD-1 fluorescence (Fig 5.10, n = 3, P = 0.00006).   
5 – Impact of Molecular and Macromolecular Cryoprotectants on Membrane Integrity 
Before and After Cryopreservation 
 195 
 
Figure 5.9. Membrane permeability of frozen/thawed A549 cells with osmolyte 
incubation and CPA treatments. Bright-field images of calcein-AM / EthD-1 treated 
cells 24 h post-thaw (green = 460 nmλ illumination, red = 525-660 nmλ illumination). 
Scale bar = 50 µm. 
Brightfield (20X) Green Red Combined
10% DMSO
5 mg·mL-1  PVA
100 mM Alanine
100 mM Alanine 
+ 5 mg·mL-1  
PVA
100 mM Betaine
100 mM Betaine 
+ 5 mg·mL-1  
PVA
200 mM Proline
200 mM Proline 
+ 5 mg·mL-1  
PVA
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The fact that we only saw a significant difference in EthD-1 fluorescence with 
100 mM Alanine was surprising, since this does not match the trend seen with 
cells recovered in Section 4.4.1.2 (combined for comparison in Fig 5.11), as we 
would expect to see increasing calcein fluorescence/decreasing EthD-1 
fluorescence with increasing cell recovery. There could be several reasons for 
this discrepancy, the simplest being that this assay alone is not a good 
determinant of cell recovery for cryopreserved cells. Perhaps the cells remain 
partially functional while attached to the plate but the membranes of our low 
recovery conditions are too fragile to survive being removed from their culture 
Figure 5.10. Calcein/EthD-1 fluorescent readings of frozen/thawed A549 cells 
with osmolyte and PVA treatments.  A) Calcein readings.  B) Ethidium homodimer-
1 readings. * P < 0.001 from 10% DMSO in F-12K. 
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plate during trypsinisation for cell recovery assessment. This is an interesting 
finding as the calcein-AM/EthD-1 assay is often used as the only measurement of 
cell recovery in cryopreservation studies and by comparing our combined results, 
we can see that it may not be an accurate measurement of recovery on its own.  
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Figure 5.11. Calcein/EthD-1 fluorescent readings and cell recovery of 
frozen/thawed A549 cells with osmolyte and PVA treatments. A) Calcein 
readings. B) Ethidium homodimer-1 readings. * P < 0.001 from 10% DMSO in 
F-12K. C) Cells recovered with intact membranes. * P < 0.001 from 10% DMSO in 
F-12K, ** P < 0.001 from 10% DMSO+5 mg·ml-1 PVA in F-12K. 
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5.4.3.2 Polyproline Post-Freeze Membrane Permeability 
To determine the effect of polyproline on cell membrane permeability post-thaw, 
A549 cells were plated and incubated for 24 h, then treated with the polyproline 
(+ 10 % DMSO) for 10 min, frozen for 24 h to -80 °C, thawed with 37 °C cell 
media (F-12K) and incubated for 24 h. Cells were then treated with calcein-AM 
and EthD-1 24 h post-thaw after freezing with polyproline in the CPA (Fig 5.12). 
Cells frozen with polyproline did not significantly differ in their calcein or EthD-1 





Figure 5.12. Membrane permeability of frozen/thawed A549 cells polyproline 
treatments.  Bright-field images of calcein-AM / EthD-1 treated cells 24 h post-thaw 
(green = 460 nmλ illumination, red = 525-660 nmλ illumination).  Scale bar = 50 µm. 
Brightfield (20X) Green Red Combined
10% DMSO
5 mg·mL-1  
Polyproline
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Polyproline did not appear to alter the post-freeze/thaw membrane permeability 
compared to 10% DMSO and this correlates with our previous cell recovery data 
from Section 4.4.1.5 where 10% DMSO had a recovery of 19.8% and 5 mg·ml-1 
polyproline had a recovery of 20.3%. 
 
5.4.3.3 Polyampholyte Post-Freeze Membrane Permeability 
Similar to PVA and polyproline, we wanted to determine the effect that 
polyampholyte (P2) had on cell membrane permeability after freezing. Cells were 
plated and incubated for 24 h then treated with polyampholyte (+ 10% DMSO) for 
10 min, frozen for 24 h to -80 °C, thawed with 37 °C cell media (F-12K) and 
incubated for 24 h, then treated with calcein-AM and EthD-1 (Fig 5.14). Cells 
frozen with 5 mg·mL-1 polyampholyte had significantly higher calcein uptake and 
significantly lower EthD-1 uptake from 10% DMSO (Fig 5.15, n = 3, P = 0.004).   
 
Figure 5.13. Calcein/EthD-1 fluorescent readings of frozen/thawed A549 cells 
with polyproline.   
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Cells frozen with 5 mg·mL-1 polyampholyte had a significantly higher calcein-AM 
uptake with a significantly lower EthD-1 uptake than cells frozen with just 10% 
DMSO. These results do trend with our recovery results from Section 4.4.1.6.2; 
10% DMSO had 19% recovery with an 81% recovery for 5 mg·mL-1 
polyampholyte. This could imply that the calcein-AM/EthD-1 assay only trends 
correctly when there are large disparities between the recoveries. It could 
alternatively imply that the osmolyte/PVA treatment and the polyampholyte 
treatment protect cells through different mechanisms.  
Figure 5.14. Membrane permeability of frozen/thawed A549 cells with 
polyampholyte treatment.  Bright-field images of calcein-AM/EthD-1 treated cells 24 h 
post-thaw (green = 460 nmλ illumination, red = 525-660 nmλ illumination).  Scale bar = 
50 µm. 
Brightfield Green Red Combined
10% DMSO
5 mg·mL-1  
Polyampholyte
Figure 5.15. Calcein/EthD-1 fluorescent readings of frozen/thawed A549 cells 
with polyampholyte.  * P < 0.01 from 10% DMSO.  
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These results have shown that none of our macromolecular cryoprotectants or 
small molecule osmolytes increased membrane permeability at room 
temperature. PVA, a highly IRI active polymer, and polyproline, a weakly IRI 
active polymer, did not show increased calcein uptake/retention (showing 
membrane health) following cryopreservation. Polyampholyte, a weakly IRI active 
polymer, did show significant increases in calcein uptake and retention following 
cryopreservation. These results could imply that PVA and polyproline offer 
incomplete protection that is manifested primarily when the cells are manipulated 
off the plate, while polyampholyte provides membrane protection which is evident 
directly after thawing. Alternatively, it could imply that the calcein/EthD-1 assay is 
not well suited for analysing medium variability differences (i.e. 19%:55% vs. 
19%:80%).  
 
5.4.4 Polyampholyte Phenotype Investigation 
An unknown circular phenotype was noticed during toxicity screening of 
polyampholyte (Section 3.4.1.3) as shown in (Fig 5.16). This phenotype was not 
observed when cells were treated with either PVA or polyproline, suggesting it is 
a unique attribute of polyampholyte and begs further investigation. The 
phenotype presented for high concentrations (≥ 20 mg·mL-1) for 10 min 
exposures and at lower concentrations (≤ 10 mg·mL-1) for 24 h exposures. While 
the simplest explanation for this phenotype would simply be degradation of the 
cell and membrane, our toxicity results show that cell metabolism (assessed by 
alamarBlue reduction) was only significantly lower for concentrations > 10 mg·mL-
1 after 24 h incubation. In addition, the phenotype was present at lower 
concentrations where the cells appear to be metabolising normally.  
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The observed phenotype was first investigated to determine if it was due to lipid 
droplet formation. Lipid droplets are lipid-rich cellular organelles and their 
biogenesis is a highly regulated cellular process that culminates in the 
compartmentalisation of lipids and enzymes, protein kinases and other proteins. 
It is thought that lipid droplets are inducible organelles with roles in cell signaling, 
regulation of lipid metabolism, membrane trafficking and control of the synthesis 
and secretion of inflammatory mediators.15 Nile red is a dye that can be applied to 
cells in an aqueous solvent and it dissolves preferentially in lipids; its 
fluorescence is quenched in an aqueous environment so it is seen only in the 
Figure 5.16. Polyampholyte observed phenotype. A) Control cells. B) 10 mg·mL-1 
polyampholyte P2 (24 h). Scale bar = 100 µm. 
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substances it is intended to stain, and its fluorescence color changes in the 




Cells were incubated in varying concentrations of polyampholyte for 10 min and 
24 h then treated with nile red and imaged on a fluorescent microscope to assess 
the presence of lipid droplets. Cells did not fluoresce for the presence of lipid 
droplets as phenotype circles remained unfluoresced (Fig 5.24) with the 
unflouresced circle shown (Fig 5.25). As a further assessment, cells were 
incubated with polyampholyte P2 then analysed by confocal microscopy, to 
obtain more detailed cell images. Z-stack images were collected to allow the 
whole cell to be captured. Confocal images were taken following nile red 
treatment (Fig 5.26) and to definitively show that there were no lipid droplets 





Figure 5.17. Nile red staining.  Nile red fluorescence of cultured monkey aortic 
smooth muscle cells and mouse peritoneal macrophages. (a and b). Adapted with 
permission from Greenspan et al. (1985).16 
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From the z-stack images, we again see a lack of nile red staining within the 
circular phenotype, which instead appear as holes moving through the body of 
Figure 5.18. Confocal z-stack imaging of nile red treatment of cells incubated with 5 
mg·mL-1 polyampholyte for 24 h. Scale bar = 10 µm. 
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the cell. If they are indeed holes, we would expect the membrane to be 
permeable, which is what we next investigated.   
To explore membrane permeability, the cells were again incubated in varying 
concentrations of polyampholyte for 10 min and 24 h. Calcein-AM and ethidium 
homodimer-1 (EthD-1) were then added and cells imaged after a 45 min 
incubation. Surprisingly, we saw no increase in permeability for the cells that 
contained the circular phenotype (Fig 5.27) and we observed a lack of 




If the circular phenotype is indeed holes, they appear to be non-permeable, such 
as a toroid, membranes with a “doughnut-like” toroidal shape17 (Fig 5.2018). 
 
Figure 5.19. Bright-field images of polyampholyte incubated membrane 
permeability of 5 and 10 mg·ml-1 polyampholyte incubated cells.  A) 5 mg·mL-1 (24 h) 
bright-field. B) 5 mg·mL-1 (24 h) combined channels (green = 460 nmλ illumination, red = 
525-660 nmλ illumination). C) 10 mg·mL-1 (24 h) bright-field. D) 10 mg·mL-1 (24 h) 
combined channels. Scale bar = 50 µm. 
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We next investigated if the circles might be a result of the polyampholyte 
triggering the formation of phagocytes, a process where cells ingest a harmful 
foreign substance. Neutral red is a pH indicating histological stain and will stain 
Figure 5.20. Spontaneous membrane resealing.  Spontaneous resealing of plasma 
membrane injuries in the nanometer range is opposed by the forces of the underlying 
membrane cytoskeleton. For an injury to a phospholipid bilayer alone (A1-4), the lipid 
disorder present on the curved edges of the disruption provides the driving force to 
spontaneously reseal the injury and is a function of disruption diameter squared. 
However, if the injured phospholipid bilayer is tethered to underlying cytoskeleton (B1-
4), the membrane tension from adhesion to the cytoskeleton confers an opposing 
force for resealing, a function of disruption diameter cubed, and prevents spontaneous 
repair of membrane disruptions that exceed diameters in the nanometer range. 
Reprinted with permission from Cooper and McNeil (2015).18 
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phagocytes purple.19  We observed no significant purple staining of the cells with 
neutral red (Fig 5.28) and when looking at the cells we observed no staining at all 




Since the phenotype did not appear to be either lipid droplets or phagocytes, we 
next investigated if the phenotype might be due to aggregated polymer vesicles. 
Utilising a rhodamine-6G fluorescently tagged polyampholyte, we again 
incubated our cells and imaged them for the presence of internalised 
polyampholyte. We saw no internalised vesicles of polymer with the tagged-
Figure 5.21. Enhanced images of neutral red staining. A) Control cells.  
B) 10 mg·mL-1 polyampholyte (24 h). Scale bar = 50 µm.  
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polymer incubated cells (Fig 5.22). To completely rule out the presence of 
internal polyampholyte, confocal imaging was conducted with the tagged-
polyampholyte. Again, we observed no fluorescence for the cells incubated with 
tagged-polymer (Fig 5.29) and moving through the z-stack image there was no 




Figure 5.22. Imaging of rhodamine-6G tagged-polyampholyte incubated cells.  
Images of treated cells (green = 460 nmλ illumination).  Scale bar = 100 µm.  
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Figure 5.23. Confocal z-stack imaging of cells incubated with 5 mg·mL-1 
rhodamine-6G tagged-polyampholyte for 24 h. Scale bar = 10 µm. 
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While we were unable to find a definitive cause for the observed phenotype, we 
were able to rule out lipid bodies, phagocytes, polymer vesicles, and most 
surprisingly, membrane permeability. Future studies are needed to determine the 




We have shown that our CPA compounds do not impact the membrane 
permeability of cells at 37 ˚C. Similarly, we found that the osmolyte incubation 
also did not impact permeability under physiological conditions. From post-freeze 
analysis, we found that cells frozen with osmolyte pre-treatment along with PVA 
did not show significantly different permeability from cells frozen with just DMSO, 
even though the post-freeze cell recoveries for these conditions were significantly 
different in Chapter 4. These disparities between post-freeze permeability when 
compared to post-freeze viability may indicate that the trypsinisation process is a 
major area of potential damage exposure following the stressful event of 
cryopreservation, such that less protected cells will not endure the process of 
being removed from the plate as well as better protected cells. The post-freeze 
permeability for cells frozen with polyampholyte did show significant differences, 
correlating with their post-freeze cell recoveries observed in Chapter 4. It has 
been shown that DMSO dehydrates the phospholipid head-groups, whereas 
other CPAs (glycerol, ethylene glycol, dimethyl formamide, and propylene glycol) 
caused an increase in the hydration level of the lipid head-groups; resulting in the 
freezing-and-thawing of liposomes in the presence of CPAs showing 
carboxyfluorescein (CF)-retention at the same levels as before freezing (with the 
exception of glycerol), which implied it is the exposure to CPAs and not the 
freezing step itself that causes CF-leakage during cryopreservation processing.20 
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However, exposure to high CPA concentrations already caused leakage before 
freezing, increasing in the order DMSO, ethylene glycol, dimethyl 
formamide/propylene glycol, and glycerol.20 Our results suggest that all of our 
CPAs act similarly to those previously studied, with the exception of 
polyampholyte, which appears to cause no leakage, either before, during, or after 
cryopreservation. We additionally examined an observed phenotype for the 
presence of lipid bodies, membrane permeability, phagocytes, and polymer 
vesicles and found none of those to be the cause of the morphology. While we 
were unable to determine a definitive cause, we were able to rule out several of 
the most obvious reasons for the observed phenotype. Freeze-fracturing and 
atomic force microscopy may be able to help to identify the cause of the 
observed phenotype.  
 
5.6 Materials and Methods 
5.6.1 Reagents 
All non-specified cell related chemicals were obtained from Sigma Aldrich Co Ltd, 
(Irvine, UK).   
Polyproline was synthesised as in Section 2.6.1.1. 
Polyampholyte was synthesised as in Section 2.6.1.2. 
5.6.1.1 Synthesis of fluorescently labelled polyampholytes   
Performed and written by Dr Christopher Stubbs. As a representative 
example, poly(methyl vinyl ether-alt-maleic anhydride), average Mn ~80,000 Da, 
(300 mg) was dissolved in tetrahydrofuran (50 mL) and heated to 50 °C with 
stirring. After dissolution, N-[4-(aminomethyl)benzyl]rhodamine 6G-amide 
bis(trifluoroacetate) (3 mg) and triethylamine (10 mg) were added and left for 20 
minutes before dimethylamino ethanol (2 g) was added in excess, forming a pink 
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waxy solid, which was allowed to stir for 30 minutes. 50 mL water was added, 
and the reaction left to stir overnight followed by purification in dialysis tubing 
(Spectrapor, 12 – 14 kDa MWCO) for 48 hours with 7 water changes. The 
resulting solution was freeze-dried to evolve a white solid.  
5.6.2 Cell Culture 
A549 cells were cultured as per Section 3.6.2 
5.6.3 Membrane Kinetics 
Methods adapted from Su.8 A549 cells were dissociated and incubated with 1 µM 
of calcein-AM (BD Biosciences, Workingham, UK) in completed cell media for 
30 min at 37 °C with frequent mixing. Cells were then centrifuged and rinsed 
twice with media. Cells were plated at a density of 4·105 in 100 µL in 96-U-well 
suspension plates (Sarstedt Ltd., Leicester, UK) and centrifuged at 500 rpm for 
2 min.  Experimental solutions of 50 µL were added at 4x and 50 µL of 0.32% 
trypan blue was added for a final concentration of 0.08%. Plate was placed in the 
BioTek plate reader at 37 °C and read every 10 min at 494/517 nm for 4 h.  Plate 
was then imaged with the CKX41 microscope with LED illumination, the XC30 
camera, and processed using the CellSens software. 
5.6.4 Osmolyte Incubation Calcein/Ethidium Homodimer-1 Uptake  
A549 cells were seeded at 4·106 cells per well in 500 µL of cell culture medium in 
24-well plates. Cells were incubated with osmolyte solutions for 24 h in a 
humidified atmosphere of 5% CO2 and 95% air at 37 °C. Following the 24 h 
incubation, cells were incubated with 0.3 µM calcein-AM (ThermoFisher) and 10 
µM ethidium homodimer-1 (ThermoFisher) in PBS.  Cells were incubated at room 
temperature for 45 min. Solution was removed and wells were washed twice with 
PBS.  Plate was read using the BioTex plate reader at 494/517 nm and 528/617 
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nm.  Plate was then imaged with the CKX41 microscope with pE-300-W LED 
illumination, the XC30 camera, and processed using the CellSens software. 
5.6.5 Post-Freeze Membrane Calcein/Ethidium Homodimer-1 Uptake 
A549 cells were cryopreserved as monolayers as previously indicated in Section 
4.6.8. Following the 24 h post-thaw incubation, cells were incubated with 0.3 µM 
calcein and 10 µM ethidium homodimer-1 in PBS.  Cells were incubated at room 
temperature for 45 min.  Solution was removed and wells were washed twice with 
PBS.  Plate was read using the BioTex plate reader at 494/517 nm and 528/617 
nm.  Plate was then imaged with the CKX41 microscope with pE-300-W LED 
illumination, the XC30 camera, and processed using the CellSens software. 
5.6.6 Nile Red Staining  
5.6.6.1 Bright-field Nile Red Staining 
A549 cells were seeded at 4·104 cells per well in 200 µL of cell culture medium 
with indicated concentrations of polyampholyte in 96-well plates. Cells were 
incubated with polymer for 10 min and exchanged against completed cell media 
or incubated with polymer for 24 h in a humidified atmosphere of 5% CO2 and 
95% air at 37 °C. Following the incubation period, 200 nM nile red (Sigma-
Aldrich) in PBS was added to the wells. Plate was incubated for 10 min at room 
temperature. Nile red solution was removed and wells were washed with PBS.  
Cells were then imaged using a CKX41 microscope with pE-300-W LED 
illumination (CoolLED, Andover, UK), the XC30 camera, and processed using the 
CellSens software. 
5.6.6.2 Confocal Nile Red Staining   
A549 cells were seeded at 5·105 cells per well in 1 mL of cell culture medium with 
indicated concentrations of polyampholyte in 12-well plates (ThermoFisher) with 
12 mm coverslips (Appleton Woods). Cells were incubated with polymer for 10 
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min and exchanged against completed cell media or incubated with polymer for 
24 h in a humidified atmosphere of 5% CO2 and 95% air at 37 °C. Following the 
incubation period, 200 nM nile red in phosphate buffered saline PBS was added. 
Plate was incubated for 10 min at room temperature. Nile red solution was 
removed and wells were washed with PBS. Cells were subsequently stained with 
NucBlue™ Live ReadyProbes™ nuclear stain reagent (ThermoFisher), fixed with 
4% paraformaldehyde and imaged. Confocal imaging capture performed with 
assistance from Ruben Tomás and imaging processing was performed 
solely by Ruben Tomás. Confocal imaging was completed using a Zeiss LSM 
710 inverted microscope with 63x oil immersion objective lenses, equipped with 
three photomultiplier detectors (GaAsP, multialkali and BiG.2) and multichannel 
spectral imaging with an ultra-sensitive GASP detector. The UV and VIS Laser 
Modules allowed selection of six lasers with wavelengths of 633, 594, 561, 543, 
514, 488, 458, 405 and 355 nm. Zeiss ZEN (blue edition) 2.3 lite was utilised for 
image collection and processing.  
5.6.7 Polyampholyte Incubation Calcein/Ethidium Homodimer-1 
Uptake 
A549 cells seeded at 4·106 cells per well in 500 µL of cell culture medium in 
24-well plates. Cells were incubated with polymer for 10 min and exchanged 
against completed cell media or incubated with polymer for 24 h in a humidified 
atmosphere of 5% CO2 and 95% air at 37 °C. Following the 24 h incubation, cells 
were incubated with 0.3 µM calcein (ThermoFisher) and 10 µM ethidium 
homodimer-1 (ThermoFisher) in PBS. Cells were incubated at room temperature 
for 45 min.  Solution was removed and wells were washed twice with PBS. Plate 
was read using the BioTex plate reader at 494/517 nm and 528/617 nm. Plate 
was then imaged with the CKX41 microscope with pE-300-W LED illumination, 
the XC30 camera, and processed using the CellSens software. 
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5.6.8 Neutral Red Staining   
A549 cells were seeded at 4·104 cells per well in 200 µL of cell culture medium 
with indicated concentrations of polyampholyte in 96-well plates. Cells were 
incubated with polymer for 10 min and exchanged against completed cell media 
or incubated with polymer for 24 h in a humidified atmosphere of 5% CO2 and 
95% air at 37 °C. Following the incubation period, 100 µL neutral red was added 
and plate was incubated for 2 h at 37 °C.  Plate was washed with PBS and then 
150 µL of destain solution, consisting of 50% ethanol (VWR International, 
Leicestershire, UK), 49% deionised water, 1% glacial acetic acid (Sigma-Aldrich), 
was added for 10 min with shaking. Cells were then imaged using a CKX41 
microscope, the XC30 camera, and processed using the CellSens software. 
5.6.9 Fluorescently Labelled Polyampholytes 
5.6.9.1 Bright-field Fluorescent Labelled Polyampholyte Uptake 
A549 cells were seeded at 4·104 cells per well in 200 µL of cell culture medium 
with indicated concentrations of rhodamine-6G tagged polyampholyte in 96-well 
plates. Cells were incubated with polymer for 10 min and exchanged against 
completed cell media or incubated with polymer for 24 h in a humidified 
atmosphere of 5% CO2 and 95% air at 37 °C. Following the incubation period, 
polyampholyte solution was removed and wells were washed with PBS.  Cells 
were then imaged using a CKX41 microscope with pE-300-W LED illumination 
(CoolLED, Andover, UK), the XC30 camera, and processed using the CellSens 
software. 
5.6.9.2 Confocal Fluorescent Labelled Polyampholyte Uptake   
A549 cells were seeded at 5·105 cells per well in 1 mL of cell culture medium with 
indicated concentrations of rhodamine-6G tagged polyampholyte in 12-well plates 
with 12 mm coverslips. Cells were incubated with tagged polymer for 10 min and 
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exchanged against completed cell media or incubated with polymer for 24 h in a 
humidified atmosphere of 5% CO2 and 95% air at 37 °C. Following the incubation 
period, cells were stained with NucBlue™ Live ReadyProbes™ nuclear stain 
reagent, fixed with 4% paraformaldehyde and imaged as detailed previously in 
Section 5.6.6.1. 
5.6.10 Statistical Analysis 
Data were analysed with a one-way analysis of variance (ANOVA) on ranks 
followed by comparison of experimental groups with the appropriate control group 
(Holm–Sidak method) followed by Tukey’s post hoc test. Excel 2013 (Microsoft, 
Redmond, WA) and R were used for the analyses and graphs. Data sets are 
presented as mean ± (SEM).   
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Figure 5.24. Nile red treatment of cells incubated with polyampholyte. Scale bar 
= 50 µm.  
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Figure 5.25. Nile red treatment of cells incubated with 10 mg·mL-1 polyampholyte 
for 24 h.  Scale bar = 50 µm.  
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Figure 5.26. Confocal imaging of nile red treatment of cells incubated with 
polyampholyte.  Scale bar = 10 µm. 
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Figure 5.27. Membrane permeability of polyampholyte incubated cells.  Images 
of calcein-AM/EthD-1 treated cells.  Scale bar = 50 µm.  
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Figure 5.28. Neutral red staining of polyampholyte incubated cells.  Images of 
treated cells.  Scale bar = 50 µm.  
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The overall aim of this thesis was to develop a simple and effective method to 
cryopreserve adherent mammalian cells. The ability to cryopreserve monolayered 
cells would facilitate drug development by providing phenotypically identical cells 
for assays as well as provide insights into the cryopreservation of more complex 
biological material such as spheroids or tissues but established methods have 
failed to achieve this. In this thesis we investigated three different 
macromolecular cryoprotectants and three different small molecule osmolytes. 
Poly(vinyl alcohol), (PVA) was chosen due to its high ice recrystallisation 
inhibition (IRI) activity and its success in cryopreserving cells in suspension. 
Polyproline was chosen as a possible AF(G)P mimic due to its amphiphilicity and 
tertiary structure. Polyampholytes bearing mixed positive and negative charges 
have been studied for cryopreservation and our polyampholyte of interest was 
chosen due to its scalable synthesis of a cheap precursor and precise 1:1 ratio of 
cationic/anionic groups. Alanine was selected due to the heavy alanine rich 
regions of AF(G)Ps, betaine was selected for its osmoprotecting properties, and 
proline was chosen due to its previous use as a cryoprotectant and its 
implications as an osmoprotectant.  
The first aim of this thesis was to examine the cryoprotective agents’ physical 
interactions with ice. This allowed an investigation into how the compounds may 
be affording their protection. Initially, we investigated the IRI activity of our 
macromolecular compounds and small molecule osmolytes. In this work we 
confirmed that PVA is a potent IRI polymer, regardless of solvent (PBS or cell 
media) while polyproline and polyampholyte showed significantly less IRI activity 
in comparison. The osmolytes themselves showed little IRI activity yet did not 
inhibit PVA’s high IRI activity. We additionally demonstrated that all our solutions 
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containing macromolecular cryoprotectants, osmolytes, DMSO, or combinations 
of, freeze (i.e. ice forms, rather than vitrification) and the polymers and/or 
osmolytes did not affect DMSO’s phase transitions (Chapter 2).  
The next aim of this thesis was to evaluate if any of our macromolecular 
cryoprotectants or small molecule osmolytes were inherently toxic to our cells 
and if the osmolytes affected the proliferation rate of the cells. We found that 
none of our macromolecular cryoprotectants were toxic to our cells for a 10 min 
exposure (relevant for cryopreservation) and none of our osmolytes were toxic to 
the cells after 24 hours. Proline was the only osmolyte to affect the growth of our 
cells, significantly down-regulating growth during incubation; however, we saw no 
differences in our preliminary cell cycle analysis (Chapter 3). 
The next aim of this thesis was to evaluate if our small molecule osmolytes 
and/or macromolecular cryoprotectants were able to successfully cryopreserve 
mammalian cells and how viable the cells were post-freeze. We found that the 
combination of betaine or proline with PVA resulted in a significantly higher post-
thaw recovery of A549 monolayers compared to 10% DMSO, however, the 
combination of proline with PVA was not successful for the cryopreservation of 
suspension human endometrial cells, MC-3T3 monolayers, or Neuro-2a 
monolayers. All A549 monolayers frozen with osmolytes and PVA grew better 
than cells frozen with only 10% DMSO. Polyproline, in combination with proline 
incubation, resulted in significantly higher recoveries for A549 cells frozen as 
monolayers compared to cells frozen with 10% DMSO. The combination of 
polyproline and proline also resulted in higher post-thaw growth rates. This is an 
interesting finding as polyproline showed weak IRI, yet provided cell recovery 
equivalent to PVA, which is highly IRI active. It would be interesting to explore if 
there is a minimal amount of IRI that is sufficient to provide protection to cell 
monolayers. The polyampholyte resulted in significantly higher post-thaw 
recoveries at all concentrations tested and the inclusion of proline did not further 
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increase the recoveries seen for A549 monolayers. This is also an interesting 
finding that may be worth exploring, as proline and the polyampholyte may have 
overlapping protection mechanisms or may be protecting cells through two wholly 
different pathways. The polyampholyte also protected Neuro-2a and MC-3T3 
cells, as well allowed for the lowering of DMSO down to 2% with recoveries 
comparable to 10% DMSO alone. Cells frozen with 10 mg·mL-1 polyampholyte P2 
also grew better post-freeze compared to cells frozen with only 10% DMSO 
(Chapter 4).  
The last aim of this thesis was to evaluate the membrane permeability at various 
steps throughout our freezing processes to determine if our macromolecular and 
small molecule compounds had any effect on the permeability of the cells. We 
found that our CPA compounds did not impact the membrane permeability of 
cells at room temperature. Similarly, we found that our osmolyte incubation also 
did not impact permeability under physiological conditions. For our post-freeze 
analysis, we found that cells frozen with osmolyte pre-treatment along with PVA 
did not show significantly different permeability from cells frozen with just DMSO, 
even though the post-freeze cell recoveries for these conditions were significantly 
different. The post-freeze permeability for cells frozen with polyampholyte did 
show significant differences, correlating with their post-freeze cell recoveries. 
This is a significant finding for future study, as it could imply that the 
calcein/EthD-1 assay, a commonly used assay, is not sensitive enough to 
capture differences for small significant differences. However, it could be that the 
cells are viable post-thaw but are damaged through the trypsinisation process (a 
necessary step to assess cell recovery), introducing a new mode of 
analysis/damage for cryopreserved monolayers (Chapter 5).  
Our overall significant results have been compiled in Table C.1. Throughout this 
work we have developed three different strategies for the cryopreservation of 
adherent mammalian cells. We were unable to pinpoint a unifying mechanism for 
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these compounds, paving the way for future work to investigate how these 
compounds may be affording their protection. Ultimately, the high recovery, along 
with the relative ease of synthesis and use, seen with polyampholyte could 




























Rate      
(Day 6) 
  (µm2) (%)     (%)   
Target ↓ ↑ − − ↑ - 
Unfrozen 
Control 4519.59 100.0 0.69 0.39 − 0.70 
10% DMSO − 31.9 − − 16.9 0.58 
5 mg·mL-1 
PVA  365.87 88.3 − − 23.7 0.58 
100 mM 
Alanine 2326.05 93.5 0.66 0.43 24.1 0.74 
Alanine + PVA 117.9 − − − 38.7 0.64 
100 mM 
Betaine 3641.71 95.4 0.74 0.43 30.0 0.64 
Betaine + PVA 354.71 − − − 56.7 0.67 
200 mM 
Proline 2657.67 82.1 0.51 0.49 45.7 0.61 
Proline + PVA 344.34 − − − 62.7 0.64 
5 mg·mL-1 
Polyproline 1323.41 67.5 − − 20.3 0.63 
Proline + 
Polyproline − − − − 47.6 0.68 
10 mg·mL-1 P2 




Table C.1. Compiled significant results. Significantly higher than control, 
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